ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-190236,Signaling by FGFR,4/51,87/10899,7.11094738471673e-4,0.08792634307294485,0.08166533412347819,SPRY2/SPRED2/FGFR3/NCBP2,4
R-HSA-5683057,MAPK family signaling cascades,7/51,325/10899,7.3637747070268e-4,0.08792634307294485,0.08166533412347819,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/PTPRA/ETV4,7
R-HSA-74749,Signal attenuation,2/51,10/10899,9.431907659000849e-4,0.08792634307294485,0.08166533412347819,IRS2/GRB10,2
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",4/51,106/10899,0.0014867840354765099,0.08792634307294485,0.08166533412347819,IRS2/IL1RAP/PDGFA/FGFR3,4
R-HSA-5673001,RAF/MAP kinase cascade,6/51,280/10899,0.0018587473163114445,0.08792634307294485,0.08166533412347819,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/PTPRA,6
R-HSA-199418,Negative regulation of the PI3K/AKT network,4/51,113/10899,0.0018813454171771854,0.08792634307294485,0.08166533412347819,IRS2/IL1RAP/PDGFA/FGFR3,4
R-HSA-74751,Insulin receptor signalling cascade,3/51,54/10899,0.002023927132587486,0.08792634307294485,0.08166533412347819,IRS2/GRB10/FGFR3,3
R-HSA-5684996,MAPK1/MAPK3 signaling,6/51,286/10899,0.002068855131128114,0.08792634307294485,0.08166533412347819,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/PTPRA,6
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,7/51,433/10899,0.0037965000838157356,0.14342333649970557,0.1332105292566925,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/NCBP2/ALK,7
R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,2/51,24/10899,0.0055478410624658836,0.1684425430860452,0.15644818243285932,ACSL3/ELOVL2,2
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,3/51,78/10899,0.005738006101410845,0.1684425430860452,0.15644818243285932,IRS2/PDGFA/FGFR3,3
R-HSA-74752,Signaling by Insulin receptor,3/51,79/10899,0.005945030932448654,0.1684425430860452,0.15644818243285932,IRS2/GRB10/FGFR3,3
R-HSA-5654732,Negative regulation of FGFR3 signaling,2/51,29/10899,0.00804026483681648,0.2102838495782772,0.19531007700768782,SPRY2/FGFR3,2
R-HSA-182971,EGFR downregulation,2/51,31/10899,0.009154021216195794,0.22231194382189784,0.20648168156832622,SPRY1/SPRY2,2
R-HSA-5694530,Cargo concentration in the ER,2/51,33/10899,0.010332589576594027,0.2342053637361313,0.21752820161250586,SEC24B/CNIH3,2
R-HSA-2219528,PI3K/AKT Signaling in Cancer,3/51,104/10899,0.012617726003065434,0.26752555801714095,0.2484757504803167,IRS2/PDGFA/FGFR3,3
R-HSA-75105,Fatty acyl-CoA biosynthesis,2/51,38/10899,0.013554346240321775,0.26752555801714095,0.2484757504803167,ACSL3/ELOVL2,2
R-HSA-5654741,Signaling by FGFR3,2/51,40/10899,0.014949957653899053,0.26752555801714095,0.2484757504803167,SPRY2/FGFR3,2
R-HSA-8853659,RET signaling,2/51,40/10899,0.014949957653899053,0.26752555801714095,0.2484757504803167,IRS2/GRB10,2
R-HSA-109704,PI3K Cascade,2/51,44/10899,0.017917842980857156,0.3046033306745716,0.28291331022406035,IRS2/FGFR3,2
R-HSA-112399,IRS-mediated signalling,2/51,48/10899,0.02111347044407881,0.3095779222375461,0.2875336739048415,IRS2/FGFR3,2
R-HSA-177929,Signaling by EGFR,2/51,50/10899,0.02279381946230558,0.3095779222375461,0.2875336739048415,SPRY1/SPRY2,2
R-HSA-5654736,Signaling by FGFR1,2/51,50/10899,0.02279381946230558,0.3095779222375461,0.2875336739048415,SPRY2/SPRED2,2
R-HSA-2428928,IRS-related events triggered by IGF1R,2/51,52/10899,0.024527693838830723,0.3095779222375461,0.2875336739048415,IRS2/FGFR3,2
R-HSA-2428924,IGF1R signaling cascade,2/51,53/10899,0.02541435734633293,0.3095779222375461,0.2875336739048415,IRS2/FGFR3,2
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),2/51,54/10899,0.026313989277630817,0.3095779222375461,0.2875336739048415,IRS2/FGFR3,2
R-HSA-73887,Death Receptor Signalling,3/51,146/10899,0.030719861946686897,0.3095779222375461,0.2875336739048415,TRIO/RBCK1/VAV3,3
R-HSA-193648,NRAGE signals death through JNK,2/51,59/10899,0.031001960155652063,0.3095779222375461,0.2875336739048415,TRIO/VAV3,2
R-HSA-3000171,Non-integrin membrane-ECM interactions,2/51,59/10899,0.031001960155652063,0.3095779222375461,0.2875336739048415,LAMA2/PDGFA,2
R-HSA-8980692,RHOA GTPase cycle,3/51,147/10899,0.031258685461024734,0.3095779222375461,0.2875336739048415,TRIO/VAV3/DLC1,3
R-HSA-1226099,Signaling by FGFR in disease,2/51,63/10899,0.034972180589933705,0.3095779222375461,0.2875336739048415,FGFR3/NCBP2,2
R-HSA-9013148,CDC42 GTPase cycle,3/51,155/10899,0.03574857202179733,0.3095779222375461,0.2875336739048415,TRIO/VAV3/DLC1,3
R-HSA-1257604,PIP3 activates AKT signaling,4/51,267/10899,0.03581585830794788,0.3095779222375461,0.2875336739048415,IRS2/IL1RAP/PDGFA/FGFR3,4
R-HSA-9614085,FOXO-mediated transcription,2/51,65/10899,0.037027724886034806,0.3095779222375461,0.2875336739048415,GADD45A/PPARGC1A,2
R-HSA-204005,COPII-mediated vesicle transport,2/51,68/10899,0.040196242855759005,0.3095779222375461,0.2875336739048415,SEC24B/CNIH3,2
R-HSA-5654738,Signaling by FGFR2,2/51,73/10899,0.04569609729830048,0.3095779222375461,0.2875336739048415,SPRY2/NCBP2,2
R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,1/51,10/10899,0.04583868576188166,0.3095779222375461,0.2875336739048415,NCBP2,1
R-HSA-2151209,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,1/51,10/10899,0.04583868576188166,0.3095779222375461,0.2875336739048415,PPARGC1A,1
R-HSA-9013408,RHOG GTPase cycle,2/51,74/10899,0.04682782948594952,0.3095779222375461,0.2875336739048415,TRIO/VAV3,2
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",2/51,76/10899,0.04912210730586749,0.3095779222375461,0.2875336739048415,TRIO/VAV3,2
R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,1/51,11/10899,0.05030762019352275,0.3095779222375461,0.2875336739048415,EPAS1,1
R-HSA-2586552,Signaling by Leptin,1/51,11/10899,0.05030762019352275,0.3095779222375461,0.2875336739048415,IRS2,1
R-HSA-400451,Free fatty acids regulate insulin secretion,1/51,11/10899,0.05030762019352275,0.3095779222375461,0.2875336739048415,ACSL3,1
R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,1/51,11/10899,0.05030762019352275,0.3095779222375461,0.2875336739048415,NCBP2,1
R-HSA-9664873,Pexophagy,1/51,11/10899,0.05030762019352275,0.3095779222375461,0.2875336739048415,EPAS1,1
R-HSA-1474244,Extracellular matrix organization,4/51,300/10899,0.051204519416975416,0.3095779222375461,0.2875336739048415,LAMA2/ADAMTS9/PDGFA/ADAM19,4
R-HSA-416482,G alpha (12/13) signalling events,2/51,80/10899,0.053830669366470664,0.3095779222375461,0.2875336739048415,TRIO/VAV3,2
R-HSA-1839130,Signaling by activated point mutants of FGFR3,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,FGFR3,1
R-HSA-2033514,FGFR3 mutant receptor activation,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,FGFR3,1
R-HSA-629594,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,CHRNA9,1
R-HSA-71064,Lysine catabolism,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,PIPOX,1
R-HSA-73621,Pyrimidine catabolism,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,NT5E,1
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,IRS2,1
R-HSA-9700645,ALK mutants bind TKIs,1/51,12/10899,0.05475603233258719,0.3095779222375461,0.2875336739048415,ALK,1
R-HSA-9013149,RAC1 GTPase cycle,3/51,185/10899,0.05536582302024839,0.3095779222375461,0.2875336739048415,TRIO/VAV3/DLC1,3
R-HSA-9006925,Intracellular signaling by second messengers,4/51,309/10899,0.05594683252085843,0.3095779222375461,0.2875336739048415,IRS2/IL1RAP/PDGFA/FGFR3,4
R-HSA-6802957,Oncogenic MAPK signaling,2/51,84/10899,0.05869317467409199,0.3095779222375461,0.2875336739048415,DUSP6/SPRED2,2
R-HSA-190239,FGFR3 ligand binding and activation,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,FGFR3,1
R-HSA-190372,FGFR3c ligand binding and activation,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,FGFR3,1
R-HSA-202670,ERKs are inactivated,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,DUSP6,1
R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,ELOVL2,1
R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,ELOVL2,1
R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,FGFR3,1
R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,SPRED2,1
R-HSA-9637687,Suppression of phagosomal maturation,1/51,13/10899,0.05918401454541322,0.3095779222375461,0.2875336739048415,RAB5A,1
R-HSA-418885,DCC mediated attractive signaling,1/51,14/10899,0.06359165879106687,0.3185126252611382,0.29583215968526777,TRIO,1
R-HSA-9027284,Erythropoietin activates RAS,1/51,14/10899,0.06359165879106687,0.3185126252611382,0.29583215968526777,IRS2,1
R-HSA-9013404,RAC2 GTPase cycle,2/51,88/10899,0.06370252505222765,0.3185126252611382,0.29583215968526777,TRIO/VAV3,2
R-HSA-181431,Acetylcholine binding and downstream events,1/51,15/10899,0.06797905662309744,0.3255335105894807,0.3023531058106632,CHRNA9,1
R-HSA-622327,Postsynaptic nicotinic acetylcholine receptors,1/51,15/10899,0.06797905662309744,0.3255335105894807,0.3023531058106632,CHRNA9,1
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,1/51,15/10899,0.06797905662309744,0.3255335105894807,0.3023531058106632,GRB10,1
R-HSA-1295596,Spry regulation of FGF signaling,1/51,16/10899,0.07234629919129132,0.34163530173665346,0.3173083297863655,SPRY2,1
R-HSA-193704,p75 NTR receptor-mediated signalling,2/51,97/10899,0.07547506130903343,0.3443378947895136,0.31981847813267517,TRIO/VAV3,2
R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1/51,17/10899,0.07669347724341347,0.3443378947895136,0.31981847813267517,TNPO1,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/51,17/10899,0.07669347724341347,0.3443378947895136,0.31981847813267517,GADD45A,1
R-HSA-5635838,Activation of SMO,1/51,18/10899,0.08102068112694438,0.3443378947895136,0.31981847813267517,GAS1,1
R-HSA-5654704,SHC-mediated cascade:FGFR3,1/51,18/10899,0.08102068112694438,0.3443378947895136,0.31981847813267517,FGFR3,1
R-HSA-5654710,PI-3K cascade:FGFR3,1/51,18/10899,0.08102068112694438,0.3443378947895136,0.31981847813267517,FGFR3,1
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,1/51,18/10899,0.08102068112694438,0.3443378947895136,0.31981847813267517,GADD45A,1
R-HSA-74259,Purine catabolism,1/51,18/10899,0.08102068112694438,0.3443378947895136,0.31981847813267517,NT5E,1
R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/51,19/10899,0.0853280007908106,0.35379902766921467,0.3286059080519022,NCBP2,1
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,1/51,19/10899,0.0853280007908106,0.35379902766921467,0.3286059080519022,ALK,1
R-HSA-2022870,Chondroitin sulfate biosynthesis,1/51,20/10899,0.08961552578710363,0.3542939391583167,0.32906557816561927,CHST7,1
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/51,20/10899,0.08961552578710363,0.3542939391583167,0.32906557816561927,IL1RAP,1
R-HSA-5654706,FRS-mediated FGFR3 signaling,1/51,20/10899,0.08961552578710363,0.3542939391583167,0.32906557816561927,FGFR3,1
R-HSA-77595,Processing of Intronless Pre-mRNAs,1/51,20/10899,0.08961552578710363,0.3542939391583167,0.32906557816561927,NCBP2,1
R-HSA-70895,Branched-chain amino acid catabolism,1/51,21/10899,0.09388334527279707,0.3662566119449103,0.3401764197630746,BCAT1,1
R-HSA-198753,ERK/MAPK targets,1/51,22/10899,0.09813154801145174,0.3662566119449103,0.3401764197630746,DUSP6,1
R-HSA-5655332,Signaling by FGFR3 in disease,1/51,22/10899,0.09813154801145174,0.3662566119449103,0.3401764197630746,FGFR3,1
R-HSA-71403,Citric acid cycle (TCA cycle),1/51,22/10899,0.09813154801145174,0.3662566119449103,0.3401764197630746,IDH3B,1
R-HSA-187037,Signaling by NTRK1 (TRKA),2/51,115/10899,0.10085151032116375,0.3662566119449103,0.3401764197630746,DUSP6/IRS2,2
R-HSA-112409,RAF-independent MAPK1/3 activation,1/51,23/10899,0.10236022237491749,0.3662566119449103,0.3401764197630746,DUSP6,1
R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/51,23/10899,0.10236022237491749,0.3662566119449103,0.3401764197630746,NCBP2,1
R-HSA-9637690,Response of Mtb to phagocytosis,1/51,23/10899,0.10236022237491749,0.3662566119449103,0.3401764197630746,RAB5A,1
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/51,24/10899,0.10656945634502402,0.3662566119449103,0.3401764197630746,EPAS1,1
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,1/51,24/10899,0.10656945634502402,0.3662566119449103,0.3401764197630746,SATB2,1
R-HSA-9748787,Azathioprine ADME,1/51,24/10899,0.10656945634502402,0.3662566119449103,0.3401764197630746,VAV3,1
R-HSA-982772,Growth hormone receptor signaling,1/51,24/10899,0.10656945634502402,0.3662566119449103,0.3401764197630746,IRS2,1
R-HSA-8878166,Transcriptional regulation by RUNX2,2/51,121/10899,0.10977875207311978,0.3662566119449103,0.3401764197630746,SATB2/PPARGC1A,2
R-HSA-5654708,Downstream signaling of activated FGFR3,1/51,25/10899,0.11075933751526834,0.3662566119449103,0.3401764197630746,FGFR3,1
R-HSA-9006335,Signaling by Erythropoietin,1/51,25/10899,0.11075933751526834,0.3662566119449103,0.3401764197630746,IRS2,1
R-HSA-1630316,Glycosaminoglycan metabolism,2/51,124/10899,0.11431955912536614,0.3662566119449103,0.3401764197630746,CHST2/CHST7,2
R-HSA-6803529,FGFR2 alternative splicing,1/51,26/10899,0.11492995309249099,0.3662566119449103,0.3401764197630746,NCBP2,1
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,1/51,26/10899,0.11492995309249099,0.3662566119449103,0.3401764197630746,NT5E,1
R-HSA-9664424,Cell recruitment (pro-inflammatory response),1/51,26/10899,0.11492995309249099,0.3662566119449103,0.3401764197630746,NT5E,1
R-HSA-201556,Signaling by ALK,1/51,27/10899,0.11908138989855022,0.3662566119449103,0.3401764197630746,ALK,1
R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,1/51,27/10899,0.11908138989855022,0.3662566119449103,0.3401764197630746,TNPO1,1
R-HSA-9635486,Infection with Mycobacterium tuberculosis,1/51,27/10899,0.11908138989855022,0.3662566119449103,0.3401764197630746,RAB5A,1
R-HSA-2022854,Keratan sulfate biosynthesis,1/51,28/10899,0.12321373437198413,0.3662566119449103,0.3401764197630746,CHST2,1
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/51,28/10899,0.12321373437198413,0.3662566119449103,0.3401764197630746,LAMA2,1
R-HSA-186763,Downstream signal transduction,1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,PDGFA,1
R-HSA-5218920,VEGFR2 mediated vascular permeability,1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,VAV3,1
R-HSA-72086,mRNA Capping,1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,NCBP2,1
R-HSA-75067,Processing of Capped Intronless Pre-mRNA,1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,NCBP2,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,PPARGC1A,1
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",1/51,29/10899,0.1273270725696689,0.3662566119449103,0.3401764197630746,SEC24B,1
R-HSA-166520,Signaling by NTRKs,2/51,134/10899,0.1297935927207422,0.3662566119449103,0.3401764197630746,DUSP6/IRS2,2
R-HSA-2424491,DAP12 signaling,1/51,30/10899,0.13142149016846782,0.3662566119449103,0.3401764197630746,VAV3,1
R-HSA-3000157,Laminin interactions,1/51,30/10899,0.13142149016846782,0.3662566119449103,0.3401764197630746,LAMA2,1
R-HSA-525793,Myogenesis,1/51,30/10899,0.13142149016846782,0.3662566119449103,0.3401764197630746,CDH4,1
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/51,30/10899,0.13142149016846782,0.3662566119449103,0.3401764197630746,RBCK1,1
R-HSA-8874081,MET activates PTK2 signaling,1/51,30/10899,0.13142149016846782,0.3662566119449103,0.3401764197630746,LAMA2,1
R-HSA-196807,Nicotinate metabolism,1/51,31/10899,0.13549707246687703,0.36707747339339014,0.34093882977714257,NT5E,1
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,1/51,31/10899,0.13549707246687703,0.36707747339339014,0.34093882977714257,DUSP6,1
R-HSA-5654733,Negative regulation of FGFR4 signaling,1/51,31/10899,0.13549707246687703,0.36707747339339014,0.34093882977714257,SPRY2,1
R-HSA-2871796,FCERI mediated MAPK activation,1/51,32/10899,0.1395539043866587,0.36707747339339014,0.34093882977714257,VAV3,1
R-HSA-8941326,RUNX2 regulates bone development,1/51,32/10899,0.1395539043866587,0.36707747339339014,0.34093882977714257,SATB2,1
R-HSA-113418,Formation of the Early Elongation Complex,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,NCBP2,1
R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,NCBP2,1
R-HSA-1839126,FGFR2 mutant receptor activation,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,NCBP2,1
R-HSA-2871809,FCERI mediated Ca+2 mobilization,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,VAV3,1
R-HSA-418990,Adherens junctions interactions,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,CDH4,1
R-HSA-5654726,Negative regulation of FGFR1 signaling,1/51,33/10899,0.1435920704744732,0.36707747339339014,0.34093882977714257,SPRY2,1
R-HSA-159227,Transport of the SLBP independent Mature mRNA,1/51,34/10899,0.14761165490349992,0.3690291372587498,0.34275152067376147,NCBP2,1
R-HSA-1638074,Keratan sulfate/keratin metabolism,1/51,34/10899,0.14761165490349992,0.3690291372587498,0.34275152067376147,CHST2,1
R-HSA-5654727,Negative regulation of FGFR2 signaling,1/51,34/10899,0.14761165490349992,0.3690291372587498,0.34275152067376147,SPRY2,1
R-HSA-114604,GPVI-mediated activation cascade,1/51,35/10899,0.15161274147505255,0.37353863841679613,0.34693991184222556,VAV3,1
R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,1/51,35/10899,0.15161274147505255,0.37353863841679613,0.34693991184222556,NCBP2,1
R-HSA-1266695,Interleukin-7 signaling,1/51,36/10899,0.15559541362019036,0.377874575934748,0.3509670983914069,IRS2,1
R-HSA-8956319,Nucleotide catabolism,1/51,36/10899,0.15559541362019036,0.377874575934748,0.3509670983914069,NT5E,1
R-HSA-5083635,Defective B3GALTL causes PpS,1/51,37/10899,0.15955975440131576,0.3847540177053004,0.3573566727913007,ADAMTS9,1
R-HSA-199977,ER to Golgi Anterograde Transport,2/51,154/10899,0.16205132932787225,0.3860554709353018,0.35856545288108527,SEC24B/CNIH3,2
R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,1/51,38/10899,0.16350584651377487,0.3860554709353018,0.35856545288108527,ADAMTS9,1
R-HSA-9607240,FLT3 Signaling,1/51,38/10899,0.16350584651377487,0.3860554709353018,0.35856545288108527,GRB10,1
R-HSA-5357905,Regulation of TNFR1 signaling,1/51,40/10899,0.17134361368830198,0.3937231114058222,0.3656871003769247,RBCK1,1
R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,1/51,41/10899,0.17523545232002657,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-5654743,Signaling by FGFR4,1/51,41/10899,0.17523545232002657,0.3937231114058222,0.3656871003769247,SPRY2,1
R-HSA-8875878,MET promotes cell motility,1/51,41/10899,0.17523545232002657,0.3937231114058222,0.3656871003769247,LAMA2,1
R-HSA-9658195,Leishmania infection,2/51,164/10899,0.17869535405858405,0.3937231114058222,0.3656871003769247,NT5E/VAV3,2
R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,1/51,42/10899,0.17910936942554134,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-375280,Amine ligand-binding receptors,1/51,42/10899,0.17910936942554134,0.3937231114058222,0.3656871003769247,HRH1,1
R-HSA-1433557,Signaling by SCF-KIT,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,GRB10,1
R-HSA-167169,HIV Transcription Elongation,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-5655253,Signaling by FGFR2 in disease,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,NCBP2,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,DUSP6,1
R-HSA-6782315,tRNA modification in the nucleus and cytosol,1/51,43/10899,0.18296544588858799,0.3937231114058222,0.3656871003769247,QTRT1,1
R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,1/51,45/10899,0.19062439863564817,0.402560841839257,0.37389551873615207,NCBP2,1
R-HSA-2172127,DAP12 interactions,1/51,45/10899,0.19062439863564817,0.402560841839257,0.37389551873615207,VAV3,1
R-HSA-3899300,SUMOylation of transcription cofactors,1/51,45/10899,0.19062439863564817,0.402560841839257,0.37389551873615207,PPARGC1A,1
R-HSA-8854214,TBC/RABGAPs,1/51,46/10899,0.19442743490518766,0.40805757943064075,0.379000847768397,RAB5A,1
R-HSA-9707616,Heme signaling,1/51,47/10899,0.19821295050638887,0.40993521428199187,0.38074478106686555,PPARGC1A,1
R-HSA-8978868,Fatty acid metabolism,2/51,177/10899,0.20071123110740466,0.40993521428199187,0.38074478106686555,ACSL3/ELOVL2,2
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/51,48/10899,0.2019810245502679,0.40993521428199187,0.38074478106686555,GADD45A,1
R-HSA-75893,TNF signaling,1/51,49/10899,0.2057317357978885,0.40993521428199187,0.38074478106686555,RBCK1,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,2/51,182/10899,0.2092688806334696,0.40993521428199187,0.38074478106686555,SATB2/PPARGC1A,2
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/51,50/10899,0.2094651626618801,0.40993521428199187,0.38074478106686555,CHST7,1
R-HSA-3214842,HDMs demethylate histones,1/51,50/10899,0.2094651626618801,0.40993521428199187,0.38074478106686555,ARID5B,1
R-HSA-373752,Netrin-1 signaling,1/51,50/10899,0.2094651626618801,0.40993521428199187,0.38074478106686555,TRIO,1
R-HSA-381038,XBP1(S) activates chaperone genes,1/51,50/10899,0.2094651626618801,0.40993521428199187,0.38074478106686555,EXTL3,1
R-HSA-72165,mRNA Splicing - Minor Pathway,1/51,50/10899,0.2094651626618801,0.40993521428199187,0.38074478106686555,NCBP2,1
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/51,51/10899,0.21318138320794366,0.40993521428199187,0.38074478106686555,VAV3,1
R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,1/51,51/10899,0.21318138320794366,0.40993521428199187,0.38074478106686555,BICD1,1
R-HSA-948021,Transport to the Golgi and subsequent modification,2/51,185/10899,0.21442297436639293,0.40993521428199187,0.38074478106686555,SEC24B/CNIH3,2
R-HSA-381070,IRE1alpha activates chaperones,1/51,52/10899,0.21688047515635767,0.40993521428199187,0.38074478106686555,EXTL3,1
R-HSA-2990846,SUMOylation,2/51,188/10899,0.2195900157125608,0.40993521428199187,0.38074478106686555,SATB2/PPARGC1A,2
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,1/51,53/10899,0.22056251588347353,0.40993521428199187,0.38074478106686555,RAB5A,1
R-HSA-191859,snRNP Assembly,1/51,53/10899,0.22056251588347353,0.40993521428199187,0.38074478106686555,NCBP2,1
R-HSA-194441,Metabolism of non-coding RNA,1/51,53/10899,0.22056251588347353,0.40993521428199187,0.38074478106686555,NCBP2,1
R-HSA-5620924,Intraflagellar transport,1/51,54/10899,0.2242275824232065,0.40993521428199187,0.38074478106686555,TNPO1,1
R-HSA-8848021,Signaling by PTK6,1/51,54/10899,0.2242275824232065,0.40993521428199187,0.38074478106686555,EPAS1,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/51,54/10899,0.2242275824232065,0.40993521428199187,0.38074478106686555,EPAS1,1
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,1/51,54/10899,0.2242275824232065,0.40993521428199187,0.38074478106686555,CHRNA9,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/51,55/10899,0.22787575146851902,0.40993521428199187,0.38074478106686555,SEC24B,1
R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,1/51,55/10899,0.22787575146851902,0.40993521428199187,0.38074478106686555,IDH3B,1
R-HSA-9013409,RHOJ GTPase cycle,1/51,55/10899,0.22787575146851902,0.40993521428199187,0.38074478106686555,TRIO,1
R-HSA-9700206,Signaling by ALK in cancer,1/51,55/10899,0.22787575146851902,0.40993521428199187,0.38074478106686555,ALK,1
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,1/51,55/10899,0.22787575146851902,0.40993521428199187,0.38074478106686555,ALK,1
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,1/51,56/10899,0.23150709937289993,0.41427586203571565,0.38477634244803316,PPARGC1A,1
R-HSA-112382,Formation of RNA Pol II elongation complex ,1/51,58/10899,0.2387196354842689,0.4160723808221449,0.3864449357481223,NCBP2,1
R-HSA-186797,Signaling by PDGF,1/51,58/10899,0.2387196354842689,0.4160723808221449,0.3864449357481223,PDGFA,1
R-HSA-75955,RNA Polymerase II Transcription Elongation,1/51,58/10899,0.2387196354842689,0.4160723808221449,0.3864449357481223,NCBP2,1
R-HSA-72187,mRNA 3'-end processing,1/51,59/10899,0.24230097471407264,0.4160723808221449,0.3864449357481223,NCBP2,1
R-HSA-9013406,RHOQ GTPase cycle,1/51,59/10899,0.24230097471407264,0.4160723808221449,0.3864449357481223,DLC1,1
R-HSA-9664407,Parasite infection,1/51,59/10899,0.24230097471407264,0.4160723808221449,0.3864449357481223,VAV3,1
R-HSA-9664417,Leishmania phagocytosis,1/51,59/10899,0.24230097471407264,0.4160723808221449,0.3864449357481223,VAV3,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/51,59/10899,0.24230097471407264,0.4160723808221449,0.3864449357481223,VAV3,1
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),1/51,61/10899,0.24941417057457804,0.4240040899767827,0.3938118482756496,DUSP6,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/51,61/10899,0.24941417057457804,0.4240040899767827,0.3938118482756496,VAV3,1
R-HSA-4086398,Ca2+ pathway,1/51,62/10899,0.2529461762306674,0.4278691538230195,0.3974016908572936,FZD3,1
R-HSA-375165,NCAM signaling for neurite out-growth,1/51,63/10899,0.25646188583777596,0.429062460433283,0.398510025170232,PTPRA,1
R-HSA-9033241,Peroxisomal protein import,1/51,63/10899,0.25646188583777596,0.429062460433283,0.398510025170232,PIPOX,1
R-HSA-421270,Cell-cell junction organization,1/51,64/10899,0.25996137308604794,0.429062460433283,0.398510025170232,CDH4,1
R-HSA-450294,MAP kinase activation,1/51,64/10899,0.25996137308604794,0.429062460433283,0.398510025170232,DUSP6,1
R-HSA-4608870,Asymmetric localization of PCP proteins,1/51,64/10899,0.25996137308604794,0.429062460433283,0.398510025170232,FZD3,1
R-HSA-8873719,RAB geranylgeranylation,1/51,65/10899,0.263444711339173,0.432711120074004,0.4018988731337499,RAB5A,1
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,1/51,66/10899,0.2669119736358042,0.4362984184431415,0.40523072920415626,EPAS1,1
R-HSA-416476,G alpha (q) signalling events,2/51,216/10899,0.26820920063726383,0.43632118763956795,0.4052518770646143,TRIO/HRH1,2
R-HSA-3906995,Diseases associated with O-glycosylation of proteins,1/51,68/10899,0.27379856089746235,0.43911089955253396,0.40784294076086747,ADAMTS9,1
R-HSA-5658442,Regulation of RAS by GAPs,1/51,68/10899,0.27379856089746235,0.43911089955253396,0.40784294076086747,SPRED2,1
R-HSA-73856,RNA Polymerase II Transcription Termination,1/51,68/10899,0.27379856089746235,0.43911089955253396,0.40784294076086747,NCBP2,1
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/51,69/10899,0.27721803032726844,0.44171936263516676,0.41026566189024777,BAG5,1
R-HSA-167172,Transcription of the HIV genome,1/51,70/10899,0.28062171273292946,0.44171936263516676,0.41026566189024777,NCBP2,1
R-HSA-400253,Circadian Clock,1/51,70/10899,0.28062171273292946,0.44171936263516676,0.41026566189024777,PPARGC1A,1
R-HSA-9013026,RHOB GTPase cycle,1/51,70/10899,0.28062171273292946,0.44171936263516676,0.41026566189024777,DLC1,1
R-HSA-4551638,SUMOylation of chromatin organization proteins,1/51,71/10899,0.28400967954894385,0.4449921246388982,0.4133053789215773,SATB2,1
R-HSA-448424,Interleukin-17 signaling,1/51,72/10899,0.28738200189314433,0.44821046166820677,0.4162945464410589,DUSP6,1
R-HSA-8939902,Regulation of RUNX2 expression and activity,1/51,73/10899,0.2907387505680725,0.45137522919244133,0.4192339590022675,PPARGC1A,1
R-HSA-6807505,RNA polymerase II transcribes snRNA genes,1/51,74/10899,0.29407999606234825,0.45141953083790487,0.4192751060413977,NCBP2,1
R-HSA-9013106,RHOC GTPase cycle,1/51,74/10899,0.29407999606234825,0.45141953083790487,0.4192751060413977,DLC1,1
R-HSA-1234174,Cellular response to hypoxia,1/51,75/10899,0.29740580855203147,0.45141953083790487,0.4192751060413977,EPAS1,1
R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,1/51,75/10899,0.29740580855203147,0.45141953083790487,0.4192751060413977,NCBP2,1
R-HSA-2995410,Nuclear Envelope (NE) Reassembly,1/51,75/10899,0.29740580855203147,0.45141953083790487,0.4192751060413977,TNPO1,1
R-HSA-3000178,ECM proteoglycans,1/51,76/10899,0.30071625790198053,0.4524049897640415,0.420190392969698,LAMA2,1
R-HSA-9659379,Sensory processing of sound,1/51,76/10899,0.30071625790198053,0.4524049897640415,0.420190392969698,CHRNA9,1
R-HSA-422356,Regulation of insulin secretion,1/51,78/10899,0.30729134509420053,0.46026016445827395,0.42748622085907795,ACSL3,1
R-HSA-8951664,Neddylation,2/51,240/10899,0.3099739050956297,0.46108769074928435,0.42825482112936636,EPAS1/FEM1C,2
R-HSA-6806834,Signaling by MET,1/51,79/10899,0.3105561211223121,0.46108769074928435,0.42825482112936636,LAMA2,1
R-HSA-674695,RNA Polymerase II Pre-transcription Events,1/51,81/10899,0.3170404812114018,0.4666396693154832,0.43341145756856025,NCBP2,1
R-HSA-9663891,Selective autophagy,1/51,81/10899,0.3170404812114018,0.4666396693154832,0.43341145756856025,EPAS1,1
R-HSA-1483255,PI Metabolism,1/51,84/10899,0.3266550618224864,0.47462701290446735,0.44083004294532574,RAB5A,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/51,84/10899,0.3266550618224864,0.47462701290446735,0.44083004294532574,PPARGC1A,1
R-HSA-72202,Transport of Mature Transcript to Cytoplasm,1/51,84/10899,0.3266550618224864,0.47462701290446735,0.44083004294532574,NCBP2,1
R-HSA-5632684,Hedgehog 'on' state,1/51,85/10899,0.3298303361495374,0.4772013374078414,0.4432210564159517,GAS1,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/51,86/10899,0.33299092916381245,0.47770850597340186,0.44369211081120913,VAV3,1
R-HSA-6794362,Protein-protein interactions at synapses,1/51,86/10899,0.33299092916381245,0.47770850597340186,0.44369211081120913,IL1RAP,1
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/51,88/10899,0.33926833707699,0.4846690529671286,0.45015701513974793,TNPO1,1
R-HSA-3371556,Cellular response to heat stress,1/51,89/10899,0.34238528415025593,0.4850458192128626,0.45050695282928416,BAG5,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/51,89/10899,0.34238528415025593,0.4850458192128626,0.45050695282928416,ETV4,1
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,1/51,90/10899,0.3454878142620351,0.48602016589277097,0.4514119187858554,RAB5A,1
R-HSA-446728,Cell junction organization,1/51,91/10899,0.34857599276815376,0.48602016589277097,0.4514119187858554,CDH4,1
R-HSA-76002,"Platelet activation, signaling and aggregation",2/51,263/10899,0.349606013746224,0.48602016589277097,0.4514119187858554,PDGFA/VAV3,2
R-HSA-9012999,RHO GTPase cycle,3/51,449/10899,0.35122376223452256,0.48602016589277097,0.4514119187858554,TRIO/VAV3/DLC1,3
R-HSA-2682334,EPH-Ephrin signaling,1/51,92/10899,0.35164988473418135,0.48602016589277097,0.4514119187858554,VAV3,1
R-HSA-4086400,PCP/CE pathway,1/51,92/10899,0.35164988473418135,0.48602016589277097,0.4514119187858554,FZD3,1
R-HSA-381119,Unfolded Protein Response (UPR),1/51,94/10899,0.35775506786453315,0.48871476424230487,0.45391464171111917,EXTL3,1
R-HSA-9013423,RAC3 GTPase cycle,1/51,94/10899,0.35775506786453315,0.48871476424230487,0.45391464171111917,TRIO,1
R-HSA-1592230,Mitochondrial biogenesis,1/51,95/10899,0.3607864877200545,0.48871476424230487,0.45391464171111917,PPARGC1A,1
R-HSA-373080,Class B/2 (Secretin family receptors),1/51,95/10899,0.3607864877200545,0.48871476424230487,0.45391464171111917,FZD3,1
R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),1/51,95/10899,0.3607864877200545,0.48871476424230487,0.45391464171111917,NCBP2,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/51,97/10899,0.3668073035986197,0.49100190245484526,0.4560389186887108,DUSP6,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/51,97/10899,0.3668073035986197,0.49100190245484526,0.4560389186887108,DUSP6,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/51,97/10899,0.3668073035986197,0.49100190245484526,0.4560389186887108,DUSP6,1
R-HSA-15869,Metabolism of nucleotides,1/51,99/10899,0.37277251050877624,0.49508849051946846,0.4598345113183918,NT5E,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/51,99/10899,0.37277251050877624,0.49508849051946846,0.4598345113183918,VAV3,1
R-HSA-449147,Signaling by Interleukins,3/51,473/10899,0.38220651552716856,0.5056428610087055,0.46963733220622805,DUSP6/IRS2/IL1RAP,3
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/51,103/10899,0.38453810668583843,0.5067556444697096,0.4706708772164485,DUSP6,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/51,104/10899,0.38744553133932336,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/51,105/10899,0.3903394894589802,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/51,105/10899,0.3903394894589802,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-72306,tRNA processing,1/51,107/10899,0.39608725035343495,0.5082859663905863,0.47209222884574586,QTRT1,1
R-HSA-163685,Integration of energy metabolism,1/51,108/10899,0.39894117457804334,0.5082859663905863,0.47209222884574586,ACSL3,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/51,108/10899,0.39894117457804334,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-194138,Signaling by VEGF,1/51,108/10899,0.39894117457804334,0.5082859663905863,0.47209222884574586,VAV3,1
R-HSA-9748784,Drug ADME,1/51,108/10899,0.39894117457804334,0.5082859663905863,0.47209222884574586,VAV3,1
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/51,109/10899,0.401781875170808,0.5082859663905863,0.47209222884574586,POFUT1,1
R-HSA-71387,Metabolism of carbohydrates,2/51,295/10899,0.403480734082563,0.5082859663905863,0.47209222884574586,CHST2/CHST7,2
R-HSA-166166,MyD88-independent TLR4 cascade ,1/51,110/10899,0.4046094121834388,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/51,110/10899,0.4046094121834388,0.5082859663905863,0.47209222884574586,DUSP6,1
R-HSA-1852241,Organelle biogenesis and maintenance,2/51,296/10899,0.40513381438779084,0.5082859663905863,0.47209222884574586,TNPO1/PPARGC1A,2
R-HSA-5173105,O-linked glycosylation,1/51,111/10899,0.4074238454004787,0.5092798067505984,0.4730153003875527,ADAMTS9,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/51,113/10899,0.4130136382570907,0.5115804274099273,0.4751520997615425,DUSP6,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/51,113/10899,0.4130136382570907,0.5115804274099273,0.4751520997615425,DUSP6,1
R-HSA-446203,Asparagine N-linked glycosylation,2/51,304/10899,0.4182828357619759,0.5115804274099273,0.4751520997615425,SEC24B/CNIH3,2
R-HSA-9020702,Interleukin-1 signaling,1/51,115/10899,0.41855172671771634,0.5115804274099273,0.4751520997615425,IL1RAP,1
R-HSA-927802,Nonsense-Mediated Decay (NMD),1/51,115/10899,0.41855172671771634,0.5115804274099273,0.4751520997615425,NCBP2,1
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),1/51,115/10899,0.41855172671771634,0.5115804274099273,0.4751520997615425,NCBP2,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/51,116/10899,0.4213015284552343,0.5115804274099273,0.4751520997615425,DUSP6,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/51,116/10899,0.4213015284552343,0.5115804274099273,0.4751520997615425,DUSP6,1
R-HSA-1989781,PPARA activates gene expression,1/51,117/10899,0.4240385795587106,0.5130715909251303,0.47653708135461015,PPARGC1A,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/51,119/10899,0.42947466139224877,0.5178063293381723,0.48093467121192474,PPARGC1A,1
R-HSA-2132295,MHC class II antigen presentation,1/51,123/10899,0.4401963498818082,0.5283072161150878,0.490687816825159,SEC24B,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/51,124/10899,0.442845754684706,0.5283072161150878,0.490687816825159,NT5E,1
R-HSA-9007101,Rab regulation of trafficking,1/51,124/10899,0.442845754684706,0.5283072161150878,0.490687816825159,RAB5A,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/51,126/10899,0.4481077375389795,0.5327154921792063,0.4947821908785198,SEC24B,1
R-HSA-114608,Platelet degranulation ,1/51,129/10899,0.45590947992037423,0.5382264693504418,0.4999007455267262,PDGFA,1
R-HSA-1500931,Cell-Cell communication,1/51,129/10899,0.45590947992037423,0.5382264693504418,0.4999007455267262,CDH4,1
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,1/51,130/10899,0.4584859531352359,0.5393952389826304,0.5009862900767466,LMO2,1
R-HSA-8856688,Golgi-to-ER retrograde transport,1/51,133/10899,0.46614381555823736,0.5457148628928896,0.5068559098076375,BICD1,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/51,134/10899,0.4686727646021287,0.5457148628928896,0.5068559098076375,VAV3,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/51,134/10899,0.4686727646021287,0.5457148628928896,0.5068559098076375,PDGFA,1
R-HSA-162599,Late Phase of HIV Life Cycle,1/51,136/10899,0.4736954776698368,0.5478110966249813,0.5088028761222737,NCBP2,1
R-HSA-1632852,Macroautophagy,1/51,136/10899,0.4736954776698368,0.5478110966249813,0.5088028761222737,EPAS1,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/51,137/10899,0.47618934839722127,0.5488284015425601,0.5097477413707988,GLG1,1
R-HSA-1474228,Degradation of the extracellular matrix,1/51,140/10899,0.48360165258895194,0.555488384730553,0.5159334842698634,ADAMTS9,1
R-HSA-3781865,Diseases of glycosylation,1/51,143/10899,0.4909110953364355,0.5619857657050102,0.5219682034411861,ADAMTS9,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/51,146/10899,0.49811907590076443,0.564534952687533,0.5243358693692257,DUSP6,1
R-HSA-3858494,Beta-catenin independent WNT signaling,1/51,146/10899,0.49811907590076443,0.564534952687533,0.5243358693692257,FZD3,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/51,146/10899,0.49811907590076443,0.564534952687533,0.5243358693692257,RAB5A,1
R-HSA-162587,HIV Life Cycle,1/51,149/10899,0.5052269748916589,0.5687985810038544,0.5282958956692146,NCBP2,1
R-HSA-5358351,Signaling by Hedgehog,1/51,149/10899,0.5052269748916589,0.5687985810038544,0.5282958956692146,GAS1,1
R-HSA-9612973,Autophagy,1/51,151/10899,0.5099106467873135,0.5721769633917049,0.5314337121285185,EPAS1,1
R-HSA-446652,Interleukin-1 family signaling,1/51,153/10899,0.5145508429002812,0.5754844953489987,0.5345057232343642,IL1RAP,1
R-HSA-8957322,Metabolism of steroids,1/51,154/10899,0.5168547612896432,0.5761659634048482,0.5351386657010974,SEC24B,1
R-HSA-71291,Metabolism of amino acids and derivatives,2/51,374/10899,0.5266463005507352,0.5851625561674836,0.5434946342112851,PIPOX/BCAT1,2
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/51,381/10899,0.5367461867820509,0.5929173991474491,0.5506972747499528,SEC24B/RBCK1,2
R-HSA-9609507,Protein localization,1/51,163/10899,0.5371134086394539,0.5929173991474491,0.5506972747499528,PIPOX,1
R-HSA-168898,Toll-like Receptor Cascades,1/51,168/10899,0.5480058774014005,0.6010387042466973,0.5582402825820719,DUSP6,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/51,168/10899,0.5480058774014005,0.6010387042466973,0.5582402825820719,RAB5A,1
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,1/51,171/10899,0.5544203159597241,0.6061186733964828,0.5629585201824919,NCBP2,1
R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,1/51,178/10899,0.5690422809143778,0.6201101779195142,0.5759537256218399,IDH3B,1
R-HSA-112316,Neuronal System,2/51,410/10899,0.5770474078756929,0.6268246603122541,0.582190086977326,CHRNA9/IL1RAP,2
R-HSA-72163,mRNA Splicing - Major Pathway,1/51,185/10899,0.5831935219982692,0.631483431463094,0.5865171190059697,NCBP2,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/51,190/10899,0.5930216031551977,0.6400868097548166,0.594507872837291,NT5E,1
R-HSA-72172,mRNA Splicing,1/51,193/10899,0.5988090142211571,0.644288179858207,0.5984100741717093,NCBP2,1
R-HSA-5617833,Cilium Assembly,1/51,201/10899,0.6138505262907945,0.656222804415483,0.6094948647821824,TNPO1,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/51,202/10899,0.6156913959074678,0.656222804415483,0.6094948647821824,BICD1,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/51,202/10899,0.6156913959074678,0.656222804415483,0.6094948647821824,SEC24B,1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/51,205/10899,0.6211625346147531,0.6599851930281752,0.6129893433698222,CHRNA9,1
R-HSA-1483257,Phospholipid metabolism,1/51,212/10899,0.6336332848028092,0.6711380586696422,0.6233480421080269,RAB5A,1
R-HSA-376176,Signaling by ROBO receptors,1/51,218/10899,0.6440014718639879,0.6800015541420991,0.6315803908440549,NCBP2,1
R-HSA-500792,GPCR ligand binding,2/51,467/10899,0.648861830117287,0.683012452755039,0.6343768911037514,FZD3/HRH1,2
R-HSA-162906,HIV Infection,1/51,231/10899,0.6654889124148218,0.6983525624106155,0.6486246709696118,NCBP2,1
R-HSA-157118,Signaling by NOTCH,1/51,236/10899,0.673410202927435,0.7018060064163169,0.6518322041018424,POFUT1,1
R-HSA-68882,Mitotic Anaphase,1/51,236/10899,0.673410202927435,0.7018060064163169,0.6518322041018424,TNPO1,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/51,237/10899,0.6749722473474578,0.7018060064163169,0.6518322041018424,TNPO1,1
R-HSA-8878171,Transcriptional regulation by RUNX1,1/51,239/10899,0.678074393991834,0.7028819937720231,0.6528315731628697,LMO2,1
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/51,246/10899,0.6887050177088845,0.7117316292432241,0.6610510488327159,NCBP2,1
R-HSA-5668914,Diseases of metabolism,1/51,249/10899,0.6931549295511716,0.7141596243860556,0.663306152680547,ADAMTS9,1
R-HSA-112315,Transmission across Chemical Synapses,1/51,270/10899,0.7226048499637427,0.7422527159748415,0.6893988074069736,CHRNA9,1
R-HSA-3247509,Chromatin modifying enzymes,1/51,274/10899,0.7278913774349105,0.7431923973809897,0.6902715765148512,ARID5B,1
R-HSA-4839726,Chromatin organization,1/51,274/10899,0.7278913774349105,0.7431923973809897,0.6902715765148512,ARID5B,1
R-HSA-9694516,SARS-CoV-2 Infection,1/51,298/10899,0.7575977606550706,0.7712073012656407,0.7162916110826384,SEC24B,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/51,309/10899,0.7701271901397543,0.7816216258134819,0.7259643583406953,RBCK1,1
R-HSA-195721,Signaling by WNT,1/51,332/10899,0.794308405123868,0.8037644575658188,0.746530455943485,FZD3,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/51,335/10899,0.7972725500403189,0.8043699317914197,0.7470928159053434,HRH1,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/51,362/10899,0.8221328364768977,0.8269975278169978,0.7681091589631558,GADD45A,1
R-HSA-9679506,SARS-CoV Infections,1/51,413/10899,0.861204332135852,0.8637447578943648,0.8022397132145804,SEC24B,1
R-HSA-68886,M Phase,1/51,418/10899,0.8645475432697827,0.8645475432697827,0.8029853343062997,TNPO1,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,6/39,199/4383,0.007560934240020374,0.14326459026925636,0.1345016067961724,SPRY4/NT5E/SPRED2/ETV4/ARL4A/ADAM19,6
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,6/39,200/4383,0.007744031906446291,0.14326459026925636,0.1345016067961724,TRIB2/DUSP6/ETV5/SPRY2/TMEM158/ETV4,6
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,5/39,200/4383,0.030665760885860118,0.37176944445872123,0.3490296349114595,POSTN/LAMA2/GADD45A/NT5E/GAS1,5
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,2/39,36/4383,0.040191291292834726,0.37176944445872123,0.3490296349114595,POSTN/PDGFA,2
HALLMARK_APICAL_SURFACE,HALLMARK_APICAL_SURFACE,2/39,44/4383,0.05774032215084453,0.4272783839162495,0.4011432907321831,SHROOM2/GAS1,2
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,4/39,200/4383,0.09998227220917498,0.6165573452899124,0.5788447338425919,CHST2/IRS2/NT5E/RBCK1,4
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,2/39,96/4383,0.2099263021138691,0.8395249065874635,0.7881741655017438,RAB5A/SCRN1,2
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,2/39,100/4383,0.22307976816574754,0.8395249065874635,0.7881741655017438,ACSL3/ARID5B,2
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,3/39,200/4383,0.26215085030794005,0.8395249065874635,0.7881741655017438,CHST2/IRS2/PPARGC1A,3
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,3/39,200/4383,0.26215085030794005,0.8395249065874635,0.7881741655017438,RBCK1/ARID5B/ARL4A,3
HALLMARK_PANCREAS_BETA_CELLS,HALLMARK_PANCREAS_BETA_CELLS,1/39,40/4383,0.3017101260581633,0.8395249065874635,0.7881741655017438,LMO2,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/39,158/4383,0.4133384226329466,0.8395249065874635,0.7881741655017438,TYRO3/MARK2,2
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,2/39,199/4383,0.5347912935683097,0.8395249065874635,0.7881741655017438,TRIO/SHROOM2,2
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,GADD45A/ARL4A,2
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,SHROOM2/CDH4,2
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,ELOVL2/DLC1,2
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,CHST2/HRH1,2
HALLMARK_KRAS_SIGNALING_DN,HALLMARK_KRAS_SIGNALING_DN,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,CHST2/FGFR3,2
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,ACSL3/BCAT1,2
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,GADD45A/PDGFA,2
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,2/39,200/4383,0.5375452374396263,0.8395249065874635,0.7881741655017438,GADD45A/IRS2,2
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/39,105/4383,0.6131966590568234,0.8395249065874635,0.7881741655017438,VAV3,1
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,1/39,112/4383,0.6372319445937698,0.8395249065874635,0.7881741655017438,PIPOX,1
HALLMARK_SPERMATOGENESIS,HALLMARK_SPERMATOGENESIS,1/39,135/4383,0.7063965649212894,0.8395249065874635,0.7881741655017438,ARL4A,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/39,138/4383,0.7144109561637568,0.8395249065874635,0.7881741655017438,DUSP6,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/39,144/4383,0.7298053515215329,0.8395249065874635,0.7881741655017438,DLC1,1
HALLMARK_DNA_REPAIR,HALLMARK_DNA_REPAIR,1/39,150/4383,0.7443900805274493,0.8395249065874635,0.7881741655017438,NCBP2,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/39,158/4383,0.7626483694621845,0.8395249065874635,0.7881741655017438,IDH3B,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/39,161/4383,0.7691622261051693,0.8395249065874635,0.7881741655017438,GADD45A,1
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,BCAT1,1
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,DUSP6,1
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,FGFR3,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,LMO2,1
HALLMARK_MYC_TARGETS_V1,HALLMARK_MYC_TARGETS_V1,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,NCBP2,1
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,LAMA2,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,IDH3B,1
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7881741655017438,BCAT1,1
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,22/73,161/21728,5.7569636653620615e-30,1.0293451033667366e-26,8.193068290073164e-27,FZD3/TRIB2/ACSL3/IRS2/GLG1/SPRY2/ELOVL2/CDH4/PIPOX/POFUT1/PDGFA/GAS1/RBCK1/FGFR3/EXTL3/QTRT1/KLHL4/PTPRA/VAV3/LMO2/DLC1/ADAM19,22
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,8/73,185/21728,1.9894070956601522e-7,9.451748399351828e-5,7.523115410292988e-5,CHRNA9/POSTN/GRB10/NT5E/HRH1/PDGFA/DLC1/ADAM19,8
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,9/73,258/21728,2.0432245417821579e-7,9.451748399351828e-5,7.523115410292988e-5,GADD45A/IRS2/CDH4/GAS1/VAV3/ARID5B/DPY19L1/ALK/ADAM19,9
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,11/73,437/21728,2.2292487199895868e-7,9.451748399351828e-5,7.523115410292988e-5,POSTN/TRIB2/GADD45A/ACSL3/OTUD4/CHST2/SCRN1/PDGFA/GAS1/TYRO3/ARID5B,11
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,8/73,192/21728,2.6431063756576697e-7,9.451748399351828e-5,7.523115410292988e-5,CHRNA9/POSTN/GRB10/NT5E/HRH1/PDGFA/DLC1/ADAM19,8
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,11/73,466/21728,4.2192390411208367e-7,1.2573332342540093e-4,1.000773891858837e-4,GADD45A/CHST2/ETV5/TRIO/SPRY2/NT5E/TMEM158/HRH1/PDGFA/BCAT1/DPY19L1,11
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,8/73,216/21728,6.467741466428718e-7,1.6520459631392208e-4,1.3149453327235527e-4,OTUD4/TRIO/SPRY2/GRB10/IL1RAP/SPRED2/PDGFA/ARID5B,8
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,10/73,438/21728,1.99999668665314e-6,4.469992594669768e-4,3.557888842572428e-4,GADD45A/ACSL3/DUSP6/SATB2/ETV5/CDH4/PIPOX/GAS1/EXTL3/ALK,10
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,10/73,495/21728,5.910909803038833e-6,0.001174300747537048,9.346842168080119e-4,CHRNA9/OTUD4/TRIO/GRB10/IL1RAP/TMEM158/SPRED2/EXTL3/KBTBD2/ADAM19,10
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,9/73,445/21728,1.779541387044042e-5,0.002857895993244081,0.002274741188547037,GADD45A/OTUD4/DUSP6/CHST2/IRS2/SPRED2/FEM1C/PPARGC1A/ARID5B,9
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,7/73,248/21728,1.989890916479571e-5,0.002857895993244081,0.002274741188547037,TRIB2/ACSL3/DUSP6/ETV5/SPRY4/SPRY1/ETV4,7
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,5/73,100/21728,2.1882949335677183e-5,0.002857895993244081,0.002274741188547037,DUSP6/SPRY4/SPRY2/PDGFA/LMO2,5
BIOCARTA_SPRY_PATHWAY,BIOCARTA_SPRY_PATHWAY,3/73,17/21728,2.3917978912490952e-5,0.002857895993244081,0.002274741188547037,SPRY4/SPRY1/SPRY2,3
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,8/73,353/21728,2.4036364765643117e-5,0.002857895993244081,0.002274741188547037,POSTN/ETV5/TMEM158/GAS1/RASSF2/LMO2/DPY19L1/ADAM19,8
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,7/73,257/21728,2.501012547545348e-5,0.002857895993244081,0.002274741188547037,POSTN/SATB2/CHST2/GRB10/SHROOM2/ARID5B/DLC1,7
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,9/73,466/21728,2.557401336236314e-5,0.002857895993244081,0.002274741188547037,FNDC3A/ACSL3/SATB2/TRIO/IL1RAP/SEC24B/PTPRA/ARID5B/DLC1,9
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,4/73,52/21728,2.809508335940997e-5,0.0029549417086250016,0.002351984687425528,TRIO/GRB10/BCAT1/DPY19L1,4
ASTIER_INTEGRIN_SIGNALING,ASTIER_INTEGRIN_SIGNALING,4/73,57/21728,4.0476659261721125e-5,0.004020681486664298,0.003200259843382863,ACSL3/SPRY1/RASSF2/ETV4,4
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,5/73,118/21728,4.852792051531328e-5,0.004412196045254806,0.0035118857018630037,CHRNA9/POSTN/NT5E/DLC1/ADAM19,5
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,7/73,286/21728,4.935342332499783e-5,0.004412196045254806,0.0035118857018630037,CHST2/NT5E/IL1RAP/TMEM158/HRH1/LMO2/ADAM19,7
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,8/73,395/21728,5.3271581427968426e-5,0.004535694647295597,0.0036101843654442758,BICD1/DUSP6/ETV5/SPRY1/SPRY2/NT5E/VAV3/PGPEP1,8
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,8/73,434/21728,1.0262380292718743e-4,0.008340516346991414,0.0066386306965338475,TRIB2/DUSP6/GLG1/IL1RAP/CDH4/PDGFA/LMO2/ALK,8
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,7/73,327/21728,1.1410865816242392e-4,0.008537573715336403,0.006795478431140242,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/PTPRA/ETV4,7
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,8/73,441/21728,1.1459830490384432e-4,0.008537573715336403,0.006795478431140242,SPRY1/GRB10/TNPO1/PIPOX/GAS1/EXTL3/ALK/ADAM19,8
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,8/73,451/21728,1.3369451351426836e-4,0.009561831606540472,0.007610736095633297,CHRNA9/OTUD4/TRIO/TMEM158/SPRED2/EXTL3/DPY19L1/KBTBD2,8
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,5/73,155/21728,1.7598219086434138e-4,0.012102159894824709,0.009632709394679738,MACF1/VAV3/ARID5B/ARL4A/ADAM19,5
REACTOME_SIGNALING_BY_FGFR,REACTOME_SIGNALING_BY_FGFR,4/73,87/21728,2.114029179626601e-4,0.01399957101174949,0.01114295302477647,SPRY2/SPRED2/FGFR3/NCBP2,4
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,3/73,35/21728,2.204270947454329e-4,0.014075844478744071,0.011203662860745311,GADD45A/IRS2/ETV5,3
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,7/73,371/21728,2.475622530570842e-4,0.014719594237194983,0.011716055227062061,ACSL3/DUSP6/ETV5/IL1RAP/PDGFA/ETV4/LMO2,7
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,6/73,262/21728,2.5138662816280035e-4,0.014719594237194983,0.011716055227062061,LAMA2/IRS2/SCRN1/ELOVL2/NT5E/GAS1,6
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,8/73,496/21728,2.5520549292675865e-4,0.014719594237194983,0.011716055227062061,TRIB2/DUSP6/MACF1/NT5E/FEM1C/ARID5B/ARL4A/ADAM19,8
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,4/73,93/21728,2.7312438229261843e-4,0.015260824860600054,0.012146847528276977,GRB10/TYRO3/ARID5B/KBTBD2,4
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,5/73,177/21728,3.254062174863738e-4,0.017631100511079887,0.014033467497338992,BICD1/LAMA2/IL1RAP/GAS1/BCAT1,5
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,5/73,182/21728,3.6980224033170936e-4,0.019447247226855775,0.015479028759395387,LAMA2/ACSL3/SPRED2/CNIH3/DLC1,5
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,6/73,289/21728,4.240348216543898e-4,0.02144880558793359,0.01707216834739563,TRIB2/GADD45A/SATB2/SEC24B/GAS1/ARID5B,6
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,6/73,290/21728,4.3185514606577696e-4,0.02144880558793359,0.01707216834739563,RAB5A/DUSP6/BAG5/PIPOX/GAS1/KLHL4,6
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,6/73,295/21728,4.72664334166162e-4,0.021712334786090335,0.017281924308721375,BICD1/POSTN/TRIB2/EPAS1/GRB10/BCAT1,6
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,4/73,108/21728,4.8266784884926626e-4,0.021712334786090335,0.017281924308721375,ETV5/ELOVL2/EPAS1/DLC1,4
REACTOME_SIGNAL_ATTENUATION,REACTOME_SIGNAL_ATTENUATION,2/73,10/21728,4.923535033032824e-4,0.021712334786090335,0.017281924308721375,IRS2/GRB10,2
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,5/73,194/21728,4.95003812775593e-4,0.021712334786090335,0.017281924308721375,TRIB2/SCRN1/FGFR3/ARID5B/DLC1,5
PID_RHOA_REG_PATHWAY,PID_RHOA_REG_PATHWAY,3/73,46/21728,4.978779229472616e-4,0.021712334786090335,0.017281924308721375,TRIO/VAV3/DLC1,3
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,5/73,198/21728,5.431034290395544e-4,0.022480066074957065,0.017892999725269015,TRIO/NT5E/FEM1C/ARID5B/ARL4A,5
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,3/73,48/21728,5.645557859992799e-4,0.022480066074957065,0.017892999725269015,NT5E/PDGFA/ALK,3
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,4/73,113/21728,5.726315556121317e-4,0.022480066074957065,0.017892999725269015,IRS2/IL1RAP/PDGFA/FGFR3,4
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,7/73,430/21728,5.994115778823529e-4,0.022480066074957065,0.017892999725269015,GADD45A/RAB5A/NT5E/HRH1/NCBP2/BCAT1/KBTBD2,7
WP_MICROTUBULE_CYTOSKELETON_REGULATION,WP_MICROTUBULE_CYTOSKELETON_REGULATION,3/73,49/21728,5.999296965464813e-4,0.022480066074957065,0.017892999725269015,TRIO/MARK2/PTPRA,3
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,6/73,309/21728,6.030962567567334e-4,0.022480066074957065,0.017892999725269015,LAMA2/IRS2/EPAS1/PDGFA/FGFR3/PPARGC1A,6
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,5/73,203/21728,6.080764481071779e-4,0.022480066074957065,0.017892999725269015,DUSP6/TNPO1/TMEM158/PDGFA/ARL4A,5
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,7/73,432/21728,6.160644506000537e-4,0.022480066074957065,0.017892999725269015,DUSP6/IRS2/SPRED2/PDGFA/FGFR3/NCBP2/ALK,7
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,4/73,120/21728,7.177731866271816e-4,0.025555405708772773,0.02034081509376003,TRIB2/ACSL3/SPRY4/ALK,4
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,7/73,445/21728,7.335008766412188e-4,0.025555405708772773,0.02034081509376003,BICD1/DUSP6/CHST2/ETV5/NT5E/IL1RAP/BCAT1,7
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,7/73,446/21728,7.432220899643088e-4,0.025555405708772773,0.02034081509376003,FZD3/LAMA2/CDH4/PDGFA/FGFR3/PPARGC1A/RASSF2,7
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,4/73,122/21728,7.636130259537355e-4,0.025761133781231682,0.020504564271885805,DUSP6/ETV5/SPRY1/SPRY2,4
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,3/73,54/21728,7.980249216437457e-4,0.025943064725436678,0.020649372135164483,IRS2/GRB10/FGFR3,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,3/73,54/21728,7.980249216437457e-4,0.025943064725436678,0.020649372135164483,MACF1/BCAT1/ARID5B,3
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,5/73,225/21728,9.655368263318505e-4,0.029013193242327748,0.023093039717194813,ACSL3/OTUD4/SATB2/ETV5/GLG1,5
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,6/73,339/21728,9.760244170265987e-4,0.029013193242327748,0.023093039717194813,LAMA2/GADD45A/IRS2/SPRY2/BCAT1/LMO2,6
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,5/73,226/21728,9.84829205524962e-4,0.029013193242327748,0.023093039717194813,SPRY2/GRB10/NT5E/FGFR3/EXTL3,5
YIH_RESPONSE_TO_ARSENITE_C2,YIH_RESPONSE_TO_ARSENITE_C2,2/73,14/21728,9.870194201385086e-4,0.029013193242327748,0.023093039717194813,GADD45A/RAB5A,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,4/73,131/21728,9.957674309950327e-4,0.029013193242327748,0.023093039717194813,ACSL3/SPRY1/LMO2/ARID5B,4
WP_ADIPOGENESIS,WP_ADIPOGENESIS,4/73,131/21728,9.957674309950327e-4,0.029013193242327748,0.023093039717194813,GADD45A/IRS2/EPAS1/PPARGC1A,4
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,6/73,341/21728,0.0010060503249576735,0.029013193242327748,0.023093039717194813,GADD45A/ADAMTS9/IRS2/TRIO/TMEM158/ARID5B,6
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,3/73,60/21728,0.0010852085877910698,0.02953069100772626,0.023504941859440655,GADD45A/IRS2/ALK,3
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,5/73,232/21728,0.0011066717821110017,0.02953069100772626,0.023504941859440655,FNDC3A/ADAMTS9/IL1RAP/HRH1/DLC1,5
TSUNODA_CISPLATIN_RESISTANCE_UP,TSUNODA_CISPLATIN_RESISTANCE_UP,2/73,15/21728,0.0011363944924228065,0.02953069100772626,0.023504941859440655,NT5E/VAV3,2
WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,2/73,15/21728,0.0011363944924228065,0.02953069100772626,0.023504941859440655,ACSL3/ELOVL2,2
GRABARCZYK_BCL11B_TARGETS_DN,GRABARCZYK_BCL11B_TARGETS_DN,3/73,61/21728,0.0011386020453335963,0.02953069100772626,0.023504941859440655,BICD1/ETV5/CDH4,3
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,3/73,61/21728,0.0011386020453335963,0.02953069100772626,0.023504941859440655,GADD45A/NT5E/ETV4,3
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,7/73,480/21728,0.001139607203318295,0.02953069100772626,0.023504941859440655,POSTN/DUSP6/EPAS1/NT5E/CDH4/CHST7/PDGFA,7
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,4/73,138/21728,0.001207687845394846,0.030634574586595634,0.024383577558623155,GADD45A/ACSL3/DUSP6/ARID5B,4
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,5/73,237/21728,0.0012164735993558668,0.030634574586595634,0.024383577558623155,TRIO/SPRY2/SPRED2/VAV3/ANKRD10,5
WP_OMEGA9_FATTY_ACID_SYNTHESIS,WP_OMEGA9_FATTY_ACID_SYNTHESIS,2/73,16/21728,0.0012959158776220977,0.03205289402068953,0.025512488352744757,ACSL3/ELOVL2,2
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,3/73,64/21728,0.0013086472390997402,0.03205289402068953,0.025512488352744757,GADD45A/VAV3/ALK,3
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,5/73,242/21728,0.0013341497033452026,0.032235941480827326,0.02565818490643974,ACSL3/EPAS1/NT5E/IL1RAP/GAS1,5
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,5/73,243/21728,0.0013586597714541253,0.032390448951466345,0.025781165066750558,CHRNA9/TMEM158/SPRED2/EXTL3/DPY19L1,5
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,5/73,244/21728,0.0013835011772556627,0.032548685591225326,0.025907113457751464,GADD45A/TRIO/FEM1C/ARID5B/ARL4A,5
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,3/73,66/21728,0.0014304170681098398,0.032576943981236735,0.025929605712134738,IRS2/ETV5/SPRED2,3
LEI_HOXC8_TARGETS_DN,LEI_HOXC8_TARGETS_DN,2/73,17/21728,0.0014655155974500455,0.032576943981236735,0.025929605712134738,GAS1/ADAM19,2
WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,2/73,17/21728,0.0014655155974500455,0.032576943981236735,0.025929605712134738,POSTN/EPAS1,2
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,5/73,248/21728,0.0014862352259993384,0.032576943981236735,0.025929605712134738,CHST2/TMEM158/CHST7/FGFR3/DPY19L1,5
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,3/73,67/21728,0.001493878368958371,0.032576943981236735,0.025929605712134738,ACSL3/IRS2/PPARGC1A,3
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,5/73,250/21728,0.0015396619792999503,0.032576943981236735,0.025929605712134738,DUSP6/SPRY4/NT5E/PDGFA/GAS1,5
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,5/73,250/21728,0.0015396619792999503,0.032576943981236735,0.025929605712134738,TRIB2/SCRN1/SPRY1/NT5E/TMEM158,5
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,6/73,371/21728,0.0015476356425811566,0.032576943981236735,0.025929605712134738,TRIO/SCRN1/MACF1/IL1RAP/CDH4/ARID5B,6
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,3/73,68/21728,0.0015590809325331646,0.032576943981236735,0.025929605712134738,GADD45A/DUSP6/IRS2,3
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,5/73,251/21728,0.0015668999901489705,0.032576943981236735,0.025929605712134738,POSTN/GADD45A/DUSP6/IL1RAP/GAS1,5
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,5/73,253/21728,0.001622439191768624,0.03334392269979655,0.026540082120643432,DUSP6/ETV5/NT5E/TMEM158/SPRED2,5
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,3/73,71/21728,0.0017653097447729905,0.03571556635496018,0.02842779095249391,SCRN1/GLG1/FGFR3,3
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,6/73,382/21728,0.0017937959108716979,0.03571556635496018,0.02842779095249391,ACSL3/DUSP6/SCRN1/PDGFA/FEM1C/ARID5B,6
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,5/73,259/21728,0.0017977634071288681,0.03571556635496018,0.02842779095249391,BICD1/TRIB2/SATB2/ETV5/QTRT1,5
WP_FARNESOID_X_RECEPTOR_PATHWAY,WP_FARNESOID_X_RECEPTOR_PATHWAY,2/73,19/21728,0.0018346797832953859,0.03596345289871712,0.028625096149220267,IRS2/PPARGC1A,2
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,4/73,155/21728,0.0018504684936700084,0.03596345289871712,0.028625096149220267,SPRY4/SPRY1/SPRY2/SPRED2,4
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,5/73,262/21728,0.0018904618786295439,0.03634565418268414,0.02892930911043739,LAMA2/GADD45A/ACSL3/IDH3B/FEM1C,5
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,4/73,159/21728,0.0020304987729432055,0.03788529770635061,0.030154787765798906,DUSP6/IL1RAP/PDGFA/ARL4A,4
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,2/73,20/21728,0.002034109943965133,0.03788529770635061,0.030154787765798906,TRIB2/SPRY4,2
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,2/73,20/21728,0.002034109943965133,0.03788529770635061,0.030154787765798906,EPAS1/NT5E,2
YAMASHITA_LIVER_CANCER_STEM_CELL_DN,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,3/73,76/21728,0.002145435775495262,0.03954679553180957,0.03147725630460764,GADD45A/ACSL3/PPARGC1A,3
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,4/73,163/21728,0.002222307615827608,0.0401103574857434,0.031925823219548496,RAB5A/SPRY2/GRB10/VAV3,4
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,2/73,21/21728,0.0022433498257652604,0.0401103574857434,0.031925823219548496,DUSP6/FGFR3,2
WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,2/73,21/21728,0.0022433498257652604,0.0401103574857434,0.031925823219548496,GADD45A/SPRED2,2
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,4/73,164/21728,0.002272145396324804,0.0401103574857434,0.031925823219548496,BICD1/DUSP6/GAS1/ARID5B,4
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,3/73,78/21728,0.002310607841740252,0.0401103574857434,0.031925823219548496,IRS2/PDGFA/FGFR3,3
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,3/73,78/21728,0.002310607841740252,0.0401103574857434,0.031925823219548496,IRS2/GRB10/FGFR3,3
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,4/73,167/21728,0.0024262798837111216,0.04131608030548081,0.032885517822330186,TRIB2/GRB10/IL1RAP/FGFR3,4
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,4/73,167/21728,0.0024262798837111216,0.04131608030548081,0.032885517822330186,GRB10/IL1RAP/SPRED2/ADAM19,4
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,2/73,22/21728,0.002462333093225481,0.0414284326440457,0.03297494462189437,IRS2/PPARGC1A,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,4/73,168/21728,0.002479218284626896,0.0414284326440457,0.03297494462189437,EPAS1/GRB10/EXTL3/ARL4A,4
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,5/73,280/21728,0.002521976057744129,0.041752714733763914,0.03323305682329496,MACF1/SPRY1/CDH4/VAV3/BCAT1,5
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,2/73,23/21728,0.002690993735253446,0.04374087998757419,0.03481553617284841,POSTN/NT5E,2
XIE_ST_HSC_S1PR3_OE_DN,XIE_ST_HSC_S1PR3_OE_DN,2/73,23/21728,0.002690993735253446,0.04374087998757419,0.03481553617284841,TRIB2/CHST2,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,4/73,173/21728,0.0027558785814530934,0.044020217342446884,0.03503787463027681,GADD45A/IRS2/SPRED2/KBTBD2,4
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,3/73,83/21728,0.0027574185359921987,0.044020217342446884,0.03503787463027681,TMEM158/HRH1/BCAT1,3
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,3/73,84/21728,0.002852706295101774,0.044742446102122566,0.03561273232666296,IL1RAP/PDGFA/ETV4,3
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,3/73,84/21728,0.002852706295101774,0.044742446102122566,0.03561273232666296,POSTN/FZD3/EPAS1,3
HASLINGER_B_CLL_WITH_13Q14_DELETION,HASLINGER_B_CLL_WITH_13Q14_DELETION,2/73,24/21728,0.002929266063752451,0.04508208878834395,0.03588307078879137,NT5E/ARL4A,2
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,2/73,24/21728,0.002929266063752451,0.04508208878834395,0.03588307078879137,ACSL3/ELOVL2,2
SANA_TNF_SIGNALING_DN,SANA_TNF_SIGNALING_DN,3/73,85/21728,0.002950002454270829,0.04508208878834395,0.03588307078879137,POSTN/EPAS1/NT5E,3
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,6/73,423/21728,0.00298118994911079,0.04517260702550926,0.035955118743958854,POSTN/LAMA2/MACF1/EPAS1/LMO2/ANKRD10,6
WANG_MLL_TARGETS,WANG_MLL_TARGETS,5/73,293/21728,0.003064894743838971,0.04605068741163093,0.0366540264809402,FNDC3A/POSTN/GRB10/ARID5B/ADAM19,5
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,4/73,179/21728,0.0031149755917426036,0.046413136316964795,0.036942517544175435,TRIB2/LAMA2/ARL4A/DLC1,4
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,3/73,88/21728,0.003254078504280569,0.048085060873170715,0.038273285235209474,DUSP6/CDH4/DLC1,3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,2/73,26/21728,0.003434384634498962,0.05033344038101758,0.040062882017623785,SCRN1/DPY19L1,2
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,3/73,90/21728,0.0034670858544699596,0.05039958949424624,0.04011553337820612,BAG5/CHST7/ARL4A,3
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,5/73,303/21728,0.0035365899359202013,0.050995345205042904,0.04058972490122336,IRS2/ELOVL2/TMEM158/PPARGC1A/DLC1,5
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,2/73,27/21728,0.003701101103166236,0.05294055017968984,0.04213801003352211,DUSP6/ETV5,2
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,3/73,94/21728,0.0039182600237680585,0.0556019755753753,0.04425637052743872,LAMA2/GAS1/RASSF2,3
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,2/73,29/21728,0.004262526356588112,0.05872227628855147,0.04673997264931213,IRS2/GRB10,2
REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,2/73,29/21728,0.004262526356588112,0.05872227628855147,0.04673997264931213,SPRY2/FGFR3,2
XIE_LT_HSC_S1PR3_OE_UP,XIE_LT_HSC_S1PR3_OE_UP,2/73,29/21728,0.004262526356588112,0.05872227628855147,0.04673997264931213,IL1RAP/ETV4,2
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,3/73,97/21728,0.00427904249909591,0.05872227628855147,0.04673997264931213,RAB5A/IRS2/PTPRA,3
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,6/73,456/21728,0.004302359168792082,0.05872227628855147,0.04673997264931213,IRS2/SPRY2/NT5E/IL1RAP/HRH1/GAS1,6
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,4/73,199/21728,0.004540919239485131,0.0608067746019982,0.04839912825968537,EPAS1/GRB10/IDH3B/EXTL3,4
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,4/73,199/21728,0.004540919239485131,0.0608067746019982,0.04839912825968537,DUSP6/GRB10/PIPOX/ARL4A,4
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,2/73,30/21728,0.004557107268829842,0.0608067746019982,0.04839912825968537,DUSP6/SPRED2,2
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,4/73,200/21728,0.004621990413713896,0.061215695257188486,0.0487246084938884,TMEM158/LZTS1/KLHL4/ADAM19,4
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,3/73,100/21728,0.0046593784127750126,0.06125712207383619,0.048757582152258644,ACSL3/SPRY1/DLC1,3
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,5/73,325/21728,0.004754980821478397,0.062057705903674265,0.04939480653583398,FZD3/LAMA2/EPAS1/PDGFA/FGFR3,5
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,2/73,31/21728,0.004860848979763871,0.0625266041425741,0.04976802590413292,NT5E/TMEM158,2
REACTOME_EGFR_DOWNREGULATION,REACTOME_EGFR_DOWNREGULATION,2/73,31/21728,0.004860848979763871,0.0625266041425741,0.04976802590413292,SPRY1/SPRY2,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,3/73,102/21728,0.004923947678878016,0.0628858460702421,0.05005396437475998,TRIO/MACF1/TMEM158,3
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,4/73,205/21728,0.005042014189030827,0.06393703099281643,0.05089065459925105,TRIB2/DUSP6/TRIO/RASSF2,4
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,3/73,105/21728,0.0053375330477579,0.06684398463932428,0.05320444320756295,IRS2/PDGFA/FGFR3,3
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,5/73,336/21728,0.005464761330382721,0.06684398463932428,0.05320444320756295,POSTN/NT5E/LMO2/ARID5B/DLC1,5
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,2/73,33/21728,0.005495562495514915,0.06684398463932428,0.05320444320756295,RAB5A/VAV3,2
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,2/73,33/21728,0.005495562495514915,0.06684398463932428,0.05320444320756295,SPRY4/PDGFA,2
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,2/73,33/21728,0.005495562495514915,0.06684398463932428,0.05320444320756295,POSTN/PDGFA,2
REACTOME_CARGO_CONCENTRATION_IN_THE_ER,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,2/73,33/21728,0.005495562495514915,0.06684398463932428,0.05320444320756295,SEC24B/CNIH3,2
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,5/73,339/21728,0.005670688963036433,0.06850805314803474,0.054528957880691724,GADD45A/SATB2/ELOVL2/PIPOX/ALK,5
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,3/73,108/21728,0.005771440640885636,0.06895063614823621,0.05488123164512855,SPRY1/EPAS1/VAV3,3
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,6/73,485/21728,0.005784449341294984,0.06895063614823621,0.05488123164512855,BICD1/POSTN/HRH1/CHST7/GAS1/PPARGC1A,6
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,3/73,110/21728,0.006072132498282983,0.07067374188603387,0.05625273697746249,DUSP6/ETV5/TRIO,3
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,2/73,35/21728,0.00616616539945262,0.07067374188603387,0.05625273697746249,LAMA2/NT5E,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,2/73,35/21728,0.00616616539945262,0.07067374188603387,0.05625273697746249,ETV5/SPRY4,2
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,2/73,35/21728,0.00616616539945262,0.07067374188603387,0.05625273697746249,POSTN/NT5E,2
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,2/73,35/21728,0.00616616539945262,0.07067374188603387,0.05625273697746249,POSTN/NT5E,2
WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,2/73,35/21728,0.00616616539945262,0.07067374188603387,0.05625273697746249,LAMA2/IRS2,2
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,4/73,221/21728,0.006556765695572626,0.0746719558196424,0.05943511378085277,SATB2/ELOVL2/VAV3/ARID5B,4
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,3/73,115/21728,0.006864369053720469,0.07679640048847129,0.06112606467703589,NT5E/POFUT1/FGFR3,3
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,3/73,115/21728,0.006864369053720469,0.07679640048847129,0.06112606467703589,POSTN/MACF1/RASSF2,3
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,2/73,37/21728,0.00687216111753658,0.07679640048847129,0.06112606467703589,ACSL3/ELOVL2,2
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,3/73,116/21728,0.007029830306992923,0.07796409676626634,0.06205549206875785,RAB5A/SPRED2/DPY19L1,3
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,5/73,359/21728,0.007186065752915361,0.07796409676626634,0.06205549206875785,POSTN/GADD45A/DUSP6/NCBP2/ARL4A,5
GENTILE_UV_RESPONSE_CLUSTER_D2,GENTILE_UV_RESPONSE_CLUSTER_D2,2/73,38/21728,0.007238277440268575,0.07796409676626634,0.06205549206875785,SATB2/GAS1,2
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,2/73,38/21728,0.007238277440268575,0.07796409676626634,0.06205549206875785,RAB5A/PPARGC1A,2
PID_RAC1_REG_PATHWAY,PID_RAC1_REG_PATHWAY,2/73,38/21728,0.007238277440268575,0.07796409676626634,0.06205549206875785,TRIO/VAV3,2
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,2/73,38/21728,0.007238277440268575,0.07796409676626634,0.06205549206875785,EPAS1/NT5E,2
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,3/73,118/21728,0.0073678333820824315,0.07888434782732567,0.06278796553782191,FZD3/PDGFA/FGFR3,3
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,4/73,229/21728,0.007416320382717102,0.07893083835891772,0.06282496965810476,SPRY4/ELOVL2/NT5E/CNIH3,4
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,4/73,230/21728,0.007528735253224998,0.0791403932533279,0.0629917647936532,FNDC3A/GADD45A/NT5E/LMO2,4
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,2/73,39/21728,0.007613057963966666,0.0791403932533279,0.0629917647936532,GADD45A/DLC1,2
PID_RET_PATHWAY,PID_RET_PATHWAY,2/73,39/21728,0.007613057963966666,0.0791403932533279,0.0629917647936532,IRS2/GRB10,2
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,2/73,39/21728,0.007613057963966666,0.0791403932533279,0.0629917647936532,GADD45A/ARL4A,2
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,4/73,233/21728,0.007872718674257907,0.08077761733837731,0.06429491265835754,LAMA2/GAS1/LMO2/ARL4A,4
PID_FOXM1_PATHWAY,PID_FOXM1_PATHWAY,2/73,40/21728,0.007996441984839365,0.08077761733837731,0.06429491265835754,ETV5/GAS1,2
REACTOME_RET_SIGNALING,REACTOME_RET_SIGNALING,2/73,40/21728,0.007996441984839365,0.08077761733837731,0.06429491265835754,IRS2/GRB10,2
REACTOME_SIGNALING_BY_FGFR3,REACTOME_SIGNALING_BY_FGFR3,2/73,40/21728,0.007996441984839365,0.08077761733837731,0.06429491265835754,SPRY2/FGFR3,2
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,2/73,40/21728,0.007996441984839365,0.08077761733837731,0.06429491265835754,SCRN1/GAS1,2
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,2/73,41/21728,0.008388369099406098,0.0833244663874339,0.06632207615436868,DUSP6/SPRY4,2
LIN_MELANOMA_COPY_NUMBER_DN,LIN_MELANOMA_COPY_NUMBER_DN,2/73,41/21728,0.008388369099406098,0.0833244663874339,0.06632207615436868,FNDC3A/BAG5,2
PID_ERBB1_INTERNALIZATION_PATHWAY,PID_ERBB1_INTERNALIZATION_PATHWAY,2/73,41/21728,0.008388369099406098,0.0833244663874339,0.06632207615436868,RAB5A/SPRY2,2
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,3/73,125/21728,0.008626001754592945,0.08474335789677026,0.06745144229155385,TMEM158/LZTS1/KLHL4,3
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,3/73,125/21728,0.008626001754592945,0.08474335789677026,0.06745144229155385,SCRN1/CHST7/BCAT1,3
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,5/73,378/21728,0.008869374870325873,0.08665815447072492,0.06897552386931596,SPRY2/NT5E/TMEM158/FEM1C/LMO2,5
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,2/73,43/21728,0.009197612489533378,0.08893067050599869,0.07078433211121524,TRIB2/ALK,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,3/73,128/21728,0.00920143962170568,0.08893067050599869,0.07078433211121524,DUSP6/SATB2/PDGFA,3
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,4/73,245/21728,0.009351885825029941,0.08989877341480396,0.07155489323961789,GADD45A/RAB5A/GLG1/BCAT1,4
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,2/73,44/21728,0.009614809448124359,0.09144297496407634,0.07278399985366255,NCBP2/LMO2,2
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,2/73,44/21728,0.009614809448124359,0.09144297496407634,0.07278399985366255,GRB10/PTPRA,2
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,4/73,249/21728,0.009882527328039379,0.09301593691549008,0.0740359982984473,GADD45A/DUSP6/PDGFA/FGFR3,4
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,5/73,389/21728,0.009959729910559623,0.09301593691549008,0.0740359982984473,POSTN/ADAMTS9/SPRY1/TMEM158/ADAM19,5
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,3/73,132/21728,0.010002930603081786,0.09301593691549008,0.0740359982984473,SPRED2/ETV4/ADAM19,3
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,2/73,45/21728,0.01004031086392035,0.09301593691549008,0.0740359982984473,GADD45A/TRIO,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,2/73,45/21728,0.01004031086392035,0.09301593691549008,0.0740359982984473,TRIB2/PDGFA,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,3/73,134/21728,0.010418459148311538,0.09602167503701561,0.07642841437068475,FZD3/EPAS1/FGFR3,3
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,2/73,46/21728,0.010474057815782777,0.09603905320317745,0.07644224651518657,DUSP6/SPRY4,2
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,5/73,395/21728,0.010591828445621778,0.09662341459577418,0.07690736873512698,GADD45A/TRIO/MACF1/EPAS1/DLC1,5
DELACROIX_RAR_TARGETS_UP,DELACROIX_RAR_TARGETS_UP,2/73,47/21728,0.010915991675234164,0.09807936238853611,0.07806622980648817,DUSP6/PGPEP1,2
PID_LKB1_PATHWAY,PID_LKB1_PATHWAY,2/73,47/21728,0.010915991675234164,0.09807936238853611,0.07806622980648817,MARK2/ETV4,2
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,2/73,47/21728,0.010915991675234164,0.09807936238853611,0.07806622980648817,GADD45A/FGFR3,2
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,5/73,400/21728,0.011139222553575296,0.09958464962896314,0.07926436259175684,POSTN/LAMA2/TRIO/GRB10/GAS1,5
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,5/73,402/21728,0.011363509249270065,0.10011086078866611,0.07968320015676239,ETV5/SPRY1/NT5E/VAV3/ANKRD10,5
REACTOME_IRS_MEDIATED_SIGNALLING,REACTOME_IRS_MEDIATED_SIGNALLING,2/73,48/21728,0.011366054105200907,0.10011086078866611,0.07968320015676239,IRS2/FGFR3,2
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,2/73,48/21728,0.011366054105200907,0.10011086078866611,0.07968320015676239,ACSL3/ELOVL2,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,2/73,49/21728,0.011824187058760666,0.10312998273689791,0.08208626908058751,PIPOX/ADAM19,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,2/73,49/21728,0.011824187058760666,0.10312998273689791,0.08208626908058751,GADD45A/PDGFA,2
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,3/73,141/21728,0.01195116574803985,0.1037314774635692,0.08256502857102645,TRIO/RBCK1/VAV3,3
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,3/73,142/21728,0.012180140268096488,0.10414746448756536,0.08289613327869325,TRIB2/SCRN1/EPAS1,3
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,2/73,50/21728,0.012290332777895017,0.10414746448756536,0.08289613327869325,SPRY4/PIPOX,2
REACTOME_SIGNALING_BY_EGFR,REACTOME_SIGNALING_BY_EGFR,2/73,50/21728,0.012290332777895017,0.10414746448756536,0.08289613327869325,SPRY1/SPRY2,2
REACTOME_SIGNALING_BY_FGFR1,REACTOME_SIGNALING_BY_FGFR1,2/73,50/21728,0.012290332777895017,0.10414746448756536,0.08289613327869325,SPRY2/SPRED2,2
ZHAN_MULTIPLE_MYELOMA_MS_UP,ZHAN_MULTIPLE_MYELOMA_MS_UP,2/73,50/21728,0.012290332777895017,0.10414746448756536,0.08289613327869325,SPRY2/FGFR3,2
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,5/73,411/21728,0.012411114577922867,0.10467487200625512,0.08331592308516243,SPRY2/ELOVL2/NT5E/SPRED2/DPY19L1,5
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,4/73,267/21728,0.012512142982791047,0.1047018752552225,0.0833374163105268,GADD45A/DUSP6/PDGFA/FGFR3,4
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,5/73,412/21728,0.012531432496989717,0.1047018752552225,0.0833374163105268,LAMA2/ADAMTS9/SPRY4/FEM1C/RASSF2,5
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,4/73,268/21728,0.012670110112536288,0.10536817154053434,0.08386775457600519,SATB2/CDH4/ANKRD10/DPY19L1,4
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,2/73,51/21728,0.01276443379224682,0.10566114639137647,0.08410094779297125,GADD45A/GAS1,2
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,PDGFA/PPARGC1A,2
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,TRIB2/GRB10,2
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,DUSP6/SPRY1,2
PID_KIT_PATHWAY,PID_KIT_PATHWAY,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,GRB10/SPRED2,2
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,GRB10/RBCK1,2
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,2/73,52/21728,0.013246432917882583,0.10619023667425302,0.08452207699493118,LAMA2/LMO2,2
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,4/73,272/21728,0.013314760020489749,0.10619023667425302,0.08452207699493118,FNDC3A/ACSL3/RAB5A/SPRY2,4
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,3/73,147/21728,0.013362865353303654,0.10619023667425302,0.08452207699493118,LAMA2/ADAMTS9/ETV4,3
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,3/73,147/21728,0.013362865353303654,0.10619023667425302,0.08452207699493118,POSTN/LZTS1/DLC1,3
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,3/73,148/21728,0.01360700898183446,0.10765191176778767,0.08568549670908332,FNDC3A/GADD45A/ARID5B,3
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,3/73,149/21728,0.013853694255665905,0.1091207283221614,0.08685460066617345,TRIO/VAV3/DLC1,3
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,5/73,425/21728,0.014168466089561947,0.11017406912248442,0.08769300686070819,EPAS1/TMEM158/HRH1/CDH4/RBCK1,5
BECKER_TAMOXIFEN_RESISTANCE_DN,BECKER_TAMOXIFEN_RESISTANCE_DN,2/73,54/21728,0.014233898191998827,0.11017406912248442,0.08769300686070819,DUSP6/ELOVL2,2
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,2/73,54/21728,0.014233898191998827,0.11017406912248442,0.08769300686070819,SEC24B/ARID5B,2
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,2/73,54/21728,0.014233898191998827,0.11017406912248442,0.08769300686070819,IRS2/FGFR3,2
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,2/73,55/21728,0.014739251393660297,0.11243885124910052,0.089495659301062,GADD45A/BAG5,2
PID_FGF_PATHWAY,PID_FGF_PATHWAY,2/73,55/21728,0.014739251393660297,0.11243885124910052,0.089495659301062,SPRY2/FGFR3,2
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,2/73,55/21728,0.014739251393660297,0.11243885124910052,0.089495659301062,IRS2/HRH1,2
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,4/73,281/21728,0.014840922200664275,0.11243885124910052,0.089495659301062,DUSP6/SPRY2/NT5E/ETV4,4
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,4/73,281/21728,0.014840922200664275,0.11243885124910052,0.089495659301062,GADD45A/OTUD4/PGGT1B/FEM1C,4
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,4/73,282/21728,0.015017042635105891,0.11329313177877356,0.09017562355169072,FNDC3A/GADD45A/DUSP6/FGFR3,4
GRADE_COLON_VS_RECTAL_CANCER_DN,GRADE_COLON_VS_RECTAL_CANCER_DN,2/73,56/21728,0.015252276810526488,0.11410489931891783,0.09082174960507293,BICD1/QTRT1,2
OUILLETTE_CLL_13Q14_DELETION_DN,OUILLETTE_CLL_13Q14_DELETION_DN,2/73,56/21728,0.015252276810526488,0.11410489931891783,0.09082174960507293,FZD3/DUSP6,2
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,3/73,155/21728,0.015387368288983192,0.11463589375292478,0.091244394415374,TRIO/VAV3/DLC1,3
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,2/73,57/21728,0.015772918672388198,0.11534196214432302,0.09180638927300408,ELOVL2/GAS1,2
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,2/73,57/21728,0.015772918672388198,0.11534196214432302,0.09180638927300408,SPRED2/KBTBD2,2
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,2/73,57/21728,0.015772918672388198,0.11534196214432302,0.09180638927300408,GADD45A/ADAM19,2
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,4/73,289/21728,0.01628704538330506,0.11534196214432302,0.09180638927300408,TRIB2/IRS2/ANKRD10/ARID5B,4
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,2/73,58/21728,0.016301121488136134,0.11534196214432302,0.09180638927300408,IRS2/GAS1,2
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,2/73,58/21728,0.016301121488136134,0.11534196214432302,0.09180638927300408,PPARGC1A/VAV3,2
CROMER_TUMORIGENESIS_UP,CROMER_TUMORIGENESIS_UP,2/73,58/21728,0.016301121488136134,0.11534196214432302,0.09180638927300408,POSTN/CHST2,2
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,2/73,58/21728,0.016301121488136134,0.11534196214432302,0.09180638927300408,SCRN1/RASSF2,2
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,2/73,58/21728,0.016301121488136134,0.11534196214432302,0.09180638927300408,NT5E/ARL4A,2
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,4/73,290/21728,0.016473818873695204,0.11534196214432302,0.09180638927300408,BICD1/CHST2/LMO2/DLC1,4
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,4/73,290/21728,0.016473818873695204,0.11534196214432302,0.09180638927300408,POFUT1/ETV4/DPY19L1/KBTBD2,4
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,DUSP6/GLG1,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,NT5E/VAV3,2
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,BICD1/IRS2,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,GADD45A/PDGFA,2
CORRE_MULTIPLE_MYELOMA_DN,CORRE_MULTIPLE_MYELOMA_DN,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,LAMA2/GAS1,2
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,SPRY2/GAS1,2
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,GADD45A/PPARGC1A,2
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,LAMA2/PDGFA,2
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,TRIO/VAV3,2
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,2/73,59/21728,0.01683683004455722,0.11534196214432302,0.09180638927300408,EPAS1/LZTS1,2
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,3/73,161/21728,0.017013320616129247,0.11586117730934506,0.09221965837880285,SCRN1/CHST7/BCAT1,3
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,4/73,293/21728,0.017042220152325364,0.11586117730934506,0.09221965837880285,GADD45A/DUSP6/FGFR3/CNIH3,4
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,2/73,60/21728,0.017379989405135358,0.11770992824387128,0.09369117095591309,SPRY1/ETV4,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,3/73,164/21728,0.017861067051436825,0.12051165240743035,0.0959212021987789,SCRN1/ELOVL2/NCBP2,3
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,4/73,300/21728,0.018415983978694272,0.12198278449525572,0.09709214920380649,FNDC3A/OTUD4/ARID5B/KBTBD2,4
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,4/73,300/21728,0.018415983978694272,0.12198278449525572,0.09709214920380649,GADD45A/OTUD4/RAB5A/SPRY1,4
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,4/73,300/21728,0.018415983978694272,0.12198278449525572,0.09709214920380649,POSTN/CHST2/RASSF2/ADAM19,4
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,3/73,166/21728,0.018439145357772843,0.12198278449525572,0.09709214920380649,TRIO/FGFR3/ALK,3
GEORGES_CELL_CYCLE_MIR192_TARGETS,GEORGES_CELL_CYCLE_MIR192_TARGETS,2/73,62/21728,0.018488442169023657,0.12198278449525572,0.09709214920380649,MACF1/HRH1,2
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,2/73,62/21728,0.018488442169023657,0.12198278449525572,0.09709214920380649,IRS2/GAS1,2
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,4/73,301/21728,0.018617703241859507,0.12223696995623369,0.09729446802121038,LAMA2/ADAMTS9/PDGFA/ADAM19,4
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,3/73,167/21728,0.01873206362863984,0.12223696995623369,0.09729446802121038,BICD1/DUSP6/SPRY4,3
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,3/73,167/21728,0.01873206362863984,0.12223696995623369,0.09729446802121038,FNDC3A/EPAS1/TYRO3,3
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,2/73,63/21728,0.019053627072062786,0.1229887552521598,0.0978928512309667,GADD45A/GAS1,2
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,2/73,63/21728,0.019053627072062786,0.1229887552521598,0.0978928512309667,FGFR3/NCBP2,2
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,2/73,63/21728,0.019053627072062786,0.1229887552521598,0.0978928512309667,GADD45A/FGFR3,2
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,2/73,64/21728,0.01962604577635192,0.125777479301043,0.10011253503768405,POSTN/TMEM158,2
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,3/73,170/21728,0.019626351635901006,0.125777479301043,0.10011253503768405,TRIB2/CHST7/BCAT1,3
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,4/73,307/21728,0.019856972749168866,0.1268009545554069,0.10092716976269288,IRS2/IL1RAP/PDGFA/FGFR3,4
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,2/73,65/21728,0.02020564471104114,0.12811238561468638,0.10197100279704226,GADD45A/IRS2,2
LEE_LIVER_CANCER_ACOX1_DN,LEE_LIVER_CANCER_ACOX1_DN,2/73,65/21728,0.02020564471104114,0.12811238561468638,0.10197100279704226,IL1RAP/PIPOX,2
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,3/73,173/21728,0.020543963680685784,0.12979719809564022,0.10331202862669585,IRS2/SPRY2/ARL4A,3
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,2/73,66/21728,0.020792370574882767,0.1299260597460446,0.10341459600650668,TRIB2/SPRY4,2
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,2/73,66/21728,0.020792370574882767,0.1299260597460446,0.10341459600650668,IL1RAP/PIPOX,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,2/73,66/21728,0.020792370574882767,0.1299260597460446,0.10341459600650668,GADD45A/PPARGC1A,2
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,3/73,174/21728,0.020855021894359504,0.1299260597460446,0.10341459600650668,GADD45A/DUSP6/PGPEP1,3
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,2/73,67/21728,0.02138617033506508,0.13155836967252632,0.10471383244863745,RBCK1/LMO2,2
CADWELL_ATG16L1_TARGETS_DN,CADWELL_ATG16L1_TARGETS_DN,2/73,67/21728,0.02138617033506508,0.13155836967252632,0.10471383244863745,SATB2/PPARGC1A,2
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,2/73,67/21728,0.02138617033506508,0.13155836967252632,0.10471383244863745,GADD45A/IRS2,2
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,5/73,473/21728,0.021450303940565674,0.13155836967252632,0.10471383244863745,FZD3/DUSP6/EPAS1/IL1RAP/FGFR3,5
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,3/73,176/21728,0.0214849239062515,0.13155836967252632,0.10471383244863745,SPRY2/TMEM158/DPY19L1,3
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,4/73,315/21728,0.021587212692791336,0.1317335709717096,0.10485328385361554,DUSP6/NT5E/TMEM158/PDGFA,4
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,4/73,316/21728,0.02180980211149167,0.13263920467805138,0.10557412264495789,DUSP6/IRS2/GRB10/NT5E,4
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,2/73,68/21728,0.021986991226050866,0.13326352648196255,0.1060710513385219,SEC24B/CNIH3,2
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,3/73,179/21728,0.02244924820432493,0.13560559388288168,0.10793521896247264,RAB5A/DUSP6/PIPOX,3
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/73,70/21728,0.02320948666772023,0.1392569200063214,0.11084149055018634,GLG1/PDGFA,2
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,2/73,70/21728,0.02320948666772023,0.1392569200063214,0.11084149055018634,PDGFA/ETV4,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,4/73,323/21728,0.023407501826382553,0.13968418876718525,0.11118157495186297,FGFR3/ETV4/LMO2/ALK,4
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,3/73,182/21728,0.02343694442402437,0.13968418876718525,0.11118157495186297,FZD3/ETV5/CHST7,3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,3/73,183/21728,0.023771370481524567,0.1410924832443824,0.11230250638549687,SPRY1/NT5E/GAS1,3
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,2/73,71/21728,0.023831057013312913,0.1410924832443824,0.11230250638549687,EPAS1/IL1RAP,2
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,3/73,184/21728,0.024108393293606565,0.1417954184505544,0.11286200738558198,TRIO/VAV3/DLC1,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,3/73,184/21728,0.024108393293606565,0.1417954184505544,0.11286200738558198,TRIB2/DUSP6/ARID5B,3
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,2/73,72/21728,0.024459440077236435,0.1429198655493423,0.11375701061033253,TRIO/ARL4A,2
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,2/73,72/21728,0.024459440077236435,0.1429198655493423,0.11375701061033253,GADD45A/ALK,2
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,3/73,186/21728,0.024790227956136186,0.14381127221332982,0.1144665253929247,TRIO/TMEM158/TYRO3,3
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,4/73,329/21728,0.02483243378296851,0.14381127221332982,0.1144665253929247,ACSL3/TMEM158/SPRED2/FEM1C,4
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,5/73,493/21728,0.025094547789512717,0.14381127221332982,0.1144665253929247,EPAS1/GRB10/SPRED2/PGPEP1/ARID5B,5
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,2/73,73/21728,0.025094584413064263,0.14381127221332982,0.1144665253929247,TRIO/ELOVL2,2
REACTOME_SIGNALING_BY_FGFR2,REACTOME_SIGNALING_BY_FGFR2,2/73,73/21728,0.025094584413064263,0.14381127221332982,0.1144665253929247,SPRY2/NCBP2,2
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,2/73,73/21728,0.025094584413064263,0.14381127221332982,0.1144665253929247,SPRY1/GAS1,2
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,2/73,74/21728,0.025736438834771495,0.1465501676323931,0.11664654812139141,ETV5/LMO2,2
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,2/73,74/21728,0.025736438834771495,0.1465501676323931,0.11664654812139141,TRIO/VAV3,2
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,5/73,497/21728,0.02586842510954577,0.14683410824085028,0.11687255053669467,IRS2/TRIO/GRB10/TMEM158/DLC1,5
MCCLUNG_COCAINE_REWARD_5D,MCCLUNG_COCAINE_REWARD_5D,2/73,75/21728,0.026384952415605296,0.14929207252880464,0.1188289662421664,GADD45A/MARK2,2
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,2/73,76/21728,0.0270400744869596,0.1525162560967942,0.12139525388135274,TRIO/VAV3,2
FUJII_YBX1_TARGETS_DN,FUJII_YBX1_TARGETS_DN,3/73,193/21728,0.02725837563710757,0.15326407433694444,0.12199047951462903,TRIO/IL1RAP/NCBP2,3
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,3/73,195/21728,0.027986883841941236,0.1568669225999716,0.12485816516846907,EPAS1/GRB10/EXTL3,3
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,4/73,342/21728,0.02809732947121948,0.15699382842043885,0.12495917580621295,TRIB2/SPRY1/SEC24B/PDGFA,4
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,2/73,78/21728,0.028369942710820894,0.1570447602691881,0.12499971499113524,GLG1/MARK2,2
KEGG_PEROXISOME,KEGG_PEROXISOME,2/73,78/21728,0.028369942710820894,0.1570447602691881,0.12499971499113524,ACSL3/PIPOX,2
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,2/73,78/21728,0.028369942710820894,0.1570447602691881,0.12499971499113524,ARID5B/DLC1,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,3/73,197/21728,0.028725741637373348,0.1585235371840233,0.12617674689320585,SCRN1/DPY19L1/DLC1,3
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,2/73,79/21728,0.029044588806786675,0.1592997692838484,0.12679458852688275,SPRY2/DLC1,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/73,79/21728,0.029044588806786675,0.1592997692838484,0.12679458852688275,GADD45A/PDGFA,2
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,3/73,199/21728,0.029474937953356324,0.16105893994246442,0.12819479971871653,LAMA2/PDGFA/VAV3,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,2/73,80/21728,0.02972564327797162,0.16105893994246442,0.12819479971871653,LMO2/ARL4A,2
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,2/73,80/21728,0.02972564327797162,0.16105893994246442,0.12819479971871653,TRIO/VAV3,2
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,2/73,80/21728,0.02972564327797162,0.16105893994246442,0.12819479971871653,LAMA2/ARL4A,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,3/73,200/21728,0.029853409235685878,0.16126252481391645,0.12835684301684627,BICD1/MACF1/HRH1,3
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,2/73,81/21728,0.03041305672978323,0.16377298625309306,0.13035504380912621,OTUD4/EPAS1,2
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,4/73,351/21728,0.03050134475519015,0.16377298625309306,0.13035504380912621,LAMA2/ADAMTS9/ETV5/ETV4,4
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,3/73,202/21728,0.03061808969610654,0.16390761789412722,0.13046220381070295,LAMA2/PDGFA/VAV3,3
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,2/73,82/21728,0.03110678001911848,0.16504131357324583,0.13136456843931965,SPRY1/EPAS1,2
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,2/73,82/21728,0.03110678001911848,0.16504131357324583,0.13136456843931965,DUSP6/SPRED2,2
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,2/73,82/21728,0.03110678001911848,0.16504131357324583,0.13136456843931965,DUSP6/TRIO,2
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,3/73,204/21728,0.031393075280951234,0.16606751065781303,0.1321813696040052,POSTN/GAS1/NCBP2,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,2/73,83/21728,0.031806764253269774,0.16677564365057582,0.13274500778027698,SPRY2/TNPO1,2
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,2/73,83/21728,0.031806764253269774,0.16677564365057582,0.13274500778027698,FNDC3A/TRIO,2
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,2/73,83/21728,0.031806764253269774,0.16677564365057582,0.13274500778027698,CDH4/ADAM19,2
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,2/73,84/21728,0.032512960788834845,0.16920782586981717,0.13468090225832619,PDGFA/FGFR3,2
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,2/73,84/21728,0.032512960788834845,0.16920782586981717,0.13468090225832619,POSTN/GAS1,2
MATZUK_PREOVULATORY_FOLLICLE,MATZUK_PREOVULATORY_FOLLICLE,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,IRS2,1
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,FZD3,1
RADAEVA_RESPONSE_TO_IFNA1_DN,RADAEVA_RESPONSE_TO_IFNA1_DN,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,PDGFA,1
REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,PPARGC1A,1
REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER,REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,FGFR3,1
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,1/73,10/21728,0.03310053110173883,0.16920782586981717,0.13468090225832619,ELOVL2,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,2/73,85/21728,0.033225321230631565,0.16920782586981717,0.13468090225832619,RAB5A/TYRO3,2
SMID_BREAST_CANCER_LUMINAL_A_UP,SMID_BREAST_CANCER_LUMINAL_A_UP,2/73,85/21728,0.033225321230631565,0.16920782586981717,0.13468090225832619,LAMA2/ELOVL2,2
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,4/73,361/21728,0.03331160777750316,0.16920782586981717,0.13468090225832619,CHST2/PIPOX/RASSF2/ADAM19,4
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,3/73,212/21728,0.0345957387484223,0.17510450445879744,0.13937436125532446,GADD45A/GAS1/RASSF2,3
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,2/73,87/21728,0.03466834148680889,0.17510450445879744,0.13937436125532446,GLG1/IL1RAP,2
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,3/73,213/21728,0.03500758970276054,0.17518804011757824,0.13944085142998106,TRIB2/PDGFA/ARL4A,3
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,3/73,213/21728,0.03500758970276054,0.17518804011757824,0.13944085142998106,PDGFA/FGFR3/VAV3,3
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,2/73,88/21728,0.035398905742216526,0.17518804011757824,0.13944085142998106,ARMC7/ARID5B,2
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,2/73,88/21728,0.035398905742216526,0.17518804011757824,0.13944085142998106,GADD45A/ETV5,2
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,2/73,88/21728,0.035398905742216526,0.17518804011757824,0.13944085142998106,TRIO/VAV3,2
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,2/73,89/21728,0.03613544278376905,0.17518804011757824,0.13944085142998106,GADD45A/DUSP6,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/73,89/21728,0.03613544278376905,0.17518804011757824,0.13944085142998106,GADD45A/DUSP6,2
BIOCARTA_SRCRPTP_PATHWAY,BIOCARTA_SRCRPTP_PATHWAY,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,PTPRA,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,BCAT1,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,ETV4,1
PID_INTEGRIN4_PATHWAY,PID_INTEGRIN4_PATHWAY,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,LAMA2,1
REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,ACSL3,1
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,CHRNA9,1
REACTOME_PEXOPHAGY,REACTOME_PEXOPHAGY,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,EPAS1,1
REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,EPAS1,1
REACTOME_SIGNALING_BY_LEPTIN,REACTOME_SIGNALING_BY_LEPTIN,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,IRS2,1
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,1/73,11/21728,0.0363505385255154,0.17518804011757824,0.13944085142998106,NCBP2,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,3/73,218/21728,0.03710505570909621,0.17834365485984954,0.14195256173938336,ADAMTS9/DUSP6/LMO2,3
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,2/73,91/21728,0.037626246786252864,0.18036388539898154,0.14356056344014073,EPAS1/ARID5B,2
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,2/73,92/21728,0.03838042013109429,0.1829108797645981,0.14558784260081045,NT5E/TMEM158,2
BENPORATH_ES_1,BENPORATH_ES_1,4/73,379/21728,0.03874186178749025,0.1829108797645981,0.14558784260081045,SPRY4/CHST7/PIPOX/ETV4,4
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,3/73,222/21728,0.03882870681790614,0.1829108797645981,0.14558784260081045,SPRY2/BAG5/ARL4A,3
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,2/73,93/21728,0.03914037902779403,0.1829108797645981,0.14558784260081045,MACF1/EPAS1,2
KIM_MYCN_AMPLIFICATION_TARGETS_UP,KIM_MYCN_AMPLIFICATION_TARGETS_UP,2/73,93/21728,0.03914037902779403,0.1829108797645981,0.14558784260081045,MACF1/BCAT1,2
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,3/73,223/21728,0.03926593791664752,0.1829108797645981,0.14558784260081045,DUSP6/HRH1/FEM1C,3
KIM_GERMINAL_CENTER_T_HELPER_DN,KIM_GERMINAL_CENTER_T_HELPER_DN,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,IRS2,1
MIZUKAMI_HYPOXIA_UP,MIZUKAMI_HYPOXIA_UP,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,PDGFA,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,SHROOM2,1
REACTOME_ALK_MUTANTS_BIND_TKIS,REACTOME_ALK_MUTANTS_BIND_TKIS,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,ALK,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,IRS2,1
REACTOME_LYSINE_CATABOLISM,REACTOME_LYSINE_CATABOLISM,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,PIPOX,1
REACTOME_PYRIMIDINE_CATABOLISM,REACTOME_PYRIMIDINE_CATABOLISM,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,NT5E,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_6,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,1/73,12/21728,0.03958977095576033,0.1829108797645981,0.14558784260081045,LMO2,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,3/73,224/21728,0.03970568976603101,0.18297364253006043,0.14563779859922388,LAMA2/GADD45A/NCBP2,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,4/73,383/21728,0.040013775821262754,0.18391936033012288,0.14639054230915233,NT5E/HRH1/PGGT1B/FEM1C,4
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,2/73,95/21728,0.04067746887700862,0.1864905496207472,0.14843707941083847,POSTN/LMO2,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,2/73,96/21728,0.04145450812260617,0.18956690670900214,0.15088570462178902,FGFR3/KLHL4,2
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,3/73,229/21728,0.04194213896913432,0.18994894268794268,0.15118978600853555,DUSP6/SPRY2/BCAT1,3
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,2/73,97/21728,0.042237149504153755,0.18994894268794268,0.15118978600853555,TRIB2/MACF1,2
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,2/73,97/21728,0.042237149504153755,0.18994894268794268,0.15118978600853555,TRIO/VAV3,2
BIOCARTA_RAB_PATHWAY,BIOCARTA_RAB_PATHWAY,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,RAB5A,1
ONGUSAHA_BRCA1_TARGETS_UP,ONGUSAHA_BRCA1_TARGETS_UP,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,GADD45A,1
REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,ELOVL2,1
REACTOME_ERKS_ARE_INACTIVATED,REACTOME_ERKS_ARE_INACTIVATED,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,DUSP6,1
REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,FGFR3,1
REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,SPRED2,1
REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,RAB5A,1
WU_HBX_TARGETS_3_DN,WU_HBX_TARGETS_3_DN,1/73,13/21728,0.04281826362108698,0.18994894268794268,0.15118978600853555,GLG1,1
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,2/73,98/21728,0.043025347756497086,0.18994894268794268,0.15118978600853555,IL1RAP/FGFR3,2
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,2/73,98/21728,0.043025347756497086,0.18994894268794268,0.15118978600853555,EPAS1/ETV4,2
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,2/73,98/21728,0.043025347756497086,0.18994894268794268,0.15118978600853555,LAMA2/GADD45A,2
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,2/73,99/21728,0.043819057847951974,0.1929765404732466,0.15359960127153505,CDH4/FGFR3,2
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,3/73,235/21728,0.04470831176493588,0.19640899615652418,0.1563316630187335,TMEM158/CHST7/ADAM19,3
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,3/73,236/21728,0.045178029439420224,0.19728942345945896,0.15703243878322648,RAB5A/CHST2/MARK2,3
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,4/73,400/21728,0.04568449008558823,0.19728942345945896,0.15703243878322648,DUSP6/SATB2/IRS2/SEC24B,4
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,SHROOM2,1
DAZARD_UV_RESPONSE_CLUSTER_G3,DAZARD_UV_RESPONSE_CLUSTER_G3,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,LAMA2,1
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,CHRNA9,1
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,TRIO,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,IRS2,1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,GRB10,1
ZHANG_ADIPOGENESIS_BY_BMP7,ZHANG_ADIPOGENESIS_BY_BMP7,1/73,14/21728,0.04603605163654412,0.19728942345945896,0.15703243878322648,GRB10,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,3/73,238/21728,0.046124875772392576,0.19728942345945896,0.15703243878322648,SPRY1/BCAT1/DLC1,3
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,2/73,102/21728,0.04623281232075688,0.19728942345945896,0.15703243878322648,POSTN/IRS2,2
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,2/73,102/21728,0.04623281232075688,0.19728942345945896,0.15703243878322648,FZD3/FGFR3,2
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,3/73,240/21728,0.04708157524989634,0.20043299177813012,0.15953456074651592,DUSP6/LMO2/ADAM19,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,3/73,242/21728,0.0480480932988313,0.20240640911981356,0.16110530150122918,ETV5/SPRY2/NCBP2,3
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,4/73,407/21728,0.04814420755128927,0.20240640911981356,0.16110530150122918,POSTN/GLG1/EXTL3/ANKRD10,4
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,3/73,243/21728,0.04853502324624849,0.20240640911981356,0.16110530150122918,POSTN/ELOVL2/ARL4A,3
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,2/73,105/21728,0.04869457440418654,0.20240640911981356,0.16110530150122918,RAB5A/DUSP6,2
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,2/73,105/21728,0.04869457440418654,0.20240640911981356,0.16110530150122918,TRIO/FGFR3,2
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,2/73,105/21728,0.04869457440418654,0.20240640911981356,0.16110530150122918,POSTN/PDGFA,2
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,4/73,409/21728,0.048860329328238764,0.20240640911981356,0.16110530150122918,GAS1/RASSF2/BCAT1/ARID5B,4
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,4/73,410/21728,0.049220612510309895,0.20240640911981356,0.16110530150122918,ADAMTS9/GLG1/ELOVL2/EPAS1,4
BIOCARTA_PGC1A_PATHWAY,BIOCARTA_PGC1A_PATHWAY,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,PPARGC1A,1
HAHTOLA_CTCL_PATHOGENESIS,HAHTOLA_CTCL_PATHOGENESIS,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,VAV3,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,CHST2,1
LEE_SP4_THYMOCYTE,LEE_SP4_THYMOCYTE,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,SPRY2,1
LIU_IL13_PRIMING_MODEL,LIU_IL13_PRIMING_MODEL,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,ETV5,1
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,GRB10,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,1/73,15/21728,0.049243170003981485,0.20240640911981356,0.16110530150122918,ARID5B,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,2/73,106/21728,0.04952562588010225,0.20310050246243766,0.16165776482351096,RAB5A/MARK2,2
SERVITJA_ISLET_HNF1A_TARGETS_DN,SERVITJA_ISLET_HNF1A_TARGETS_DN,2/73,107/21728,0.050361837224760335,0.20605712805004914,0.1640110897937516,ETV5/ELOVL2,2
WP_THERMOGENESIS,WP_THERMOGENESIS,2/73,108/21728,0.05120316546219196,0.20743827579420557,0.16511041379592953,ACSL3/PPARGC1A,2
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,3/73,250/21728,0.05201162982600126,0.20743827579420557,0.16511041379592953,MACF1/RASSF2/ANKRD10,3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,3/73,250/21728,0.05201162982600126,0.20743827579420557,0.16511041379592953,ACSL3/SPRED2/ADAM19,3
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,2/73,109/21728,0.0520495678398575,0.20743827579420557,0.16511041379592953,TYRO3/MARK2,2
BIOCARTA_P53_PATHWAY,BIOCARTA_P53_PATHWAY,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,GADD45A,1
FERRANDO_LYL1_NEIGHBORS,FERRANDO_LYL1_NEIGHBORS,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,LMO2,1
INGA_TP53_TARGETS,INGA_TP53_TARGETS,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,GADD45A,1
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,BCAT1,1
MOOTHA_TCA,MOOTHA_TCA,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,IDH3B,1
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,SPRY2,1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,RASSF2,1
TIAN_BHLHA15_TARGETS,TIAN_BHLHA15_TARGETS,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,FNDC3A,1
WANG_RECURRENT_LIVER_CANCER_DN,WANG_RECURRENT_LIVER_CANCER_DN,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,PGGT1B,1
WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,ALK,1
WP_NAD_METABOLISM,WP_NAD_METABOLISM,1/73,16/21728,0.052439653612405435,0.20743827579420557,0.16511041379592953,NT5E,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,2/73,110/21728,0.0529010018276644,0.20880130522707274,0.16619531653538344,FGFR3/TYRO3,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,4/73,421/21728,0.05328135071381927,0.2098393283619138,0.16702153064011976,DUSP6/FGFR3/TYRO3/CNIH3,4
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,2/73,111/21728,0.05375742511698935,0.21078569322187932,0.1677747893771228,ELOVL2/VAV3,2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,2/73,111/21728,0.05375742511698935,0.21078569322187932,0.1677747893771228,TRIB2/BCAT1,2
PASINI_SUZ12_TARGETS_UP,PASINI_SUZ12_TARGETS_UP,2/73,112/21728,0.054618795619703696,0.21088162657421902,0.1678511474910774,SATB2/EPAS1,2
AMIT_SERUM_RESPONSE_20_MCF10A,AMIT_SERUM_RESPONSE_20_MCF10A,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,DUSP6,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,TNPO1,1
HE_PTEN_TARGETS_UP,HE_PTEN_TARGETS_UP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,PDGFA,1
KANG_AR_TARGETS_UP,KANG_AR_TARGETS_UP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,PDGFA,1
LIU_IL13_MEMORY_MODEL_UP,LIU_IL13_MEMORY_MODEL_UP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,SPRY4,1
MATTHEWS_AP1_TARGETS,MATTHEWS_AP1_TARGETS,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,SPRY1,1
PIONTEK_PKD1_TARGETS_DN,PIONTEK_PKD1_TARGETS_DN,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,PDGFA,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,GADD45A,1
REACTOME_PURINE_CATABOLISM,REACTOME_PURINE_CATABOLISM,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,NT5E,1
REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,TNPO1,1
RODRIGUES_NTN1_TARGETS_UP,RODRIGUES_NTN1_TARGETS_UP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,SATB2,1
WP_LEPTININSULIN_SIGNALING_OVERLAP,WP_LEPTININSULIN_SIGNALING_OVERLAP,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,IRS2,1
WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,1/73,17/21728,0.055625537238340184,0.21088162657421902,0.1678511474910774,ACSL3,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,4/73,428/21728,0.055958389237936286,0.21088162657421902,0.1678511474910774,MACF1/TNPO1/SEC24B/FEM1C,4
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/73,114/21728,0.05635621100944132,0.21088162657421902,0.1678511474910774,NT5E/IL1RAP,2
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,2/73,114/21728,0.05635621100944132,0.21088162657421902,0.1678511474910774,FNDC3A/ARL4A,2
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,2/73,115/21728,0.05723217281396733,0.21088162657421902,0.1678511474910774,BAG5/KBTBD2,2
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,2/73,115/21728,0.05723217281396733,0.21088162657421902,0.1678511474910774,DUSP6/SPRED2,2
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,4/73,433/21728,0.05791463536967789,0.21088162657421902,0.1678511474910774,POSTN/LAMA2/ETV5/PDGFA,4
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,2/73,116/21728,0.05811291566496689,0.21088162657421902,0.1678511474910774,LMO2/ARL4A,2
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,2/73,116/21728,0.05811291566496689,0.21088162657421902,0.1678511474910774,FNDC3A/IRS2,2
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,2/73,116/21728,0.05811291566496689,0.21088162657421902,0.1678511474910774,TRIB2/SCRN1,2
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,3/73,263/21728,0.05877992563433628,0.21088162657421902,0.1678511474910774,FZD3/CHST2/BCAT1,3
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,3/73,263/21728,0.05877992563433628,0.21088162657421902,0.1678511474910774,ELOVL2/FGFR3/RASSF2,3
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,ARID5B,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,SPRY1,1
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,DUSP6,1
REACTOME_ACTIVATION_OF_SMO,REACTOME_ACTIVATION_OF_SMO,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,GAS1,1
REACTOME_PI_3K_CASCADE_FGFR3,REACTOME_PI_3K_CASCADE_FGFR3,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,FGFR3,1
REACTOME_SHC_MEDIATED_CASCADE_FGFR3,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,FGFR3,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,GADD45A,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,GADD45A,1
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,IDH3B,1
STAMBOLSKY_BOUND_BY_MUTATED_TP53,STAMBOLSKY_BOUND_BY_MUTATED_TP53,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,MARK2,1
THUM_MIR21_TARGETS_HEART_DISEASE_UP,THUM_MIR21_TARGETS_HEART_DISEASE_UP,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,POSTN,1
WP_FATTY_ACID_TRANSPORTERS,WP_FATTY_ACID_TRANSPORTERS,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,ACSL3,1
WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,RAB5A,1
WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,FGFR3,1
WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,IDH3B,1
WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1/73,18/21728,0.05880085554618408,0.21088162657421902,0.1678511474910774,SATB2,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,4/73,436/21728,0.05910595820610835,0.21088162657421902,0.1678511474910774,TMEM158/IDH3B/NCBP2/ANKRD10,4
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,3/73,265/21728,0.05985660742562209,0.21088162657421902,0.1678511474910774,IRS2/MACF1/TNPO1,3
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,3/73,265/21728,0.05985660742562209,0.21088162657421902,0.1678511474910774,DUSP6/GLG1/IL1RAP,3
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,3/73,265/21728,0.05985660742562209,0.21088162657421902,0.1678511474910774,PPARGC1A/DLC1/ALK,3
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,4/73,438/21728,0.05990747953668178,0.21088162657421902,0.1678511474910774,ADAMTS9/RAB5A/GRB10/SHROOM2,4
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,2/73,119/21728,0.060783421568187904,0.21088162657421902,0.1678511474910774,BICD1/GADD45A,2
WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,2/73,119/21728,0.060783421568187904,0.21088162657421902,0.1678511474910774,FZD3/FGFR3,2
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,2/73,119/21728,0.060783421568187904,0.21088162657421902,0.1678511474910774,GADD45A/PTPRA,2
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,2/73,119/21728,0.060783421568187904,0.21088162657421902,0.1678511474910774,POSTN/GAS1,2
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,3/73,267/21728,0.060942608289397716,0.21088162657421902,0.1678511474910774,IL1RAP/CHST7/PPARGC1A,3
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2/73,120/21728,0.061682880746331346,0.21088162657421902,0.1678511474910774,SATB2/PPARGC1A,2
BIOCARTA_IL12_PATHWAY,BIOCARTA_IL12_PATHWAY,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,ETV5,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,ACSL3,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,DUSP6,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,ADAMTS9,1
HEDENFALK_BREAST_CANCER_BRACX_UP,HEDENFALK_BREAST_CANCER_BRACX_UP,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,SPRY1,1
JEON_SMAD6_TARGETS_DN,JEON_SMAD6_TARGETS_DN,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,IRS2,1
MARSON_FOXP3_CORE_DIRECT_TARGETS,MARSON_FOXP3_CORE_DIRECT_TARGETS,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,DUSP6,1
PID_EPHA2_FWD_PATHWAY,PID_EPHA2_FWD_PATHWAY,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,VAV3,1
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,DUSP6,1
REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,ALK,1
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,NCBP2,1
REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,NCBP2,1
SCIBETTA_KDM5B_TARGETS_UP,SCIBETTA_KDM5B_TARGETS_UP,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,GADD45A,1
STREICHER_LSM1_TARGETS_DN,STREICHER_LSM1_TARGETS_DN,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,IL1RAP,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,GRB10,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,EXTL3,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/73,19/21728,0.061965643088567,0.21088162657421902,0.1678511474910774,PPARGC1A,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,3/73,269/21728,0.06203788343290783,0.21088162657421902,0.1678511474910774,DUSP6/TMEM158/GAS1,3
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,2/73,121/21728,0.06258691810813984,0.21190209929337264,0.16866339234936994,IRS2/TRIO,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,2/73,121/21728,0.06258691810813984,0.21190209929337264,0.16866339234936994,TRIB2/DUSP6,2
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,2/73,123/21728,0.06440856784913225,0.21190209929337264,0.16866339234936994,BCAT1/DPY19L1,2
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,2/73,123/21728,0.06440856784913225,0.21190209929337264,0.16866339234936994,ACSL3/FGFR3,2
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,2/73,123/21728,0.06440856784913225,0.21190209929337264,0.16866339234936994,CDH4/FGFR3,2
BIOCARTA_ATM_PATHWAY,BIOCARTA_ATM_PATHWAY,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GADD45A,1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,SPRY1,1
DAZARD_UV_RESPONSE_CLUSTER_G28,DAZARD_UV_RESPONSE_CLUSTER_G28,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GADD45A,1
HUI_MAPK14_TARGETS_UP,HUI_MAPK14_TARGETS_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GADD45A,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GAS1,1
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,ELOVL2,1
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,POSTN,1
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,CHST7,1
REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,FGFR3,1
REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,IL1RAP,1
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GAS1,1
WP_MITOCHONDRIAL_GENE_EXPRESSION,WP_MITOCHONDRIAL_GENE_EXPRESSION,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,PPARGC1A,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GADD45A,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/73,20/21728,0.06511993430670371,0.21190209929337264,0.16866339234936994,GADD45A,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,2/73,124/21728,0.06532610098565937,0.21190209929337264,0.16866339234936994,CHST2/CHST7,2
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,4/73,453/21728,0.06610422081031479,0.21190209929337264,0.16866339234936994,DUSP6/ELOVL2/NT5E/FGFR3,4
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,2/73,125/21728,0.0662480538186848,0.21190209929337264,0.16866339234936994,SATB2/GRB10,2
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,2/73,125/21728,0.0662480538186848,0.21190209929337264,0.16866339234936994,GADD45A/DUSP6,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/73,125/21728,0.0662480538186848,0.21190209929337264,0.16866339234936994,DUSP6/PTPRA,2
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,3/73,278/21728,0.0670801582493004,0.21190209929337264,0.16866339234936994,GRB10/TNPO1/VAV3,3
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,2/73,126/21728,0.06717438724687058,0.21190209929337264,0.16866339234936994,RAB5A/HRH1,2
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,2/73,126/21728,0.06717438724687058,0.21190209929337264,0.16866339234936994,VAV3/DPY19L1,2
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,2/73,126/21728,0.06717438724687058,0.21190209929337264,0.16866339234936994,GADD45A/SPRY1,2
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,2/73,127/21728,0.06810506237522015,0.21190209929337264,0.16866339234936994,GLG1/PDGFA,2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GADD45A,1
BIOCARTA_P53HYPOXIA_PATHWAY,BIOCARTA_P53HYPOXIA_PATHWAY,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GADD45A,1
BIOCARTA_RAC1_PATHWAY,BIOCARTA_RAC1_PATHWAY,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,TRIO,1
CHIBA_RESPONSE_TO_TSA_DN,CHIBA_RESPONSE_TO_TSA_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GRB10,1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GADD45A,1
FINETTI_BREAST_CANCERS_KINOME_BLUE,FINETTI_BREAST_CANCERS_KINOME_BLUE,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,FGFR3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,KLHL4,1
GESERICK_TERT_TARGETS_DN,GESERICK_TERT_TARGETS_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,DUSP6,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,IL1RAP,1
JACKSON_DNMT1_TARGETS_DN,JACKSON_DNMT1_TARGETS_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GRB10,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,GADD45A,1
MALTA_CURATED_STEMNESS_MARKERS,MALTA_CURATED_STEMNESS_MARKERS,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,EPAS1,1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,PPARGC1A,1
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,ETV5,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,VAV3,1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,ARL4A,1
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,BCAT1,1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,LAMA2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,DUSP6,1
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,IRS2,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/73,21/21728,0.06826376353075092,0.21190209929337264,0.16866339234936994,PPARGC1A,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,3/73,283/21728,0.0699605965307931,0.2131187495567966,0.1696317846466437,IRS2/RASSF2/ADAM19,3
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,2/73,129/21728,0.06997928317865429,0.2131187495567966,0.1696317846466437,RAB5A/GRB10,2
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,2/73,130/21728,0.07092275208725012,0.2131187495567966,0.1696317846466437,DUSP6/BCAT1,2
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,2/73,130/21728,0.07092275208725012,0.2131187495567966,0.1696317846466437,PPARGC1A/ALK,2
BIOCARTA_EDG1_PATHWAY,BIOCARTA_EDG1_PATHWAY,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,PDGFA,1
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,BCAT1,1
GAVIN_PDE3B_TARGETS,GAVIN_PDE3B_TARGETS,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,NT5E,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,IL1RAP,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,TYRO3,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,ARID5B,1
KANNAN_TP53_TARGETS_DN,KANNAN_TP53_TARGETS_DN,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,ARL4A,1
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,ELOVL2,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,CHST7,1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,ETV5,1
LANDIS_ERBB2_BREAST_TUMORS_65_UP,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,DUSP6,1
LU_TUMOR_ENDOTHELIAL_MARKERS_UP,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,POSTN,1
PID_HEDGEHOG_2PATHWAY,PID_HEDGEHOG_2PATHWAY,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,GAS1,1
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,IDH3B,1
REACTOME_ERK_MAPK_TARGETS,REACTOME_ERK_MAPK_TARGETS,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,DUSP6,1
WP_FATTY_ACID_BIOSYNTHESIS,WP_FATTY_ACID_BIOSYNTHESIS,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,ACSL3,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,FGFR3,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,GADD45A,1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,1/73,22/21728,0.07139716498015725,0.2131187495567966,0.1696317846466437,RASSF2,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,3/73,286/21728,0.07171559145063791,0.21346227837253817,0.1699052162720308,DUSP6/SPRED2/PIPOX,3
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,2/73,131/21728,0.0718704091612237,0.21346227837253817,0.1699052162720308,RAB5A/TYRO3,2
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,2/73,131/21728,0.0718704091612237,0.21346227837253817,0.1699052162720308,ELOVL2/ARID5B,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,4/73,467/21728,0.07218014882157618,0.21402670993860398,0.17035447535440515,SPRY2/SPRED2/IDH3B/PGPEP1,4
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,2/73,132/21728,0.0728222165236566,0.21557305156340728,0.1715852853607245,PDGFA/FGFR3,2
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,2/73,133/21728,0.07377813649854623,0.21665377057245663,0.17244548322969583,SPRY1/RBCK1,2
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,2/73,133/21728,0.07377813649854623,0.21665377057245663,0.17244548322969583,GLG1/CDH4,2
BIOCARTA_PTDINS_PATHWAY,BIOCARTA_PTDINS_PATHWAY,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,RAB5A,1
GENTILE_UV_HIGH_DOSE_UP,GENTILE_UV_HIGH_DOSE_UP,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,GADD45A,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,DPY19L1,1
REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,NCBP2,1
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,DUSP6,1
REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,RAB5A,1
WANG_RESPONSE_TO_FORSKOLIN_UP,WANG_RESPONSE_TO_FORSKOLIN_UP,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,ACSL3,1
WP_GDNFRET_SIGNALING_AXIS,WP_GDNFRET_SIGNALING_AXIS,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,SPRY1,1
ZIRN_TRETINOIN_RESPONSE_WT1_UP,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1/73,23/21728,0.07452017276401612,0.21665377057245663,0.17244548322969583,DLC1,1
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,2/73,134/21728,0.07473813160991344,0.21693470668591758,0.1726690942183919,DUSP6/IRS2,2
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,4/73,476/21728,0.07623313947036778,0.21931160572016192,0.1745609860671488,GADD45A/EPAS1/POFUT1/ARL4A,4
BIOCARTA_G2_PATHWAY,BIOCARTA_G2_PATHWAY,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,GADD45A,1
JEON_SMAD6_TARGETS_UP,JEON_SMAD6_TARGETS_UP,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,TRIO,1
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,NT5E,1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,BCAT1,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,ADAM19,1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,PDGFA,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,RASSF2,1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,IRS2,1
REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,SATB2,1
RUAN_RESPONSE_TO_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TROGLITAZONE_UP,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,ARL4A,1
SA_B_CELL_RECEPTOR_COMPLEXES,SA_B_CELL_RECEPTOR_COMPLEXES,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,VAV3,1
WANG_LSD1_TARGETS_UP,WANG_LSD1_TARGETS_UP,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,PDGFA,1
ZHAN_MULTIPLE_MYELOMA_SPIKED,ZHAN_MULTIPLE_MYELOMA_SPIKED,1/73,24/21728,0.07763282088141887,0.21931160572016192,0.1745609860671488,FGFR3,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,2/73,137/21728,0.07764219598482243,0.21931160572016192,0.1745609860671488,POSTN/MACF1,2
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,2/73,137/21728,0.07764219598482243,0.21931160572016192,0.1745609860671488,IRS2/PPARGC1A,2
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,2/73,137/21728,0.07764219598482243,0.21931160572016192,0.1745609860671488,FNDC3A/SPRY4,2
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,4/73,481/21728,0.07853395973059402,0.22136881902831346,0.17619842418831966,ACSL3/MACF1/SEC24B/EXTL3,4
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,2/73,138/21728,0.078618120851778,0.22136881902831346,0.17619842418831966,GADD45A/IRS2,2
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,2/73,139/21728,0.07959793644471547,0.2214025093260432,0.17622523996750875,TMEM158/PDGFA,2
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,4/73,484/21728,0.0799311793701569,0.2214025093260432,0.17622523996750875,LAMA2/SPRY2/NT5E/LZTS1,4
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,4/73,485/21728,0.08039969548678313,0.2214025093260432,0.17622523996750875,POSTN/LAMA2/TRIO/EPAS1,4
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,LMO2,1
IKEDA_MIR30_TARGETS_DN,IKEDA_MIR30_TARGETS_DN,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,SATB2,1
LA_MEN1_TARGETS,LA_MEN1_TARGETS,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,ADAM19,1
LU_TUMOR_ANGIOGENESIS_UP,LU_TUMOR_ANGIOGENESIS_UP,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,PDGFA,1
MATZUK_SPERMATOGONIA,MATZUK_SPERMATOGONIA,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,ETV5,1
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,SEC24B,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,FGFR3,1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,IRS2,1
STEGER_ADIPOGENESIS_DN,STEGER_ADIPOGENESIS_DN,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,POSTN,1
VALK_AML_CLUSTER_8,VALK_AML_CLUSTER_8,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,TMEM158,1
VALK_AML_WITH_EVI1,VALK_AML_WITH_EVI1,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,SPRY1,1
WANG_BARRETTS_ESOPHAGUS_DN,WANG_BARRETTS_ESOPHAGUS_DN,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,FGFR3,1
WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,PPARGC1A,1
WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1/73,25/21728,0.08073514322180098,0.2214025093260432,0.17622523996750875,POSTN,1
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,2/73,141/21728,0.08156909482497529,0.2230054152095655,0.17750107227324416,POFUT1/BCAT1,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,2/73,141/21728,0.08156909482497529,0.2230054152095655,0.17750107227324416,GRB10/GAS1,2
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,4/73,491/21728,0.08323980194061614,0.22404033831800316,0.17832481891318747,CHST2/SCRN1/EPAS1/VAV3,4
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,2/73,143/21728,0.0835553830921254,0.22404033831800316,0.17832481891318747,SPRY4/SPRY2,2
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,2/73,143/21728,0.0835553830921254,0.22404033831800316,0.17832481891318747,TNPO1/TMEM158,2
BIOCARTA_CARM_ER_PATHWAY,BIOCARTA_CARM_ER_PATHWAY,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,PPARGC1A,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,GRB10,1
JI_METASTASIS_REPRESSED_BY_STK11,JI_METASTASIS_REPRESSED_BY_STK11,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,EPAS1,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,EXTL3,1
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,ACSL3,1
PID_HDAC_CLASSIII_PATHWAY,PID_HDAC_CLASSIII_PATHWAY,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,PPARGC1A,1
PID_P38_MKK3_6PATHWAY,PID_P38_MKK3_6PATHWAY,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,GADD45A,1
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,NT5E,1
WAGNER_APO2_SENSITIVITY,WAGNER_APO2_SENSITIVITY,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,POFUT1,1
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,PDGFA,1
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,PDGFA,1
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,1/73,26/21728,0.08382717356529312,0.22404033831800316,0.17832481891318747,IRS2,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,2/73,144/21728,0.08455411176427553,0.22497433308709025,0.17906823168123515,CHST2/SPRY4,2
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,2/73,144/21728,0.08455411176427553,0.22497433308709025,0.17906823168123515,IRS2/VAV3,2
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,2/73,144/21728,0.08455411176427553,0.22497433308709025,0.17906823168123515,SPRY2/ELOVL2,2
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,2/73,145/21728,0.08555651628726169,0.22652069198618702,0.18029905543702154,FNDC3A/OTUD4,2
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,2/73,145/21728,0.08555651628726169,0.22652069198618702,0.18029905543702154,GAS1/VAV3,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,3/73,309/21728,0.08581685128703392,0.22652069198618702,0.18029905543702154,IRS2/ELOVL2/DLC1,3
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,3/73,309/21728,0.08581685128703392,0.22652069198618702,0.18029905543702154,TRIB2/CHST2/ARID5B,3
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,2/73,146/21728,0.08656256151713629,0.22652069198618702,0.18029905543702154,GADD45A/NCBP2,2
LI_WILMS_TUMOR,LI_WILMS_TUMOR,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,ETV4,1
NAKAMURA_CANCER_MICROENVIRONMENT_UP,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,POSTN,1
REACTOME_FGFR2_ALTERNATIVE_SPLICING,REACTOME_FGFR2_ALTERNATIVE_SPLICING,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,NCBP2,1
REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,RAB5A,1
REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,TNPO1,1
REACTOME_SIGNALING_BY_ALK,REACTOME_SIGNALING_BY_ALK,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,ALK,1
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,VAV3,1
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,IRS2,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/73,27/21728,0.08690894558306728,0.22652069198618702,0.18029905543702154,FGFR3,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,2/73,147/21728,0.08757221249870632,0.2279171993416112,0.18141060491572963,ACSL3/ELOVL2,2
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,3/73,314/21728,0.08902883870008474,0.23049444297102967,0.18346196096599088,ETV5/SPRY2/SEC24B,3
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,3/73,314/21728,0.08902883870008474,0.23049444297102967,0.18346196096599088,OTUD4/IL1RAP/RBCK1,3
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,2/73,149/21728,0.08960219283488176,0.23049444297102967,0.18346196096599088,NT5E/GAS1,2
BIOCARTA_PDGF_PATHWAY,BIOCARTA_PDGF_PATHWAY,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,PDGFA,1
BOYAULT_LIVER_CANCER_SUBCLASS_G2,BOYAULT_LIVER_CANCER_SUBCLASS_G2,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,SATB2,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,RASSF2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,TNPO1,1
PID_IL8_CXCR1_PATHWAY,PID_IL8_CXCR1_PATHWAY,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,RAB5A,1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,CHST2,1
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,NCBP2,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/73,28/21728,0.08998049283768383,0.23049444297102967,0.18346196096599088,TRIB2,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,2/73,150/21728,0.0906224532153078,0.23169752872532814,0.18441955659757658,PDGFA/FGFR3,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,3/73,317/21728,0.09098029369454377,0.23169752872532814,0.18441955659757658,GAS1/FGFR3/NCBP2,3
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,3/73,317/21728,0.09098029369454377,0.23169752872532814,0.18441955659757658,ACSL3/EPAS1/MARK2,3
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,SCRN1,1
AIYAR_COBRA1_TARGETS_DN,AIYAR_COBRA1_TARGETS_DN,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,FGFR3,1
BIOCARTA_INFLAM_PATHWAY,BIOCARTA_INFLAM_PATHWAY,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,PDGFA,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,PTPRA,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,GADD45A,1
LU_TUMOR_VASCULATURE_UP,LU_TUMOR_VASCULATURE_UP,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,POSTN,1
REACTOME_DAP12_SIGNALING,REACTOME_DAP12_SIGNALING,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,VAV3,1
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,PDGFA,1
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,LAMA2,1
REACTOME_MRNA_CAPPING,REACTOME_MRNA_CAPPING,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,NCBP2,1
REACTOME_MYOGENESIS,REACTOME_MYOGENESIS,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,CDH4,1
STANELLE_E2F1_TARGETS,STANELLE_E2F1_TARGETS,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,FGFR3,1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,FNDC3A,1
VALK_AML_CLUSTER_2,VALK_AML_CLUSTER_2,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,GRB10,1
WANG_RESPONSE_TO_ANDROGEN_UP,WANG_RESPONSE_TO_ANDROGEN_UP,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,ACSL3,1
WATANABE_COLON_CANCER_MSI_VS_MSS_UP,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,ETV5,1
WOTTON_RUNX_TARGETS_DN,WOTTON_RUNX_TARGETS_DN,1/73,29/21728,0.09304184878343713,0.23169752872532814,0.18441955659757658,FNDC3A,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,3/73,321/21728,0.09361014480094762,0.23246519292235326,0.18503057861239935,DUSP6/BCAT1/LMO2,3
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,3/73,321/21728,0.09361014480094762,0.23246519292235326,0.18503057861239935,IRS2/SPRY1/PPARGC1A,3
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,3/73,323/21728,0.0949369040076943,0.23439886441863314,0.1865696836771412,SCRN1/VAV3/BCAT1,3
LEI_MYB_TARGETS,LEI_MYB_TARGETS,3/73,323/21728,0.0949369040076943,0.23439886441863314,0.1865696836771412,TRIO/TMEM158/ARID5B,3
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2/73,155/21728,0.09577509441398158,0.23439886441863314,0.1865696836771412,SEC24B/CNIH3,2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,POSTN,1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,DUSP6,1
DAZARD_UV_RESPONSE_CLUSTER_G2,DAZARD_UV_RESPONSE_CLUSTER_G2,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,GADD45A,1
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,ADAMTS9,1
PID_CDC42_REG_PATHWAY,PID_CDC42_REG_PATHWAY,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,VAV3,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,PPARGC1A,1
REACTOME_LAMININ_INTERACTIONS,REACTOME_LAMININ_INTERACTIONS,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,LAMA2,1
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,LAMA2,1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,RBCK1,1
WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,1/73,30/21728,0.09609304676669916,0.23439886441863314,0.1865696836771412,GRB10,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,2/73,156/21728,0.09681565490725082,0.23446006164941852,0.186618393588846,TRIB2/ARID5B,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,2/73,156/21728,0.09681565490725082,0.23446006164941852,0.186618393588846,CHST2/DLC1,2
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,2/73,156/21728,0.09681565490725082,0.23446006164941852,0.186618393588846,FZD3/GADD45A,2
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,3/73,327/21728,0.09761380235018789,0.23446006164941852,0.186618393588846,ACSL3/ELOVL2/SPRED2,3
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,2/73,157/21728,0.09785948179810135,0.23446006164941852,0.186618393588846,GADD45A/SPRY2,2
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,GLG1,1
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,IL1RAP,1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,IRS2,1
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,IRS2,1
HUNSBERGER_EXERCISE_REGULATED_GENES,HUNSBERGER_EXERCISE_REGULATED_GENES,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,DUSP6,1
KEGG_CITRATE_CYCLE_TCA_CYCLE,KEGG_CITRATE_CYCLE_TCA_CYCLE,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,IDH3B,1
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,PIPOX,1
MCCABE_HOXC6_TARGETS_CANCER_UP,MCCABE_HOXC6_TARGETS_CANCER_UP,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,GLG1,1
PID_AURORA_A_PATHWAY,PID_AURORA_A_PATHWAY,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,GADD45A,1
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,VAV3,1
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,DUSP6,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,SPRY2,1
REACTOME_NICOTINATE_METABOLISM,REACTOME_NICOTINATE_METABOLISM,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,NT5E,1
REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,SATB2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,EPAS1,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,FNDC3A,1
WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,TRIO,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/73,31/21728,0.0991341200262642,0.23446006164941852,0.186618393588846,MARK2,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,2/73,159/21728,0.0999568032163823,0.2360934797237669,0.18791851206083413,EPAS1/BCAT1,2
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,2/73,160/21728,0.10101023241209306,0.2369276288304964,0.18858245271331162,TRIO/BCAT1,2
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,2/73,160/21728,0.10101023241209306,0.2369276288304964,0.18858245271331162,DUSP6/ARID5B,2
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,2/73,161/21728,0.10206679734034413,0.2369276288304964,0.18858245271331162,IRS2/GRB10,2
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,RAB5A,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,TNPO1,1
KORKOLA_CORRELATED_WITH_POU5F1,KORKOLA_CORRELATED_WITH_POU5F1,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,ETV4,1
MAYBURD_RESPONSE_TO_L663536_UP,MAYBURD_RESPONSE_TO_L663536_UP,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,IL1RAP,1
NOJIMA_SFRP2_TARGETS_UP,NOJIMA_SFRP2_TARGETS_UP,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,GADD45A,1
PID_IL12_STAT4_PATHWAY,PID_IL12_STAT4_PATHWAY,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,ETV5,1
PID_NETRIN_PATHWAY,PID_NETRIN_PATHWAY,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,TRIO,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,CDH4,1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,BICD1,1
WENDT_COHESIN_TARGETS_UP,WENDT_COHESIN_TARGETS_UP,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,TNPO1,1
WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,1/73,32/21728,0.1021651016936872,0.2369276288304964,0.18858245271331162,PPARGC1A,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,3/73,335/21728,0.10305949242709853,0.23838340551054615,0.18974117758757703,LAMA2/PPARGC1A/ALK,3
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,3/73,335/21728,0.10305949242709853,0.23838340551054615,0.18974117758757703,PIPOX/NCBP2/BCAT1,3
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,2/73,163/21728,0.10418920567776226,0.2385246051692692,0.18985356540024256,PIPOX/MARK2,2
BIOCARTA_AGR_PATHWAY,BIOCARTA_AGR_PATHWAY,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,LAMA2,1
PETRETTO_HEART_MASS_QTL_CIS_UP,PETRETTO_HEART_MASS_QTL_CIS_UP,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,TRIO,1
PID_EPO_PATHWAY,PID_EPO_PATHWAY,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,IRS2,1
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,PTPRA,1
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,CDH4,1
REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,NCBP2,1
REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,NCBP2,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,SPRY2,1
VALK_AML_CLUSTER_10,VALK_AML_CLUSTER_10,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,SPRY1,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,PDGFA,1
WP_MONOAMINE_GPCRS,WP_MONOAMINE_GPCRS,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,HRH1,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/73,33/21728,0.10518602479363004,0.2385246051692692,0.18985356540024256,PPARGC1A,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,2/73,164/21728,0.10525498516697619,0.2385246051692692,0.18985356540024256,TRIO/TMEM158,2
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,2/73,164/21728,0.10525498516697619,0.2385246051692692,0.18985356540024256,SATB2/MARK2,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/73,164/21728,0.10525498516697619,0.2385246051692692,0.18985356540024256,PDGFA/FGFR3,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,3/73,341/21728,0.10722231775465298,0.24031813288524914,0.19128112307833325,ACSL3/SPRED2/ADAM19,3
BILANGES_SERUM_RESPONSE_TRANSLATION,BILANGES_SERUM_RESPONSE_TRANSLATION,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,ARID5B,1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,RASSF2,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,DLC1,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,GADD45A,1
MURAKAMI_UV_RESPONSE_6HR_UP,MURAKAMI_UV_RESPONSE_6HR_UP,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,GADD45A,1
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,ARID5B,1
PID_EPHA_FWDPATHWAY,PID_EPHA_FWDPATHWAY,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,VAV3,1
PID_HIF2PATHWAY,PID_HIF2PATHWAY,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,EPAS1,1
PID_IL1_PATHWAY,PID_IL1_PATHWAY,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,IL1RAP,1
PID_IL8_CXCR2_PATHWAY,PID_IL8_CXCR2_PATHWAY,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,RAB5A,1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,CHST2,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,SPRY2,1
SCHRAETS_MLL_TARGETS_DN,SCHRAETS_MLL_TARGETS_DN,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,GAS1,1
WP_16P112_DISTAL_DELETION_SYNDROME,WP_16P112_DISTAL_DELETION_SYNDROME,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,RAB5A,1
WP_FATTY_ACID_BETAOXIDATION,WP_FATTY_ACID_BETAOXIDATION,1/73,34/21728,0.10819692224419775,0.24031813288524914,0.19128112307833325,ACSL3,1
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,2/73,168/21728,0.10954786764514837,0.2424655053912366,0.192990323377459,GAS1/KBTBD2,2
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,3/73,345/21728,0.11003405349780113,0.2424655053912366,0.192990323377459,LAMA2/PDGFA/FGFR3,3
AIGNER_ZEB1_TARGETS,AIGNER_ZEB1_TARGETS,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,CDH4,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,TRIB2,1
GYORFFY_MITOXANTRONE_RESISTANCE,GYORFFY_MITOXANTRONE_RESISTANCE,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,LAMA2,1
JIANG_AGING_HYPOTHALAMUS_DN,JIANG_AGING_HYPOTHALAMUS_DN,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,EPAS1,1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,TRIO,1
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,MARK2,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,VAV3,1
REACTOME_NUCLEOTIDE_CATABOLISM,REACTOME_NUCLEOTIDE_CATABOLISM,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,NT5E,1
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,RBCK1,1
VALK_AML_CLUSTER_9,VALK_AML_CLUSTER_9,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,NT5E,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,IL1RAP,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,MACF1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,1/73,35/21728,0.11119782685727853,0.2424655053912366,0.192990323377459,POSTN,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,2/73,172/21728,0.11388687869094734,0.24480758171932915,0.1948544981069899,SPRY1/RBCK1,2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,ADAM19,1
KAAB_FAILED_HEART_ATRIUM_UP,KAAB_FAILED_HEART_ATRIUM_UP,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,TRIO,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,IL1RAP,1
MARZEC_IL2_SIGNALING_DN,MARZEC_IL2_SIGNALING_DN,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,NT5E,1
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,MARK2,1
MORI_PLASMA_CELL_DN,MORI_PLASMA_CELL_DN,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,LMO2,1
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,GADD45A,1
REACTOME_INTERLEUKIN_7_SIGNALING,REACTOME_INTERLEUKIN_7_SIGNALING,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,IRS2,1
REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,NCBP2,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,GADD45A,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,ARID5B,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,SPRY2,1
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,1/73,36/21728,0.11418877133888172,0.24480758171932915,0.1948544981069899,EPAS1,1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,2/73,174/21728,0.11607306900265696,0.24854927829550977,0.19783270002091674,PIPOX/MARK2,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,GADD45A,1
GENTILE_UV_RESPONSE_CLUSTER_D8,GENTILE_UV_RESPONSE_CLUSTER_D8,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,SPRED2,1
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,FGFR3,1
MATZUK_SPERMATID_DIFFERENTIATION,MATZUK_SPERMATID_DIFFERENTIATION,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,FNDC3A,1
VALK_AML_WITH_CEBPA,VALK_AML_WITH_CEBPA,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,DLC1,1
WANG_LSD1_TARGETS_DN,WANG_LSD1_TARGETS_DN,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,GADD45A,1
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1/73,37/21728,0.117169788289475,0.2488118544674362,0.1980416974213904,PPARGC1A,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,3/73,357/21728,0.1186392695932588,0.2513353246833492,0.20005025254438247,CHRNA9/TNPO1/GAS1,3
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,3/73,357/21728,0.1186392695932588,0.2513353246833492,0.20005025254438247,GADD45A/DUSP6/PTPRA,3
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,2/73,177/21728,0.11937253263390867,0.25183112244469086,0.20044488257695864,ACSL3/ELOVL2,2
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,3/73,359/21728,0.12009762996719753,0.25183112244469086,0.20044488257695864,CHST2/LMO2/DLC1,3
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,GRB10,1
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,GADD45A,1
REACTOME_FLT3_SIGNALING,REACTOME_FLT3_SIGNALING,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,GRB10,1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,DUSP6,1
WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,RAB5A,1
WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,DUSP6,1
WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,1/73,38/21728,0.12014091020431839,0.25183112244469086,0.20044488257695864,FZD3,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,2/73,178/21728,0.12047761584434115,0.25224119101836295,0.20077127649642454,CHST2/ADAM19,2
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,2/73,179/21728,0.12158528101541469,0.254262552579604,0.2023801784337835,ETV4/BCAT1,2
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,2/73,180/21728,0.12269549896797582,0.2555372266555422,0.20339475476174085,TYRO3/LMO2,2
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,2/73,180/21728,0.12269549896797582,0.2555372266555422,0.20339475476174085,NCBP2/BCAT1,2
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,1/73,39/21728,0.12310216947380137,0.2555372266555422,0.20339475476174085,ACSL3,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1/73,39/21728,0.12310216947380137,0.2555372266555422,0.20339475476174085,GADD45A,1
REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,1/73,39/21728,0.12310216947380137,0.2555372266555422,0.20339475476174085,ADAMTS9,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/73,39/21728,0.12310216947380137,0.2555372266555422,0.20339475476174085,DUSP6,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,3/73,364/21728,0.123772884397057,0.2555372266555422,0.20339475476174085,ELOVL2/TMEM158/ARID5B,3
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,2/73,181/21728,0.12380824068481526,0.2555372266555422,0.20339475476174085,RAB5A/FGFR3,2
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,3/73,367/21728,0.1259978591268999,0.2555372266555422,0.20339475476174085,DUSP6/IDH3B/PGPEP1,3
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,2/73,183/21728,0.1260411801478181,0.2555372266555422,0.20339475476174085,GADD45A/FGFR3,2
WU_CELL_MIGRATION,WU_CELL_MIGRATION,2/73,183/21728,0.1260411801478181,0.2555372266555422,0.20339475476174085,EPAS1/ARID5B,2
AIYAR_COBRA1_TARGETS_UP,AIYAR_COBRA1_TARGETS_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,GADD45A,1
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,TRIB2,1
BEIER_GLIOMA_STEM_CELL_UP,BEIER_GLIOMA_STEM_CELL_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,FGFR3,1
BENPORATH_ES_2,BENPORATH_ES_2,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,ETV4,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,GADD45A,1
CROONQUIST_NRAS_SIGNALING_UP,CROONQUIST_NRAS_SIGNALING_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,DUSP6,1
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,GADD45A,1
EHLERS_ANEUPLOIDY_UP,EHLERS_ANEUPLOIDY_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,FNDC3A,1
KAMMINGA_SENESCENCE,KAMMINGA_SENESCENCE,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,QTRT1,1
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,NT5E,1
NABA_BASEMENT_MEMBRANES,NABA_BASEMENT_MEMBRANES,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,LAMA2,1
TOMLINS_PROSTATE_CANCER_UP,TOMLINS_PROSTATE_CANCER_UP,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,BICD1,1
WP_ATM_SIGNALING_PATHWAY,WP_ATM_SIGNALING_PATHWAY,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,GADD45A,1
WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,VAV3,1
WP_PDGF_PATHWAY,WP_PDGF_PATHWAY,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,PDGFA,1
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,1/73,40/21728,0.12605359838377417,0.2555372266555422,0.20339475476174085,DUSP6,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,2/73,185/21728,0.12828387047784287,0.2574145866732143,0.20488903872729644,ARMC7/ETV4,2
WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,2/73,185/21728,0.12828387047784287,0.2574145866732143,0.20488903872729644,CHST2/CHST7,2
WP_RAS_SIGNALING,WP_RAS_SIGNALING,2/73,185/21728,0.12828387047784287,0.2574145866732143,0.20488903872729644,RAB5A/FGFR3,2
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,DUSP6,1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,DUSP6,1
HEIDENBLAD_AMPLICON_8Q24_UP,HEIDENBLAD_AMPLICON_8Q24_UP,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,BAG5,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,ELOVL2,1
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,MARK2,1
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,LAMA2,1
REACTOME_SIGNALING_BY_FGFR4,REACTOME_SIGNALING_BY_FGFR4,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,SPRY2,1
VALK_AML_WITH_FLT3_ITD,VALK_AML_WITH_FLT3_ITD,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,IL1RAP,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,FGFR3,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,TRIO,1
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,1/73,41/21728,0.12899522911588368,0.2574145866732143,0.20488903872729644,GADD45A,1
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2/73,186/21728,0.12940880137481794,0.25795199203809865,0.20531678631550063,SEC24B/CNIH3,2
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,2/73,187/21728,0.13053608529278213,0.25933168944832713,0.2064149559249607,VAV3/PGPEP1,2
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,2/73,187/21728,0.13053608529278213,0.25933168944832713,0.2064149559249607,IDH3B/ADAM19,2
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,2/73,187/21728,0.13053608529278213,0.25933168944832713,0.2064149559249607,SATB2/PPARGC1A,2
CHEN_HOXA5_TARGETS_9HR_DN,CHEN_HOXA5_TARGETS_9HR_DN,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,GLG1,1
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,IRS2,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,FGFR3,1
KEGG_FATTY_ACID_METABOLISM,KEGG_FATTY_ACID_METABOLISM,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,ACSL3,1
KORKOLA_EMBRYONAL_CARCINOMA_UP,KORKOLA_EMBRYONAL_CARCINOMA_UP,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,BCAT1,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,OTUD4,1
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,1/73,42/21728,0.13192709374790057,0.2600723744445934,0.20700450385558122,HRH1,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,3/73,377/21728,0.13351881635587323,0.2620765358328739,0.20859971532205668,CNIH3/BCAT1/DLC1,3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,3/73,377/21728,0.13351881635587323,0.2620765358328739,0.20859971532205668,BICD1/SPRY2/VAV3,3
AMIT_EGF_RESPONSE_480_MCF10A,AMIT_EGF_RESPONSE_480_MCF10A,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,GRB10,1
FUJII_YBX1_TARGETS_UP,FUJII_YBX1_TARGETS_UP,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,TRIB2,1
HAHTOLA_SEZARY_SYNDROM_DN,HAHTOLA_SEZARY_SYNDROM_DN,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,VAV3,1
HUMMEL_BURKITTS_LYMPHOMA_UP,HUMMEL_BURKITTS_LYMPHOMA_UP,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,LZTS1,1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,DUSP6,1
REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,NCBP2,1
REACTOME_SIGNALING_BY_SCF_KIT,REACTOME_SIGNALING_BY_SCF_KIT,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,GRB10,1
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,PPARGC1A,1
REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,NCBP2,1
REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,QTRT1,1
ULE_SPLICING_VIA_NOVA2,ULE_SPLICING_VIA_NOVA2,1/73,43/21728,0.13484922425405144,0.2620765358328739,0.20859971532205668,IDH3B,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,2/73,191/21728,0.13506819543323595,0.26221708299090757,0.20871158377705581,GAS1/ARID5B,2
KEGG_LYSINE_DEGRADATION,KEGG_LYSINE_DEGRADATION,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,PIPOX,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,BCAT1,1
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,RAB5A,1
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,DUSP6,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,ADAM19,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,PDGFA,1
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,FGFR3,1
REACTOME_DAP12_INTERACTIONS,REACTOME_DAP12_INTERACTIONS,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,VAV3,1
REACTOME_TBC_RABGAPS,REACTOME_TBC_RABGAPS,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,RAB5A,1
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,RBCK1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,DUSP6,1
VANHARANTA_UTERINE_FIBROID_UP,VANHARANTA_UTERINE_FIBROID_UP,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,SATB2,1
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,GADD45A,1
WP_GENES_CONTROLLING_NEPHROGENESIS,WP_GENES_CONTROLLING_NEPHROGENESIS,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,ETV4,1
WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,GAS1,1
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,TRIO,1
WP_VASOPRESSINREGULATED_WATER_REABSORPTION,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1/73,44/21728,0.1377616525053521,0.26259897087374157,0.2090155472867647,RAB5A,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,3/73,383/21728,0.1381061251387074,0.2629752414781777,0.20931503972594856,ADAMTS9/PPARGC1A/VAV3,3
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,2/73,194/21728,0.13849063295945868,0.26314692001223394,0.20945168718741333,ACSL3/ARID5B,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/73,194/21728,0.13849063295945868,0.26314692001223394,0.20945168718741333,ARL4A/DLC1,2
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,2/73,195/21728,0.13963574953062458,0.2644117192294886,0.21045840362549662,DUSP6/PDGFA,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,3/73,385/21728,0.13964731316441523,0.2644117192294886,0.21045840362549662,ELOVL2/ZNF12/PGGT1B,3
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,GADD45A,1
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,TYRO3,1
PARK_HSC_AND_MULTIPOTENT_PROGENITORS,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,LMO2,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,RASSF2,1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,TRIB2,1
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,GLG1,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,PPARGC1A,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1/73,45/21728,0.14066441026993037,0.2644117192294886,0.21045840362549662,ARL4A,1
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,2/73,196/21728,0.1407829735494816,0.2644117192294886,0.21045840362549662,POSTN/LAMA2,2
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,2/73,198/21728,0.1430836379847022,0.26544039527764285,0.21127717792027148,GADD45A/TNPO1,2
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,3/73,390/21728,0.14352613292209845,0.26544039527764285,0.21127717792027148,LAMA2/RBCK1/FGFR3,3
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,DUSP6,1
HOLLERN_MICROACINAR_BREAST_TUMOR_UP,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,PPARGC1A,1
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,NCBP2,1
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,PDGFA,1
KRASNOSELSKAYA_ILF3_TARGETS_DN,KRASNOSELSKAYA_ILF3_TARGETS_DN,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,NT5E,1
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,DUSP6,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,DLC1,1
NAKAJIMA_MAST_CELL,NAKAJIMA_MAST_CELL,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,TRIB2,1
NAKAMURA_CANCER_MICROENVIRONMENT_DN,NAKAMURA_CANCER_MICROENVIRONMENT_DN,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,BCAT1,1
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,LAMA2,1
REACTOME_HIV_TRANSCRIPTION_ELONGATION,REACTOME_HIV_TRANSCRIPTION_ELONGATION,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,NCBP2,1
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,GAS1,1
ZHAN_MULTIPLE_MYELOMA_CD1_UP,ZHAN_MULTIPLE_MYELOMA_CD1_UP,1/73,46/21728,0.14355752921335607,0.26544039527764285,0.21127717792027148,KLHL4,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,2/73,199/21728,0.1442370258022793,0.26642128319677205,0.21205791527259854,SPRY1/GAS1,2
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,2/73,200/21728,0.1453924158686085,0.2669078298953652,0.21244518192542902,ETV5/BCAT1,2
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,2/73,200/21728,0.1453924158686085,0.2669078298953652,0.21244518192542902,GRB10/NT5E,2
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,ARID5B,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,ELOVL2,1
KEGG_TYPE_II_DIABETES_MELLITUS,KEGG_TYPE_II_DIABETES_MELLITUS,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,IRS2,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,DUSP6,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,MCDOWELL_ACUTE_LUNG_INJURY_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,CHST2,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,KLHL4,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,SCRN1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,POSTN,1
YANG_BREAST_CANCER_ESR1_LASER_DN,YANG_BREAST_CANCER_ESR1_LASER_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,BICD1,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,ADAM19,1
ZHAN_MULTIPLE_MYELOMA_LB_UP,ZHAN_MULTIPLE_MYELOMA_LB_UP,1/73,47/21728,0.14644104089896715,0.2669078298953652,0.21244518192542902,ARID5B,1
BROWNE_HCMV_INFECTION_2HR_DN,BROWNE_HCMV_INFECTION_2HR_DN,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,DUSP6,1
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,TRIB2,1
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,FEM1C,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,MACF1,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,SCRN1,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,GADD45A,1
HALMOS_CEBPA_TARGETS_UP,HALMOS_CEBPA_TARGETS_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,ARL4A,1
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,RAB5A,1
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,ETV4,1
REACTOME_HEME_SIGNALING,REACTOME_HEME_SIGNALING,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,PPARGC1A,1
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,MACF1,1
WP_ENERGY_METABOLISM,WP_ENERGY_METABOLISM,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,PPARGC1A,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1/73,48/21728,0.14931497678819605,0.26858669868943114,0.21378147687984864,LAMA2,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,2/73,204/21728,0.15003348225539567,0.26933721513318015,0.21437885014721508,NT5E/LMO2,2
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,2/73,204/21728,0.15003348225539567,0.26933721513318015,0.21437885014721508,GLG1/SPRY2,2
FAELT_B_CLL_WITH_VH3_21_DN,FAELT_B_CLL_WITH_VH3_21_DN,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,SCRN1,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,SPRY2,1
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,ADAM19,1
MCCLUNG_DELTA_FOSB_TARGETS_8WK,MCCLUNG_DELTA_FOSB_TARGETS_8WK,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,RASSF2,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,GADD45A,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,GADD45A,1
WP_RETT_SYNDROME_CAUSING_GENES,WP_RETT_SYNDROME_CAUSING_GENES,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,SATB2,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,ZHAN_MULTIPLE_MYELOMA_PR_DN,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,ARID5B,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/73,49/21728,0.15217936824089295,0.27074299543752894,0.21549778042596204,GADD45A,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,2/73,207/21728,0.1535340497635068,0.2714997382663842,0.2161001095820978,EPAS1/ADAM19,2
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,ALK,1
CHUNG_BLISTER_CYTOTOXICITY_DN,CHUNG_BLISTER_CYTOTOXICITY_DN,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,GRB10,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,DPY19L1,1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,CHST7,1
REACTOME_HDMS_DEMETHYLATE_HISTONES,REACTOME_HDMS_DEMETHYLATE_HISTONES,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,ARID5B,1
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,EXTL3,1
REACTOME_NETRIN_1_SIGNALING,REACTOME_NETRIN_1_SIGNALING,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,TRIO,1
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,POSTN,1
TSUNODA_CISPLATIN_RESISTANCE_DN,TSUNODA_CISPLATIN_RESISTANCE_DN,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,EPAS1,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,GADD45A,1
WESTON_VEGFA_TARGETS_6HR,WESTON_VEGFA_TARGETS_6HR,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,POSTN,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,IL1RAP,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,BCAT1,1
ZHOU_TNF_SIGNALING_4HR,ZHOU_TNF_SIGNALING_4HR,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,GADD45A,1
ZHU_CMV_8_HR_DN,ZHU_CMV_8_HR_DN,1/73,50/21728,0.1550342465156478,0.2714997382663842,0.2161001095820978,GAS1,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,2/73,209/21728,0.15587679771319393,0.27270813533384614,0.21706193275130106,IRS2/ETV4,2
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,2/73,210/21728,0.15705080826071074,0.27433314020696503,0.21835535473908907,TRIO/TYRO3,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,3/73,408/21728,0.1577823037041261,0.27433314020696503,0.21835535473908907,FNDC3A/SATB2/HRH1,3
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,1/73,51/21728,0.1578796427701158,0.27433314020696503,0.21835535473908907,KBTBD2,1
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,1/73,51/21728,0.1578796427701158,0.27433314020696503,0.21835535473908907,DUSP6,1
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1/73,51/21728,0.1578796427701158,0.27433314020696503,0.21835535473908907,VAV3,1
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1/73,51/21728,0.1578796427701158,0.27433314020696503,0.21835535473908907,IRS2,1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,1/73,51/21728,0.1578796427701158,0.27433314020696503,0.21835535473908907,RBCK1,1
AUNG_GASTRIC_CANCER,AUNG_GASTRIC_CANCER,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,TYRO3,1
BROWNE_HCMV_INFECTION_1HR_UP,BROWNE_HCMV_INFECTION_1HR_UP,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,FGFR3,1
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,TNPO1,1
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,SPRY2,1
REACTOME_MRNA_SPLICING_MINOR_PATHWAY,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,NCBP2,1
ROSS_AML_WITH_CBFB_MYH11_FUSION,ROSS_AML_WITH_CBFB_MYH11_FUSION,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,DUSP6,1
WINTER_HYPOXIA_DN,WINTER_HYPOXIA_DN,1/73,52/21728,0.16071558806133612,0.2773740071946612,0.22077573161849873,LMO2,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,3/73,412/21728,0.16100943768099166,0.27761318666693646,0.22096610642511366,DUSP6/BCAT1/LMO2,3
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,2/73,215/21728,0.16294625144834732,0.2795538228133299,0.2225107550003662,FNDC3A/GRB10,2
HUPER_BREAST_BASAL_VS_LUMINAL_UP,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,POSTN,1
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,RAB5A,1
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,IL1RAP,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,DUSP6,1
REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,BICD1,1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,RAB5A,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,EPAS1,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/73,53/21728,0.16354211334605318,0.2795538228133299,0.2225107550003662,GADD45A,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,2/73,216/21728,0.16413024970183734,0.27982157861908835,0.22272387512834538,TRIO/HRH1,2
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,PGGT1B,1
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,ARL4A,1
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,PDGFA,1
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,NCBP2,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,GADD45A,1
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,FNDC3A,1
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,DUSP6,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,GADD45A,1
REACTOME_INTRAFLAGELLAR_TRANSPORT,REACTOME_INTRAFLAGELLAR_TRANSPORT,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,TNPO1,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,EPAS1,1
REACTOME_SNRNP_ASSEMBLY,REACTOME_SNRNP_ASSEMBLY,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,NCBP2,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,ROVERSI_GLIOMA_COPY_NUMBER_DN,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,ANKRD10,1
STARK_HYPPOCAMPUS_22Q11_DELETION_UP,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,EPAS1,1
SUNG_METASTASIS_STROMA_DN,SUNG_METASTASIS_STROMA_DN,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,SCRN1,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,VAV3,1
WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1/73,54/21728,0.1663592494810352,0.27982157861908835,0.22272387512834538,BCAT1,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,2/73,219/21728,0.16769163669002715,0.2811065470961232,0.2237466452807951,BCAT1/DLC1,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,2/73,219/21728,0.16769163669002715,0.2811065470961232,0.2237466452807951,TRIB2/DLC1,2
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,2/73,220/21728,0.16888181849306216,0.2811065470961232,0.2237466452807951,SEC24B/NCBP2,2
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,3/73,422/21728,0.16916553430197348,0.2811065470961232,0.2237466452807951,ACSL3/SPRED2/BCAT1,3
KEGG_BASAL_CELL_CARCINOMA,KEGG_BASAL_CELL_CARCINOMA,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,FZD3,1
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,IRS2,1
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,IDH3B,1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,SEC24B,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,TRIO,1
REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,CHRNA9,1
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,ALK,1
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,PPARGC1A,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/73,55/21728,0.16916702722339405,0.2811065470961232,0.2237466452807951,IRS2,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,2/73,222/21728,0.17126662244511662,0.28390976296292714,0.22597786384427027,SATB2/TYRO3,2
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,TYRO3,1
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,OTUD4,1
KEGG_HEDGEHOG_SIGNALING_PATHWAY,KEGG_HEDGEHOG_SIGNALING_PATHWAY,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,GAS1,1
LY_AGING_OLD_DN,LY_AGING_OLD_DN,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,POSTN,1
MCCLUNG_CREB1_TARGETS_DN,MCCLUNG_CREB1_TARGETS_DN,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,RBCK1,1
MODY_HIPPOCAMPUS_POSTNATAL,MODY_HIPPOCAMPUS_POSTNATAL,1/73,56/21728,0.1719654772309005,0.28390976296292714,0.22597786384427027,TYRO3,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,2/73,224/21728,0.17365719435235452,0.2864382504631088,0.22799041247269697,RAB5A/ARL4A,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,3/73,428/21728,0.17411725995883162,0.28656278720184375,0.2280895374407705,SPRY1/SPRY2/ELOVL2,3
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,3/73,428/21728,0.17411725995883162,0.28656278720184375,0.2280895374407705,GLG1/POFUT1/PTPRA,3
BROWNE_HCMV_INFECTION_10HR_DN,BROWNE_HCMV_INFECTION_10HR_DN,1/73,57/21728,0.17475463006230274,0.28656278720184375,0.2280895374407705,NT5E,1
DELASERNA_MYOD_TARGETS_DN,DELASERNA_MYOD_TARGETS_DN,1/73,57/21728,0.17475463006230274,0.28656278720184375,0.2280895374407705,POSTN,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/73,57/21728,0.17475463006230274,0.28656278720184375,0.2280895374407705,BCAT1,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/73,57/21728,0.17475463006230274,0.28656278720184375,0.2280895374407705,IL1RAP,1
SANSOM_APC_TARGETS_REQUIRE_MYC,SANSOM_APC_TARGETS_REQUIRE_MYC,2/73,225/21728,0.17485458659799305,0.28656278720184375,0.2280895374407705,POFUT1/QTRT1,2
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,3/73,431/21728,0.17660880101492385,0.28917265221124894,0.2301668584655649,ACSL3/IDH3B/PTPRA,3
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,1/73,58/21728,0.17753451617763882,0.28962747712191445,0.23052887617380685,GADD45A,1
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,1/73,58/21728,0.17753451617763882,0.28962747712191445,0.23052887617380685,NT5E,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/73,58/21728,0.17753451617763882,0.28962747712191445,0.23052887617380685,IL1RAP,1
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,1/73,58/21728,0.17753451617763882,0.28962747712191445,0.23052887617380685,PDGFA,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,3/73,433/21728,0.17827549561848788,0.29057118155501943,0.23128001734509965,TRIO/EPAS1/RBCK1,3
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,2/73,228/21728,0.17845491955004358,0.29059872145307647,0.2313019377160952,MACF1/ELOVL2,2
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,SPRED2,1
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,ZNF12,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,KBTBD2,1
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,PIPOX,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,MACF1,1
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,DUSP6,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,MARK2,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,DLC1,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,ALK,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,1/73,59/21728,0.18030516593855384,0.29096176597304535,0.2315909028585643,PDGFA,1
BERNARD_PPAPDC1B_TARGETS_DN,BERNARD_PPAPDC1B_TARGETS_DN,1/73,60/21728,0.18306660960861176,0.29409083376477796,0.23408148313315655,SPRED2,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1/73,60/21728,0.18306660960861176,0.29409083376477796,0.23408148313315655,POFUT1,1
LEE_LIVER_CANCER_CIPROFIBRATE_UP,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1/73,60/21728,0.18306660960861176,0.29409083376477796,0.23408148313315655,NT5E,1
NADLER_OBESITY_UP,NADLER_OBESITY_UP,1/73,60/21728,0.18306660960861176,0.29409083376477796,0.23408148313315655,POSTN,1
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,1/73,60/21728,0.18306660960861176,0.29409083376477796,0.23408148313315655,GRB10,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,2/73,234/21728,0.18569030641896653,0.2955908831923941,0.23527544688338442,EPAS1/FEM1C,2
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,GADD45A,1
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,TMEM158,1
ISSAEVA_MLL2_TARGETS,ISSAEVA_MLL2_TARGETS,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,NT5E,1
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,NT5E,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,RAB5A,1
PID_AR_PATHWAY,PID_AR_PATHWAY,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,VAV3,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,SHROOM2,1
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,NCBP2,1
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,DUSP6,1
YU_MYC_TARGETS_DN,YU_MYC_TARGETS_DN,1/73,61/21728,0.18581887735360791,0.2955908831923941,0.23527544688338442,MACF1,1
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,NCBP2,1
GERHOLD_ADIPOGENESIS_DN,GERHOLD_ADIPOGENESIS_DN,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,GAS1,1
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,ELOVL2,1
REACTOME_CA2_PATHWAY,REACTOME_CA2_PATHWAY,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,FZD3,1
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,PDGFA,1
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1/73,62/21728,0.18856199924187966,0.2983618182694521,0.23748097156499423,LMO2,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,2/73,237/21728,0.18932419366140016,0.29872249552609426,0.23776805248515218,DUSP6/EXTL3,2
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/73,238/21728,0.19053774720283248,0.29872249552609426,0.23776805248515218,GADD45A/LMO2,2
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,2/73,238/21728,0.19053774720283248,0.29872249552609426,0.23776805248515218,ADAMTS9/ADAM19,2
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,2/73,238/21728,0.19053774720283248,0.29872249552609426,0.23776805248515218,TRIB2/ARID5B,2
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,DPY19L1,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,NT5E,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,NCBP2,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,ADAMTS9,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,GADD45A,1
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,PTPRA,1
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,PIPOX,1
RIZKI_TUMOR_INVASIVENESS_2D_DN,RIZKI_TUMOR_INVASIVENESS_2D_DN,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,SEC24B,1
VILLANUEVA_LIVER_CANCER_KRT19_DN,VILLANUEVA_LIVER_CANCER_KRT19_DN,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,GADD45A,1
WORSCHECH_TUMOR_REJECTION_UP,WORSCHECH_TUMOR_REJECTION_UP,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,IL1RAP,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/73,63/21728,0.19129600524461854,0.29872249552609426,0.23776805248515218,PDGFA,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,3/73,450/21728,0.19261649618667634,0.30026006554644924,0.2389918807363708,GRB10/IDH3B/PTPRA,3
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,3/73,450/21728,0.19261649618667634,0.30026006554644924,0.2389918807363708,TRIO/VAV3/DLC1,3
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,SATB2,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,TRIB2,1
LEE_LIVER_CANCER_E2F1_DN,LEE_LIVER_CANCER_E2F1_DN,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,IL1RAP,1
LEE_LIVER_CANCER_MYC_E2F1_DN,LEE_LIVER_CANCER_MYC_E2F1_DN,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,IL1RAP,1
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,IRS2,1
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,FZD3,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/73,64/21728,0.19402092523617853,0.3006082975287617,0.23926905584533484,GADD45A,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,2/73,241/21728,0.1941848901821699,0.3006082975287617,0.23926905584533484,POFUT1/QTRT1,2
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,2/73,242/21728,0.19540269682286462,0.3006541698478273,0.2393055678996011,POSTN/ETV5,2
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,2/73,242/21728,0.19540269682286462,0.3006541698478273,0.2393055678996011,TNPO1/CDH4,2
BRIDEAU_IMPRINTED_GENES,BRIDEAU_IMPRINTED_GENES,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,GRB10,1
BROWNE_HCMV_INFECTION_6HR_UP,BROWNE_HCMV_INFECTION_6HR_UP,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,MARK2,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,DUSP6,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,OTUD4,1
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,ADAM19,1
KEGG_GLIOMA,KEGG_GLIOMA,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,PDGFA,1
LEE_LIVER_CANCER_MYC_TGFA_DN,LEE_LIVER_CANCER_MYC_TGFA_DN,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,IL1RAP,1
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,CDH4,1
REACTOME_RAB_GERANYLGERANYLATION,REACTOME_RAB_GERANYLGERANYLATION,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,RAB5A,1
RHODES_CANCER_META_SIGNATURE,RHODES_CANCER_META_SIGNATURE,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,NCBP2,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,FGFR3,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,FGFR3,1
WP_FERROPTOSIS,WP_FERROPTOSIS,1/73,65/21728,0.19673678899438363,0.3006541698478273,0.2393055678996011,ACSL3,1
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,TRIB2,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,ETV4,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,GADD45A,1
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,GADD45A,1
NOUZOVA_METHYLATED_IN_APL,NOUZOVA_METHYLATED_IN_APL,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,MARK2,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,NT5E,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,LAMA2,1
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,NCBP2,1
WESTON_VEGFA_TARGETS_3HR,WESTON_VEGFA_TARGETS_3HR,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,LMO2,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/73,66/21728,0.1994436262008379,0.30220779970093065,0.24054217896836114,ARID5B,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,3/73,461/21728,0.20205043535098724,0.30526093074063854,0.24297231741513203,ACSL3/EPAS1/FGFR3,3
RIGGINS_TAMOXIFEN_RESISTANCE_UP,RIGGINS_TAMOXIFEN_RESISTANCE_UP,1/73,67/21728,0.2021414664412282,0.30526093074063854,0.24297231741513203,SPRY4,1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,1/73,67/21728,0.2021414664412282,0.30526093074063854,0.24297231741513203,BAG5,1
WP_PPAR_SIGNALING_PATHWAY,WP_PPAR_SIGNALING_PATHWAY,1/73,67/21728,0.2021414664412282,0.30526093074063854,0.24297231741513203,ACSL3,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,3/73,463/21728,0.20377777128319857,0.3069879685663646,0.24434695249130164,DUSP6/IRS2/IL1RAP,3
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,3/73,463/21728,0.20377777128319857,0.3069879685663646,0.24434695249130164,POFUT1/ARID5B/KBTBD2,3
JI_RESPONSE_TO_FSH_UP,JI_RESPONSE_TO_FSH_UP,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,TNPO1,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,GADD45A,1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,NT5E,1
REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,ADAMTS9,1
REACTOME_REGULATION_OF_RAS_BY_GAPS,REACTOME_REGULATION_OF_RAS_BY_GAPS,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,SPRED2,1
WP_MELANOMA,WP_MELANOMA,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,GADD45A,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/73,68/21728,0.20483033920563365,0.3069879685663646,0.24434695249130164,FZD3,1
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,DUSP6,1
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,SPRY2,1
ENGELMANN_CANCER_PROGENITORS_DN,ENGELMANN_CANCER_PROGENITORS_DN,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,FGFR3,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,BCAT1,1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,GAS1,1
KEGG_PPAR_SIGNALING_PATHWAY,KEGG_PPAR_SIGNALING_PATHWAY,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,ACSL3,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,SHROOM2,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,PPARGC1A,1
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,GRB10,1
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,VAV3,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,GADD45A,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,1/73,69/21728,0.20751027388882815,0.30790736075786285,0.24507874234347732,KLHL4,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,3/73,470/21728,0.20985116350892358,0.30854200658913244,0.2455838884425451,OTUD4/SHROOM2/TYRO3,3
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,2/73,254/21728,0.21008964540737587,0.30854200658913244,0.2455838884425451,TRIB2/GADD45A,2
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,2/73,254/21728,0.21008964540737587,0.30854200658913244,0.2455838884425451,GAS1/ARID5B,2
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,ACSL3,1
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,EPAS1,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,LAMA2,1
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,POSTN,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,PPARGC1A,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,DLC1,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,DLC1,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,POSTN,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,NCBP2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1/73,70/21728,0.21018129979058353,0.30854200658913244,0.2455838884425451,IRS2,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,2/73,256/21728,0.21254925650710813,0.30940169240273124,0.24626815502678243,ETV5/GAS1,2
BAE_BRCA1_TARGETS_UP,BAE_BRCA1_TARGETS_UP,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,EPAS1,1
BASSO_CD40_SIGNALING_DN,BASSO_CD40_SIGNALING_DN,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,TRIB2,1
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,ADAM19,1
BURTON_ADIPOGENESIS_2,BURTON_ADIPOGENESIS_2,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,BCAT1,1
KEGG_MELANOMA,KEGG_MELANOMA,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,PDGFA,1
LIN_NPAS4_TARGETS_DN,LIN_NPAS4_TARGETS_DN,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,LMO2,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,BCAT1,1
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,DUSP6,1
REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,SATB2,1
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,SPRY1,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1/73,71/21728,0.21284344611597283,0.30940169240273124,0.24626815502678243,PGGT1B,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,2/73,257/21728,0.21378018218382322,0.3105109388665117,0.24715105931209455,ELOVL2/DLC1,2
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/73,72/21728,0.2154967419756736,0.31249649201338553,0.24873145955616227,GADD45A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/73,72/21728,0.2154967419756736,0.31249649201338553,0.24873145955616227,NT5E,1
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,FNDC3A,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,LMO2,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,DUSP6,1
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,PPARGC1A,1
REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,NCBP2,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/73,73/21728,0.21814121638626516,0.3147994309109299,0.25056448286328575,SEC24B,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2/73,261/21728,0.21871092115553167,0.3153670379242666,0.25101626944166283,PDGFA/VAV3,2
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,2/73,262/21728,0.2199452736781869,0.31605211697975283,0.25156155784565276,POSTN/LMO2,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,3/73,482/21728,0.22035721513893242,0.31605211697975283,0.25156155784565276,GADD45A/DUSP6/ADAM19,3
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,VAV3,1
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,LAMA2,1
LEE_LIVER_CANCER_DENA_DN,LEE_LIVER_CANCER_DENA_DN,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,IL1RAP,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,VAV3,1
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,DLC1,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,POSTN,1
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1/73,74/21728,0.22077689827053204,0.31605211697975283,0.25156155784565276,GADD45A,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,3/73,484/21728,0.22211912767882308,0.3177192002317885,0.25288847210254217,ETV5/MACF1/LMO2,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/73,75/21728,0.22340381645776108,0.31853749906417606,0.2535397967354092,FGFR3,1
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/73,75/21728,0.22340381645776108,0.31853749906417606,0.2535397967354092,VAV3,1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1/73,75/21728,0.22340381645776108,0.31853749906417606,0.2535397967354092,NT5E,1
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1/73,75/21728,0.22340381645776108,0.31853749906417606,0.2535397967354092,EPAS1,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,2/73,265/21728,0.2236520458042341,0.31863733697049446,0.25361926267756296,IL1RAP/PDGFA,2
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,2/73,266/21728,0.224888815501555,0.3194682493557791,0.2542806270628832,PDGFA/DLC1,2
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,2/73,266/21728,0.224888815501555,0.3194682493557791,0.2542806270628832,FZD3/IRS2,2
MORI_MATURE_B_LYMPHOCYTE_DN,MORI_MATURE_B_LYMPHOCYTE_DN,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,NCBP2,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,CHST7,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,LAMA2,1
REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,TNPO1,1
SHEPARD_BMYB_TARGETS,SHEPARD_BMYB_TARGETS,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,ARID5B,1
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,LAMA2,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,FGFR3,1
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,1/73,76/21728,0.22602199968403835,0.3194682493557791,0.2542806270628832,IRS2,1
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,EPAS1,1
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,ACSL3,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,GADD45A,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,GADD45A,1
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,GADD45A,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,CHST7,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,FGFR3,1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,FGFR3,1
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,CHRNA9,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/73,77/21728,0.22863147659254857,0.32062202364507986,0.2551989732533545,PGPEP1,1
CHEBOTAEV_GR_TARGETS_UP,CHEBOTAEV_GR_TARGETS_UP,1/73,78/21728,0.23123227573386984,0.3230025851657495,0.25709378025673685,TRIB2,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/73,78/21728,0.23123227573386984,0.3230025851657495,0.25709378025673685,CDH4,1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,1/73,78/21728,0.23123227573386984,0.3230025851657495,0.25709378025673685,GLG1,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/73,78/21728,0.23123227573386984,0.3230025851657495,0.25709378025673685,ACSL3,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/73,78/21728,0.23123227573386984,0.3230025851657495,0.25709378025673685,PIPOX,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,2/73,272/21728,0.23232059082815912,0.32426948977419867,0.258102172480111,CHRNA9/HRH1,2
CORRE_MULTIPLE_MYELOMA_UP,CORRE_MULTIPLE_MYELOMA_UP,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,LMO2,1
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,VAV3,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,DUSP6,1
PID_MET_PATHWAY,PID_MET_PATHWAY,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,RAB5A,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,BCAT1,1
PID_P73PATHWAY,PID_P73PATHWAY,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,IL1RAP,1
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,LAMA2,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/73,79/21728,0.23382442556626826,0.32434295803916807,0.2581606495166344,ARL4A,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,2/73,274/21728,0.23480168828145678,0.32519397261599126,0.25883801423338054,CHST7/PPARGC1A,2
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,2/73,274/21728,0.23480168828145678,0.32519397261599126,0.25883801423338054,GAS1/ARL4A,2
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,2/73,275/21728,0.23604288089057512,0.32615541864762065,0.2596032768230208,POSTN/LAMA2,2
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,3/73,500/21728,0.2363163981735985,0.32615541864762065,0.2596032768230208,FZD3/NT5E/RBCK1,3
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,1/73,80/21728,0.2364079544559935,0.32615541864762065,0.2596032768230208,GRB10,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/73,80/21728,0.2364079544559935,0.32615541864762065,0.2596032768230208,DPY19L1,1
TOOKER_GEMCITABINE_RESISTANCE_UP,TOOKER_GEMCITABINE_RESISTANCE_UP,1/73,80/21728,0.2364079544559935,0.32615541864762065,0.2596032768230208,ARID5B,1
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,ARID5B,1
GAVIN_FOXP3_TARGETS_CLUSTER_P2,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,OTUD4,1
HARRIS_HYPOXIA,HARRIS_HYPOXIA,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,EPAS1,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,GADD45A,1
REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,NCBP2,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,GLG1,1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,MACF1,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,1/73,81/21728,0.23898289067757117,0.32768512924194576,0.260820849367191,VAV3,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,ARID5B,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,LMO2,1
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,TMEM158,1
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,BAG5,1
REACTOME_SELECTIVE_AUTOPHAGY,REACTOME_SELECTIVE_AUTOPHAGY,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,EPAS1,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,TNPO1,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,ETV5,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/73,82/21728,0.24154926241409502,0.32918451310701363,0.2620142833631711,MARK2,1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,2/73,280/21728,0.24225462243336818,0.32989433732738943,0.2625792676713944,BICD1/SPRY2,2
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/73,83/21728,0.24410709775752004,0.3314073582311662,0.2637835560629558,PPARGC1A,1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/73,83/21728,0.24410709775752004,0.3314073582311662,0.2637835560629558,LAMA2,1
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,1/73,83/21728,0.24410709775752004,0.3314073582311662,0.2637835560629558,ACSL3,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/73,83/21728,0.24410709775752004,0.3314073582311662,0.2637835560629558,SPRY2,1
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,MACF1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,BICD1,1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,GADD45A,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,LAMA2,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,LAMA2,1
LEIN_MIDBRAIN_MARKERS,LEIN_MIDBRAIN_MARKERS,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,BCAT1,1
REACTOME_PI_METABOLISM,REACTOME_PI_METABOLISM,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,RAB5A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,PPARGC1A,1
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,NCBP2,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/73,84/21728,0.2466564247089501,0.33234490382788456,0.26452979511085595,TRIB2,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,2/73,285/21728,0.24847451211681204,0.3345080486996446,0.26625154941829715,TNPO1/ADAM19,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/73,85/21728,0.24919727117892987,0.3345080486996446,0.26625154941829715,BICD1,1
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,1/73,85/21728,0.24919727117892987,0.3345080486996446,0.26625154941829715,POSTN,1
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,1/73,85/21728,0.24919727117892987,0.3345080486996446,0.26625154941829715,PGGT1B,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1/73,85/21728,0.24919727117892987,0.3345080486996446,0.26625154941829715,VAV3,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,2/73,287/21728,0.2509643057785553,0.33538944932791914,0.2669530999007104,IL1RAP/GAS1,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,BCAT1,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,TMEM158,1
DELASERNA_MYOD_TARGETS_UP,DELASERNA_MYOD_TARGETS_UP,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,FZD3,1
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,PDGFA,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,ETV4,1
REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,VAV3,1
REACTOME_HEDGEHOG_ON_STATE,REACTOME_HEDGEHOG_ON_STATE,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,GAS1,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,TYRO3,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/73,86/21728,0.2517296649877335,0.33538944932791914,0.2669530999007104,RAB5A,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,2/73,289/21728,0.2534549636387151,0.33599815029695806,0.2674375951969194,SCRN1/TNPO1,2
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,MARK2,1
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,IL1RAP,1
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,IL1RAP,1
REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,VAV3,1
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,IL1RAP,1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,TNPO1,1
SANA_RESPONSE_TO_IFNG_DN,SANA_RESPONSE_TO_IFNG_DN,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,GADD45A,1
SMITH_TERT_TARGETS_DN,SMITH_TERT_TARGETS_DN,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,DUSP6,1
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,LAMA2,1
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1/73,87/21728,0.25425363386565114,0.33599815029695806,0.2674375951969194,GRB10,1
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,2/73,291/21728,0.25594636387946285,0.3379853017846969,0.26901926763976813,TRIO/GAS1,2
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/73,88/21728,0.25676920545327697,0.3385717841817546,0.2694860780723727,POSTN,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/73,88/21728,0.25676920545327697,0.3385717841817546,0.2694860780723727,KLHL4,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/73,292/21728,0.25719230474905835,0.3388797648425323,0.269731215157838,RASSF2/BCAT1,2
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,2/73,293/21728,0.25843838623420484,0.33937497529693084,0.2701253777236845,CHST2/CHST7,2
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,CDH4,1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,RASSF2,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,PDGFA,1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,FGFR3,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,DUSP6,1
WNT_SIGNALING,WNT_SIGNALING,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,FZD3,1
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,GAS1,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1/73,89/21728,0.2592764073017939,0.33937497529693084,0.2701253777236845,ADAMTS9,1
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,1/73,90/21728,0.261775266873261,0.3413961904955439,0.2717341631637674,LAMA2,1
KEGG_GAP_JUNCTION,KEGG_GAP_JUNCTION,1/73,90/21728,0.261775266873261,0.3413961904955439,0.2717341631637674,PDGFA,1
REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1/73,90/21728,0.261775266873261,0.3413961904955439,0.2717341631637674,RAB5A,1
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,1/73,90/21728,0.261775266873261,0.3413961904955439,0.2717341631637674,GADD45A,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/73,90/21728,0.261775266873261,0.3413961904955439,0.2717341631637674,FZD3,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2/73,296/21728,0.26217732692423673,0.3416713269245884,0.2719531578959399,TNPO1/PPARGC1A,2
WP_AMINO_ACID_METABOLISM,WP_AMINO_ACID_METABOLISM,1/73,91/21728,0.26426581154089435,0.3436416516619048,0.2735214370934271,BCAT1,1
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/73,91/21728,0.26426581154089435,0.3436416516619048,0.2735214370934271,ETV5,1
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,1/73,91/21728,0.26426581154089435,0.3436416516619048,0.2735214370934271,VAV3,1
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,2/73,298/21728,0.26467038844405255,0.34391762684445204,0.2737410994311192,GADD45A/TNPO1,2
MUELLER_PLURINET,MUELLER_PLURINET,2/73,299/21728,0.2659170062742764,0.34511255183629813,0.27469219950705,GADD45A/ARL4A,2
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/73,92/21728,0.2667480685893535,0.34511255183629813,0.27469219950705,MACF1,1
REACTOME_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_JUNCTION_ORGANIZATION,1/73,92/21728,0.2667480685893535,0.34511255183629813,0.27469219950705,CDH4,1
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,1/73,92/21728,0.2667480685893535,0.34511255183629813,0.27469219950705,VAV3,1
REACTOME_PCP_CE_PATHWAY,REACTOME_PCP_CE_PATHWAY,1/73,92/21728,0.2667480685893535,0.34511255183629813,0.27469219950705,FZD3,1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1/73,92/21728,0.2667480685893535,0.34511255183629813,0.27469219950705,EXTL3,1
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/73,93/21728,0.26922206521502234,0.3473081187622366,0.2764397601357258,ANKRD10,1
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,1/73,93/21728,0.26922206521502234,0.3473081187622366,0.2764397601357258,MACF1,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/73,93/21728,0.26922206521502234,0.3473081187622366,0.2764397601357258,ETV4,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/73,93/21728,0.26922206521502234,0.3473081187622366,0.2764397601357258,GADD45A,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,DUSP6,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,DLC1,1
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,FZD3,1
REACTOME_MITOCHONDRIAL_BIOGENESIS,REACTOME_MITOCHONDRIAL_BIOGENESIS,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,PPARGC1A,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,TRIO,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/73,94/21728,0.2716878285262918,0.3489783314691162,0.27776916528096374,DUSP6,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/73,304/21728,0.2721503997061637,0.34932154678723676,0.2780423473780431,POSTN/DPY19L1,2
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,2/73,305/21728,0.2733970415701672,0.350669950019698,0.27911560839905314,SEC24B/CNIH3,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/73,95/21728,0.27414538554383716,0.3508746953130858,0.2792785753345649,VAV3,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/73,95/21728,0.27414538554383716,0.3508746953130858,0.2792785753345649,IRS2,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/73,95/21728,0.27414538554383716,0.3508746953130858,0.2792785753345649,PPARGC1A,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/73,96/21728,0.2765947632009027,0.35325102614515286,0.28117001492302285,PGPEP1,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/73,96/21728,0.2765947632009027,0.35325102614515286,0.28117001492302285,PPARGC1A,1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1/73,96/21728,0.2765947632009027,0.35325102614515286,0.28117001492302285,VAV3,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,2/73,308/21728,0.2771366464261098,0.35343817675455375,0.2813189773767553,NT5E/TMEM158,2
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,2/73,308/21728,0.2771366464261098,0.35343817675455375,0.2813189773767553,NT5E/VAV3,2
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/73,97/21728,0.2790359883435769,0.3548480420756156,0.2824411591229437,POSTN,1
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/73,97/21728,0.2790359883435769,0.3548480420756156,0.2824411591229437,NT5E,1
REACTOME_METABOLISM_OF_NUCLEOTIDES,REACTOME_METABOLISM_OF_NUCLEOTIDES,1/73,97/21728,0.2790359883435769,0.3548480420756156,0.2824411591229437,NT5E,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/73,97/21728,0.2790359883435769,0.3548480420756156,0.2824411591229437,DUSP6,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,2/73,310/21728,0.27962931424279647,0.3553498321720825,0.2828405587522993,RBCK1/PGGT1B,2
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,2/73,311/21728,0.28087548754806846,0.3566737979186098,0.2838943687660193,TNPO1/NCBP2,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,1/73,98/21728,0.28146908773107293,0.3566737979186098,0.2838943687660193,POSTN,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/73,98/21728,0.28146908773107293,0.3566737979186098,0.2838943687660193,BCAT1,1
KEGG_PYRIMIDINE_METABOLISM,KEGG_PYRIMIDINE_METABOLISM,1/73,98/21728,0.28146908773107293,0.3566737979186098,0.2838943687660193,NT5E,1
BRUINS_UVC_RESPONSE_MIDDLE,BRUINS_UVC_RESPONSE_MIDDLE,1/73,99/21728,0.2838940880360029,0.3589834720002639,0.28573275294027833,OTUD4,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,1/73,99/21728,0.2838940880360029,0.3589834720002639,0.28573275294027833,PIPOX,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1/73,99/21728,0.2838940880360029,0.3589834720002639,0.28573275294027833,FGFR3,1
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1/73,100/21728,0.28631101584465646,0.3615283166174052,0.2877583210094971,ANKRD10,1
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,1/73,100/21728,0.28631101584465646,0.3615283166174052,0.2877583210094971,GADD45A,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,2/73,317/21728,0.2883494559619273,0.3630317700500774,0.2889549941762067,VAV3/ARL4A,2
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1/73,101/21728,0.28871989765727635,0.3630317700500774,0.2889549941762067,EPAS1,1
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,1/73,101/21728,0.28871989765727635,0.3630317700500774,0.2889549941762067,ADAM19,1
KEGG_MELANOGENESIS,KEGG_MELANOGENESIS,1/73,101/21728,0.28871989765727635,0.3630317700500774,0.2889549941762067,FZD3,1
MCCLUNG_CREB1_TARGETS_UP,MCCLUNG_CREB1_TARGETS_UP,1/73,101/21728,0.28871989765727635,0.3630317700500774,0.2889549941762067,BCAT1,1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1/73,101/21728,0.28871989765727635,0.3630317700500774,0.2889549941762067,BAG5,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,2/73,318/21728,0.28959448555537115,0.36387557285523797,0.28962661868614253,RASSF2/DPY19L1,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/73,319/21728,0.290839300886108,0.36476798786288367,0.29033693605947175,CHST2/LZTS1,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/73,102/21728,0.2911207598883305,0.36476798786288367,0.29033693605947175,SPRY2,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/73,102/21728,0.2911207598883305,0.36476798786288367,0.29033693605947175,VAV3,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/73,102/21728,0.2911207598883305,0.36476798786288367,0.29033693605947175,IL1RAP,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/73,103/21728,0.2935136288667898,0.36699466322644764,0.2921092574368051,ARID5B,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/73,103/21728,0.2935136288667898,0.36699466322644764,0.2921092574368051,DUSP6,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/73,103/21728,0.2935136288667898,0.36699466322644764,0.2921092574368051,FZD3,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,2/73,322/21728,0.2945723370785911,0.36806103333090207,0.292958034300824,TRIB2/GRB10,2
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,2/73,323/21728,0.2958161715525528,0.3692020747630672,0.2938662457786806,ELOVL2/IL1RAP,2
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/73,104/21728,0.2958985308363956,0.3692020747630672,0.2938662457786806,VAV3,1
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,1/73,105/21728,0.29827549195593617,0.3708738383986188,0.2951968853849833,GADD45A,1
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/73,105/21728,0.29827549195593617,0.3708738383986188,0.2951968853849833,GADD45A,1
LE_EGR2_TARGETS_DN,LE_EGR2_TARGETS_DN,1/73,105/21728,0.29827549195593617,0.3708738383986188,0.2951968853849833,CHST2,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/73,105/21728,0.29827549195593617,0.3708738383986188,0.2951968853849833,PGPEP1,1
XU_GH1_EXOGENOUS_TARGETS_DN,XU_GH1_EXOGENOUS_TARGETS_DN,1/73,105/21728,0.29827549195593617,0.3708738383986188,0.2951968853849833,SPRY2,1
JAZAG_TGFB1_SIGNALING_UP,JAZAG_TGFB1_SIGNALING_UP,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,BAG5,1
MACAEVA_PBMC_RESPONSE_TO_IR,MACAEVA_PBMC_RESPONSE_TO_IR,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,GADD45A,1
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,VAV3,1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,IDH3B,1
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,GRB10,1
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,1/73,106/21728,0.30064453829951543,0.3722662288639429,0.29630515802664004,FZD3,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,PPARGC1A,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,POSTN,1
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,EPAS1,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,ADAMTS9,1
TAVAZOIE_METASTASIS,TAVAZOIE_METASTASIS,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,ALK,1
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,1/73,107/21728,0.30300569585682424,0.37363736840827705,0.2973965160061171,MARK2,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,2/73,329/21728,0.30327296879086096,0.3737092130930802,0.29745370075464767,CHST2/SPRED2,2
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1/73,108/21728,0.30535899053340987,0.3755033528705205,0.29888174560281633,VAV3,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/73,108/21728,0.30535899053340987,0.3755033528705205,0.29888174560281633,ACSL3,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,1/73,108/21728,0.30535899053340987,0.3755033528705205,0.29888174560281633,FZD3,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/73,109/21728,0.30770444815094256,0.3776084785819391,0.3005573195824689,PDGFA,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/73,109/21728,0.30770444815094256,0.3776084785819391,0.3005573195824689,POSTN,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/73,109/21728,0.30770444815094256,0.3776084785819391,0.3005573195824689,NCBP2,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,2/73,333/21728,0.3082373887722686,0.37800305289767916,0.30087138085344534,ACSL3/PPARGC1A,2
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/73,110/21728,0.3100420944474864,0.378916790753319,0.3015986701392248,ETV4,1
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,1/73,110/21728,0.3100420944474864,0.378916790753319,0.3015986701392248,SPRY2,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/73,110/21728,0.3100420944474864,0.378916790753319,0.3015986701392248,SPRED2,1
LEE_EARLY_T_LYMPHOCYTE_UP,LEE_EARLY_T_LYMPHOCYTE_UP,1/73,110/21728,0.3100420944474864,0.378916790753319,0.3015986701392248,SCRN1,1
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,1/73,110/21728,0.3100420944474864,0.378916790753319,0.3015986701392248,FGFR3,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,2/73,336/21728,0.311956621713681,0.38098298477424386,0.30324325645518524,FZD3/IRS2,2
REACTOME_O_LINKED_GLYCOSYLATION,REACTOME_O_LINKED_GLYCOSYLATION,1/73,111/21728,0.3123719550777637,0.38098298477424386,0.30324325645518524,ADAMTS9,1
REACTOME_TRNA_PROCESSING,REACTOME_TRNA_PROCESSING,1/73,111/21728,0.3123719550777637,0.38098298477424386,0.30324325645518524,QTRT1,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,2/73,337/21728,0.3131955286034651,0.38172706553714764,0.3038355072449215,QTRT1/MARK2,2
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,1/73,112/21728,0.3146940556134217,0.3830312943749476,0.3048736076739251,MACF1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/73,112/21728,0.3146940556134217,0.3830312943749476,0.3048736076739251,NT5E,1
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,1/73,113/21728,0.317008421543299,0.38532362863318737,0.306698190222577,GRB10,1
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1/73,113/21728,0.317008421543299,0.38532362863318737,0.306698190222577,HRH1,1
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,1/73,114/21728,0.3193150782736871,0.38786369562048406,0.3087199555392055,ADAM19,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/73,115/21728,0.32161405112859665,0.3903909867059951,0.31073155188184703,VAV3,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/73,345/21728,0.32309013743213155,0.3918422146453555,0.31188665618775496,TNPO1/DPY19L1,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1/73,116/21728,0.3239053653500198,0.3918422146453555,0.31188665618775496,PDGFA,1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/73,116/21728,0.3239053653500198,0.3918422146453555,0.31188665618775496,VAV3,1
REACTOME_NONSENSE_MEDIATED_DECAY_NMD,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,1/73,116/21728,0.3239053653500198,0.3918422146453555,0.31188665618775496,NCBP2,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/73,116/21728,0.3239053653500198,0.3918422146453555,0.31188665618775496,VAV3,1
HOELZEL_NF1_TARGETS_DN,HOELZEL_NF1_TARGETS_DN,1/73,117/21728,0.32618904609818944,0.3938055465385299,0.3134493694337056,CHST7,1
WHITEFORD_PEDIATRIC_CANCER_MARKERS,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1/73,117/21728,0.32618904609818944,0.3938055465385299,0.3134493694337056,BCAT1,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/73,117/21728,0.32618904609818944,0.3938055465385299,0.3134493694337056,FZD3,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,1/73,118/21728,0.32846511845184423,0.3954852739339377,0.31478634779152465,MARK2,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/73,118/21728,0.32846511845184423,0.3954852739339377,0.31478634779152465,GADD45A,1
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,1/73,118/21728,0.32846511845184423,0.3954852739339377,0.31478634779152465,IDH3B,1
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,1/73,118/21728,0.32846511845184423,0.3954852739339377,0.31478634779152465,POFUT1,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1/73,119/21728,0.3307336074084857,0.3976810289484683,0.3165340581292412,FGFR3,1
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,1/73,119/21728,0.3307336074084857,0.3976810289484683,0.3165340581292412,PDGFA,1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/73,120/21728,0.33299453788463795,0.4001305334258956,0.3184837402518608,PPARGC1A,1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,1/73,122/21728,0.33749382265824435,0.4044497016842767,0.3219215805234559,TNPO1,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,1/73,122/21728,0.33749382265824435,0.4044497016842767,0.3219215805234559,FGFR3,1
REACTOME_RAB_REGULATION_OF_TRAFFICKING,REACTOME_RAB_REGULATION_OF_TRAFFICKING,1/73,122/21728,0.33749382265824435,0.4044497016842767,0.3219215805234559,RAB5A,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/73,122/21728,0.33749382265824435,0.4044497016842767,0.3219215805234559,GADD45A,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1/73,123/21728,0.33973222638618805,0.40604359677707497,0.3231902406938687,ADAM19,1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1/73,123/21728,0.33973222638618805,0.40604359677707497,0.3231902406938687,TMEM158,1
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,1/73,123/21728,0.33973222638618805,0.40604359677707497,0.3231902406938687,LMO2,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/73,123/21728,0.33973222638618805,0.40604359677707497,0.3231902406938687,NT5E,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,2/73,359/21728,0.3403221739665626,0.4064769853388203,0.323535196148643,POSTN/BCAT1,2
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,1/73,124/21728,0.34196317049513536,0.40816431832129646,0.32487822817048906,BCAT1,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,2/73,361/21728,0.3427739377638913,0.40885910655225993,0.3254312445888705,GADD45A/ACSL3,2
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/73,125/21728,0.34418667950059034,0.41027052196470365,0.32655466012968287,GADD45A,1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1/73,126/21728,0.3464027778386205,0.41154031014980297,0.32756534753475425,VAV3,1
EPPERT_HSC_R,EPPERT_HSC_R,1/73,126/21728,0.3464027778386205,0.41154031014980297,0.32756534753475425,DUSP6,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/73,126/21728,0.3464027778386205,0.41154031014980297,0.32756534753475425,IRS2,1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1/73,126/21728,0.3464027778386205,0.41154031014980297,0.32756534753475425,SEC24B,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/73,126/21728,0.3464027778386205,0.41154031014980297,0.32756534753475425,ARL4A,1
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/73,127/21728,0.34861148986610757,0.41334041371392594,0.3289981392565806,NCBP2,1
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,1/73,127/21728,0.34861148986610757,0.41334041371392594,0.3289981392565806,EXTL3,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/73,127/21728,0.34861148986610757,0.41334041371392594,0.3289981392565806,EPAS1,1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1/73,128/21728,0.350812839861005,0.4156748559784473,0.3308562376562232,LMO2,1
GAL_LEUKEMIC_STEM_CELL_UP,GAL_LEUKEMIC_STEM_CELL_UP,1/73,129/21728,0.35300685202258586,0.41772088114916184,0.33248477058381415,OTUD4,1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1/73,129/21728,0.35300685202258586,0.41772088114916184,0.33248477058381415,POSTN,1
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,1/73,130/21728,0.355193550471697,0.4194756065015814,0.33388144353593424,BCAT1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/73,130/21728,0.355193550471697,0.4194756065015814,0.33388144353593424,GADD45A,1
REACTOME_CELL_CELL_COMMUNICATION,REACTOME_CELL_CELL_COMMUNICATION,1/73,130/21728,0.355193550471697,0.4194756065015814,0.33388144353593424,CDH4,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/73,131/21728,0.3573729592510083,0.42121479969729914,0.3352657536740542,ANKRD10,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/73,131/21728,0.3573729592510083,0.42121479969729914,0.3352657536740542,POSTN,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/73,131/21728,0.3573729592510083,0.42121479969729914,0.3352657536740542,TNPO1,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2/73,374/21728,0.35864094036423766,0.42238281403256894,0.33619543422349774,PIPOX/BCAT1,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/73,132/21728,0.3595451023252628,0.42238281403256894,0.33619543422349774,GRB10,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/73,132/21728,0.3595451023252628,0.42238281403256894,0.33619543422349774,PDGFA,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/73,132/21728,0.3595451023252628,0.42238281403256894,0.33619543422349774,IRS2,1
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1/73,132/21728,0.3595451023252628,0.42238281403256894,0.33619543422349774,TNPO1,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,2/73,375/21728,0.3598561625400102,0.4224706622597099,0.33626535698523946,POFUT1/FGFR3,2
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/73,133/21728,0.3617100035815257,0.4235346996750281,0.33711227714626046,PIPOX,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/73,133/21728,0.3617100035815257,0.4235346996750281,0.33711227714626046,ALK,1
WHITFIELD_CELL_CYCLE_G1_S,WHITFIELD_CELL_CYCLE_G1_S,1/73,133/21728,0.3617100035815257,0.4235346996750281,0.33711227714626046,ANKRD10,1
WP_MRNA_PROCESSING,WP_MRNA_PROCESSING,1/73,133/21728,0.3617100035815257,0.4235346996750281,0.33711227714626046,NCBP2,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2/73,377/21728,0.36228419190200933,0.4239294078015659,0.33742644492388857,SEC24B/RBCK1,2
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,2/73,378/21728,0.3634969825709461,0.4246706423309567,0.3380164302551828,RASSF2/ADAM19,2
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,2/73,378/21728,0.3634969825709461,0.4246706423309567,0.3380164302551828,GLG1/GRB10,2
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/73,134/21728,0.3638676868294327,0.4246706423309567,0.3380164302551828,TYRO3,1
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1/73,134/21728,0.3638676868294327,0.4246706423309567,0.3380164302551828,BICD1,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/73,136/21728,0.36816149415305477,0.4291217415551903,0.3415592809270089,IL1RAP,1
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,1/73,136/21728,0.36816149415305477,0.4291217415551903,0.3415592809270089,ACSL3,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/73,137/21728,0.3702976654631155,0.43076917751987664,0.3428705569332823,VAV3,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/73,137/21728,0.3702976654631155,0.43076917751987664,0.3428705569332823,TRIB2,1
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,1/73,137/21728,0.3702976654631155,0.43076917751987664,0.3428705569332823,GADD45A,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/73,384/21728,0.3707560799797137,0.43102202275925106,0.3430718090018294,LAMA2/GAS1,2
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,2/73,385/21728,0.3719629142711772,0.4315612205200217,0.34350098324683237,EPAS1/IDH3B,2
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,2/73,385/21728,0.3719629142711772,0.4315612205200217,0.34350098324683237,DUSP6/NT5E,2
EPPERT_PROGENITOR,EPPERT_PROGENITOR,1/73,138/21728,0.3724267132340009,0.4315612205200217,0.34350098324683237,DLC1,1
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1/73,138/21728,0.3724267132340009,0.4315612205200217,0.34350098324683237,MARK2,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/73,138/21728,0.3724267132340009,0.4315612205200217,0.34350098324683237,DUSP6,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,2/73,386/21728,0.3731688662291628,0.4321411481980201,0.343962576453387,GLG1/RASSF2,2
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,2/73,388/21728,0.37557809251113516,0.43393968739381056,0.3453941230168562,SHROOM2/TMEM158,2
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,GRB10,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,PDGFA,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,IL1RAP,1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,ADAMTS9,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,IL1RAP,1
SABATES_COLORECTAL_ADENOMA_UP,SABATES_COLORECTAL_ADENOMA_UP,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,ETV4,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1/73,140/21728,0.3766635317870213,0.43393968739381056,0.3453941230168562,TNPO1,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/73,141/21728,0.378771349193893,0.4358064172192282,0.3468799458850798,LMO2,1
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,1/73,141/21728,0.378771349193893,0.4358064172192282,0.3468799458850798,FGFR3,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/73,143/21728,0.3829659162637985,0.43950132110376877,0.3498209031745527,PGPEP1,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/73,143/21728,0.3829659162637985,0.43950132110376877,0.3498209031745527,LMO2,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,1/73,143/21728,0.3829659162637985,0.43950132110376877,0.3498209031745527,ADAMTS9,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/73,143/21728,0.3829659162637985,0.43950132110376877,0.3498209031745527,VAV3,1
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,1/73,144/21728,0.3850527120994597,0.44161273202939955,0.3515014798679784,TRIO,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,POSTN,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,ARL4A,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,PIPOX,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,RAB5A,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,ACSL3,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/73,145/21728,0.3871325467926001,0.4422958425975521,0.3520452014552516,VAV3,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,2/73,399/21728,0.38876253888817913,0.44381334982020565,0.35325306073055335,NT5E/ARL4A,2
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/73,146/21728,0.3892054432427754,0.44381334982020565,0.35325306073055335,ETV5,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/73,146/21728,0.3892054432427754,0.44381334982020565,0.35325306073055335,FZD3,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,2/73,401/21728,0.39114718852208985,0.44560083223196256,0.35467580665113235,CHST2/TNPO1,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1/73,147/21728,0.3912714242752692,0.44560083223196256,0.35467580665113235,ADAM19,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,2/73,403/21728,0.393527845888324,0.44788528863674304,0.35649411882543075,ETV5/CHST7,2
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/73,149/21728,0.39538273101839816,0.44942423589376723,0.357719043287633,CDH4,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/73,149/21728,0.39538273101839816,0.44942423589376723,0.357719043287633,VAV3,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,2/73,405/21728,0.39590445720760414,0.4497313656208362,0.35796350307274843,POSTN/TMEM158,2
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,1/73,150/21728,0.39742810201036527,0.4506033268196151,0.35865754024497803,GAS1,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/73,150/21728,0.39742810201036527,0.4506033268196151,0.35865754024497803,DUSP6,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1/73,150/21728,0.39742810201036527,0.4506033268196151,0.35865754024497803,DLC1,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/73,407/21728,0.39827696957963554,0.4511979576046998,0.3591308363838185,EPAS1/NT5E,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/73,408/21728,0.39946167236719976,0.4511979576046998,0.3591308363838185,OTUD4/BCAT1,2
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/73,151/21728,0.3994666481477851,0.4511979576046998,0.3591308363838185,FZD3,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/73,151/21728,0.3994666481477851,0.4511979576046998,0.3591308363838185,DUSP6,1
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,1/73,151/21728,0.3994666481477851,0.4511979576046998,0.3591308363838185,EPAS1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/73,151/21728,0.3994666481477851,0.4511979576046998,0.3591308363838185,DUSP6,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/73,152/21728,0.4014983918881202,0.4529205834043905,0.3605019597096055,POSTN,1
REACTOME_HIV_LIFE_CYCLE,REACTOME_HIV_LIFE_CYCLE,1/73,152/21728,0.4014983918881202,0.4529205834043905,0.3605019597096055,NCBP2,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,2/73,411/21728,0.40300949022125554,0.45433856779041926,0.36163060382235185,CHRNA9/IL1RAP,2
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/73,153/21728,0.40352335561597386,0.4543449369278093,0.3616356733347452,RAB5A,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/73,153/21728,0.40352335561597386,0.4543449369278093,0.3616356733347452,SEC24B,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/73,154/21728,0.40554156164332156,0.4563299636364122,0.3632156545604788,LAMA2,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,2/73,414/21728,0.4065477402273969,0.45717443995382745,0.3638878151522281,SEC24B/ARL4A,2
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/73,155/21728,0.4075530322097459,0.4577291592908453,0.3643293437897226,DUSP6,1
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,1/73,155/21728,0.4075530322097459,0.4577291592908453,0.3643293437897226,ETV5,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/73,157/21728,0.411555855557566,0.4619346326032191,0.3676766886138892,ETV5,1
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/73,159/21728,0.4155320021369796,0.46581267700371126,0.3707634165247955,GADD45A,1
KEGG_PURINE_METABOLISM,KEGG_PURINE_METABOLISM,1/73,159/21728,0.4155320021369796,0.46581267700371126,0.3707634165247955,NT5E,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,2/73,423/21728,0.4171034413631348,0.46715150571781694,0.3718290567116969,GLG1/RASSF2,2
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/73,160/21728,0.4175101264748722,0.46715150571781694,0.3718290567116969,BICD1,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/73,160/21728,0.4175101264748722,0.46715150571781694,0.3718290567116969,IRS2,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,2/73,425/21728,0.4194368232953015,0.469013783647279,0.37331133609509076,IDH3B/RBCK1,2
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/73,162/21728,0.4214465862975153,0.46979207998750455,0.37393082076010015,EPAS1,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,1/73,162/21728,0.4214465862975153,0.46979207998750455,0.37393082076010015,SCRN1,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/73,162/21728,0.4214465862975153,0.46979207998750455,0.37393082076010015,GADD45A,1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,1/73,162/21728,0.4214465862975153,0.46979207998750455,0.37393082076010015,OTUD4,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/73,162/21728,0.4214465862975153,0.46979207998750455,0.37393082076010015,PPARGC1A,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/73,164/21728,0.42535680555847044,0.47326569280556635,0.37669564151249596,TRIB2,1
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,1/73,164/21728,0.42535680555847044,0.47326569280556635,0.37669564151249596,PIPOX,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/73,164/21728,0.42535680555847044,0.47326569280556635,0.37669564151249596,FZD3,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/73,165/21728,0.42730212893049024,0.47483915881150807,0.3779480411592835,BICD1,1
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,1/73,165/21728,0.42730212893049024,0.47483915881150807,0.3779480411592835,VAV3,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,2/73,433/21728,0.4287241011001056,0.4758108063826415,0.37872142366026806,GAS1/KBTBD2,2
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/73,166/21728,0.4292409567646537,0.4758108063826415,0.37872142366026806,GAS1,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/73,166/21728,0.4292409567646537,0.4758108063826415,0.37872142366026806,DLC1,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,1/73,166/21728,0.4292409567646537,0.4758108063826415,0.37872142366026806,NT5E,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/73,434/21728,0.4298797195296499,0.47622362981351546,0.37905001030723706,GADD45A/LMO2,2
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1/73,167/21728,0.43117331044966367,0.47706551923514773,0.3797201118603083,TNPO1,1
SERVITJA_LIVER_HNF1A_TARGETS_DN,SERVITJA_LIVER_HNF1A_TARGETS_DN,1/73,167/21728,0.43117331044966367,0.47706551923514773,0.3797201118603083,IL1RAP,1
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,1/73,168/21728,0.43309921130478046,0.4777183157390176,0.3802397049800728,TRIB2,1
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,1/73,168/21728,0.43309921130478046,0.4777183157390176,0.3802397049800728,IDH3B,1
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,1/73,168/21728,0.43309921130478046,0.4777183157390176,0.3802397049800728,TRIB2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/73,168/21728,0.43309921130478046,0.4777183157390176,0.3802397049800728,DUSP6,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/73,168/21728,0.43309921130478046,0.4777183157390176,0.3802397049800728,GADD45A,1
DARWICHE_PAPILLOMA_RISK_LOW_DN,DARWICHE_PAPILLOMA_RISK_LOW_DN,1/73,169/21728,0.4350186805800471,0.47894913847113557,0.3812193778482134,TYRO3,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/73,169/21728,0.4350186805800471,0.47894913847113557,0.3812193778482134,IL1RAP,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/73,169/21728,0.4350186805800471,0.47894913847113557,0.3812193778482134,POSTN,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,2/73,440/21728,0.4367881974148985,0.4795788521474768,0.38172059820051135,TNPO1/BAG5,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/73,170/21728,0.43693173945650987,0.4795788521474768,0.38172059820051135,IDH3B,1
LIN_NPAS4_TARGETS_UP,LIN_NPAS4_TARGETS_UP,1/73,170/21728,0.43693173945650987,0.4795788521474768,0.38172059820051135,EPAS1,1
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,1/73,170/21728,0.43693173945650987,0.4795788521474768,0.38172059820051135,DUSP6,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/73,170/21728,0.43693173945650987,0.4795788521474768,0.38172059820051135,RAB5A,1
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1/73,172/21728,0.4407387103935464,0.48346062219856506,0.38481029154154,NCBP2,1
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,1/73,173/21728,0.4426326644732117,0.4843495740992059,0.3855178524562148,ETV5,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1/73,173/21728,0.4426326644732117,0.4843495740992059,0.3855178524562148,FNDC3A,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,1/73,173/21728,0.4426326644732117,0.4843495740992059,0.3855178524562148,VAV3,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/73,173/21728,0.4426326644732117,0.4843495740992059,0.3855178524562148,DUSP6,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/73,175/21728,0.4464016143913554,0.4875785501110222,0.38808795463917467,TRIB2,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1/73,175/21728,0.4464016143913554,0.4875785501110222,0.38808795463917467,BICD1,1
VILLANUEVA_LIVER_CANCER_KRT19_UP,VILLANUEVA_LIVER_CANCER_KRT19_UP,1/73,175/21728,0.4464016143913554,0.4875785501110222,0.38808795463917467,PTPRA,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,1/73,176/21728,0.4482766518408722,0.48932762728417545,0.3894801319252356,ANKRD10,1
BAKKER_FOXO3_TARGETS_DN,BAKKER_FOXO3_TARGETS_DN,1/73,177/21728,0.4501454252454571,0.4907683050846813,0.39062683885228366,ETV5,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/73,177/21728,0.4501454252454571,0.4907683050846813,0.39062683885228366,TNPO1,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,2/73,453/21728,0.4516042045888268,0.49189910162679723,0.3915268959139466,HRH1/ARID5B,2
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/73,178/21728,0.4520079552420737,0.49189910162679723,0.3915268959139466,HRH1,1
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,1/73,178/21728,0.4520079552420737,0.49189910162679723,0.3915268959139466,IDH3B,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,2/73,454/21728,0.45273504749995586,0.4923906720984921,0.39191816123699597,MACF1/KLHL4,2
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1/73,179/21728,0.45386426240065036,0.4927196728429647,0.392180029249787,PIPOX,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/73,179/21728,0.45386426240065036,0.4927196728429647,0.392180029249787,PGPEP1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1/73,179/21728,0.45386426240065036,0.4927196728429647,0.392180029249787,NCBP2,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,2/73,456/21728,0.4549928709155313,0.4936451779107828,0.3929166846434583,LMO2/PGPEP1,2
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1/73,182/21728,0.4593960515464198,0.4969147853387772,0.3955191273860984,TYRO3,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1/73,182/21728,0.4593960515464198,0.4969147853387772,0.3955191273860984,TYRO3,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,1/73,182/21728,0.4593960515464198,0.4969147853387772,0.3955191273860984,GADD45A,1
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,1/73,182/21728,0.4593960515464198,0.4969147853387772,0.3955191273860984,PPARGC1A,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/73,182/21728,0.4593960515464198,0.4969147853387772,0.3955191273860984,GADD45A,1
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,1/73,183/21728,0.4612276717189394,0.4985943633817797,0.39685598686692936,POSTN,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,2/73,463/21728,0.46285426645846495,0.499963206267035,0.3979455168215185,FZD3/HRH1,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,1/73,184/21728,0.46305317090503917,0.499963206267035,0.3979455168215185,ARID5B,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/73,185/21728,0.4648725692769262,0.5013221675917636,0.39902718155190414,DLC1,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1/73,185/21728,0.4648725692769262,0.5013221675917636,0.39902718155190414,LMO2,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/73,186/21728,0.4666858869412619,0.5023686729987816,0.39986014711783396,TRIB2,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/73,186/21728,0.4666858869412619,0.5023686729987816,0.39986014711783396,VAV3,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/73,186/21728,0.4666858869412619,0.5023686729987816,0.39986014711783396,GADD45A,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/73,187/21728,0.4684931439393718,0.5037076015415495,0.4009258667633197,OTUD4,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/73,187/21728,0.4684931439393718,0.5037076015415495,0.4009258667633197,PIPOX,1
REACTOME_MRNA_SPLICING,REACTOME_MRNA_SPLICING,1/73,188/21728,0.4702943602474552,0.5050368264999698,0.4019838628446717,NCBP2,1
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,1/73,188/21728,0.4702943602474552,0.5050368264999698,0.4019838628446717,SPRY4,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/73,189/21728,0.47208955577679323,0.5060528331708072,0.4027925529535683,TYRO3,1
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,1/73,189/21728,0.47208955577679323,0.5060528331708072,0.4027925529535683,VAV3,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/73,189/21728,0.47208955577679323,0.5060528331708072,0.4027925529535683,NT5E,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,2/73,472/21728,0.47286640139883507,0.5065818608155286,0.4032136322987133,ARL4A/DLC1,2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/73,191/21728,0.47566196382101245,0.5092716115640541,0.40535453834605034,ADAM19,1
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,1/73,192/21728,0.4774392158357347,0.5108685325639101,0.40662560698599215,CHST2,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/73,193/21728,0.4792105260718039,0.511844934657339,0.4074027738471225,ARL4A,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1/73,193/21728,0.4792105260718039,0.511844934657339,0.4074027738471225,RASSF2,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/73,193/21728,0.4792105260718039,0.511844934657339,0.4074027738471225,IRS2,1
KONDO_PROSTATE_CANCER_WITH_H3K27ME3,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1/73,194/21728,0.4809759141190181,0.5125059204081075,0.4079288851947258,POSTN,1
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1/73,194/21728,0.4809759141190181,0.5125059204081075,0.4079288851947258,BAG5,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/73,194/21728,0.4809759141190181,0.5125059204081075,0.4079288851947258,GLG1,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/73,194/21728,0.4809759141190181,0.5125059204081075,0.4079288851947258,TMEM158,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/73,195/21728,0.4827353995034941,0.5140743861299866,0.40917730486738596,GAS1,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,1/73,199/21728,0.48971470271897244,0.5208863108039993,0.4145992536247539,ELOVL2,1
XU_GH1_AUTOCRINE_TARGETS_UP,XU_GH1_AUTOCRINE_TARGETS_UP,1/73,199/21728,0.48971470271897244,0.5208863108039993,0.4145992536247539,CHST7,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/73,200/21728,0.49144496546696426,0.5224159323751082,0.41581675531093043,ARID5B,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/73,201/21728,0.4931694413830229,0.5239375883498781,0.4170279167838427,ARL4A,1
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,1/73,202/21728,0.4948881495531835,0.5245169006526924,0.41748902018276235,NT5E,1
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,1/73,202/21728,0.4948881495531835,0.5245169006526924,0.41748902018276235,TNPO1,1
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,1/73,202/21728,0.4948881495531835,0.5245169006526924,0.41748902018276235,ARID5B,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/73,202/21728,0.4948881495531835,0.5245169006526924,0.41748902018276235,FNDC3A,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,2/73,493/21728,0.4957970631973275,0.5250873937874208,0.41794310396832274,ELOVL2/HRH1,2
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1/73,203/21728,0.4966011090014142,0.5250873937874208,0.41794310396832274,VAV3,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/73,203/21728,0.4966011090014142,0.5250873937874208,0.41794310396832274,ADAM19,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/73,203/21728,0.4966011090014142,0.5250873937874208,0.41794310396832274,BICD1,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1/73,204/21728,0.49830833868981783,0.5265811522325026,0.4191320604134836,ADAM19,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,1/73,205/21728,0.5000098575188294,0.527755386802637,0.4200666919564142,POFUT1,1
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1/73,205/21728,0.5000098575188294,0.527755386802637,0.4200666919564142,CHRNA9,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/73,206/21728,0.5017056843274122,0.5292328988657304,0.4212427171002399,MACF1,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/73,207/21728,0.5033958378932566,0.5303899576624295,0.4221636775930794,CHST2,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/73,207/21728,0.5033958378932566,0.5303899576624295,0.4221636775930794,PPARGC1A,1
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,1/73,209/21728,0.5067592001023014,0.5336192283762748,0.42473401434400315,NCBP2,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1/73,210/21728,0.5084324459962803,0.53506604675771,0.4258856088640197,ADAMTS9,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/73,211/21728,0.510100093149467,0.5358748334613672,0.42652936232177585,EPAS1,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/73,211/21728,0.510100093149467,0.5358748334613672,0.42652936232177585,RAB5A,1
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,1/73,211/21728,0.510100093149467,0.5358748334613672,0.42652936232177585,KBTBD2,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/73,214/21728,0.5150696266065206,0.5407777406767227,0.4304318293859231,LAMA2,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/73,215/21728,0.5167150629390356,0.5421869322388472,0.4315534748539511,CHST2,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,1/73,216/21728,0.5183549923029294,0.5435886957405499,0.4326692079602164,VAV3,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/73,217/21728,0.5199894328738611,0.5449830632933551,0.43377905426387375,DLC1,1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,1/73,218/21728,0.5216184027683435,0.5463700668715865,0.434883039214874,NCBP2,1
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,1/73,219/21728,0.523241920043932,0.5474292293964602,0.4357260792087685,GADD45A,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/73,219/21728,0.523241920043932,0.5474292293964602,0.4357260792087685,ACSL3,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/73,223/21728,0.5296818220555627,0.5538427472721321,0.4408309162321457,LAMA2,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/73,224/21728,0.5312783450497476,0.5545392183006123,0.4413852720725466,PIPOX,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/73,224/21728,0.5312783450497476,0.5545392183006123,0.4413852720725466,DLC1,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/73,224/21728,0.5312783450497476,0.5545392183006123,0.4413852720725466,CHST2,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/73,227/21728,0.536035911568751,0.5591786522082419,0.44507802766133464,MARK2,1
COLDREN_GEFITINIB_RESISTANCE_DN,COLDREN_GEFITINIB_RESISTANCE_DN,1/73,230/21728,0.5407458432388673,0.5634344800181205,0.4484654521279282,VAV3,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,1/73,230/21728,0.5407458432388673,0.5634344800181205,0.4484654521279282,GADD45A,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/73,234/21728,0.5469524658245143,0.5695696033163841,0.4533487010972279,NCBP2,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1/73,235/21728,0.5484911496430129,0.5708394502687468,0.4543594352780794,POSTN,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/73,236/21728,0.5500246789816843,0.5714376095405296,0.4548355399145155,ARL4A,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/73,236/21728,0.5500246789816843,0.5714376095405296,0.4548355399145155,BAG5,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/73,236/21728,0.5500246789816843,0.5714376095405296,0.4548355399145155,TNPO1,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,1/73,237/21728,0.5515530708686347,0.5723603544475443,0.455569998359284,OTUD4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1/73,237/21728,0.5515530708686347,0.5723603544475443,0.455569998359284,LMO2,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/73,238/21728,0.5530763422765073,0.5736081786487209,0.4565632035400158,ARMC7,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/73,239/21728,0.5545945101226595,0.5748492661445306,0.45755104664276774,ETV4,1
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1/73,242/21728,0.5591185606388134,0.5792027731298948,0.46101621881056026,NCBP2,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/73,243/21728,0.5606164823121527,0.5800823323924358,0.46171630365864424,DUSP6,1
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,1/73,243/21728,0.5606164823121527,0.5800823323924358,0.46171630365864424,NT5E,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/73,245/21728,0.563597282854121,0.5828293474512252,0.46390278921114825,POFUT1,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/73,246/21728,0.5650801948474018,0.5840250799925748,0.46485453205578775,ADAMTS9,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/73,247/21728,0.5665581366487302,0.5852142971276312,0.4658010889653582,ARID5B,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1/73,250/21728,0.5709623049105934,0.5894229798961553,0.46915098835488167,CHRNA9,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,1/73,254/21728,0.5767659370871385,0.5950706840806715,0.4736462762728528,RASSF2,1
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1/73,258/21728,0.582492124062049,0.6006320171989294,0.4780728171747041,HRH1,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/73,259/21728,0.5839116897324481,0.601748761522546,0.4789616893785954,FGFR3,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/73,265/21728,0.5923296571042413,0.6100722505198062,0.485586767162827,FEM1C,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1/73,266/21728,0.5937162263178362,0.6107966701129407,0.48616336865224064,EPAS1,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/73,266/21728,0.5937162263178362,0.6107966701129407,0.48616336865224064,ARID5B,1
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,1/73,267/21728,0.5950981439153946,0.611866291731297,0.48701473355746705,SHROOM2,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/73,268/21728,0.5964754252859822,0.61292991977663,0.48786132788060976,DUSP6,1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1/73,270/21728,0.5992161406516815,0.6153925671942598,0.48982147112129953,CHRNA9,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/73,271/21728,0.6005796051745831,0.6164387681126031,0.49065419432958873,GRB10,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,1/73,272/21728,0.6019384945264151,0.6174790752801091,0.4914822264092237,ARID5B,1
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,1/73,274/21728,0.6046426082262253,0.6198973529291805,0.49340705355013065,SCRN1,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,1/73,276/21728,0.6073286022768245,0.6222942927627291,0.4953148968651888,FGFR3,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1/73,279/21728,0.611323880729226,0.6260292661763208,0.49828774748050497,ETV4,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1/73,280/21728,0.6126467096120068,0.6270247949549331,0.4990801382191627,VAV3,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,1/73,284/21728,0.617893765123125,0.6320332105492834,0.5030665846359539,CHRNA9,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/73,285/21728,0.6191945371407529,0.6330016194440631,0.503837389313772,IRS2,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1/73,292/21728,0.6281784535768247,0.6418188999973501,0.5108555002922508,GADD45A,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/73,293/21728,0.6294446866841628,0.6427453453976488,0.5115929041431893,DLC1,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/73,296/21728,0.6332179227122906,0.6458606079917716,0.5140724961761893,CHST2,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,1/73,296/21728,0.6332179227122906,0.6458606079917716,0.5140724961761893,PGGT1B,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/73,308/21728,0.6479355979171515,0.6604953529508932,0.5257210156538371,RBCK1,1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,1/73,311/21728,0.6515230494395551,0.6637739101982475,0.5283305820016665,GADD45A,1
SHEN_SMARCA2_TARGETS_DN,SHEN_SMARCA2_TARGETS_DN,1/73,322/21728,0.6643712363790064,0.6764782292970749,0.538442579777255,LZTS1,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1/73,324/21728,0.666656548245328,0.6784188436326958,0.5399872109922317,TMEM158,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/73,325/21728,0.6677934419090401,0.6791892344330852,0.5406004032459267,ACSL3,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,1/73,327/21728,0.6700557683441928,0.6811027366682301,0.5421234545952237,RASSF2,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/73,329/21728,0.672302897966714,0.6829986258889118,0.5436324868726061,FZD3,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/73,331/21728,0.674534931450329,0.6848770343175401,0.5451276053204487,HRH1,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/73,334/21728,0.6778548950218117,0.687857294153802,0.5474997419615804,ARMC7,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,1/73,341/21728,0.6854721345697437,0.6951923860525817,0.5533381054651422,VAV3,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,1/73,343/21728,0.6876156688376042,0.6969709840598846,0.5547537798475002,PDGFA,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1/73,345/21728,0.689744793505165,0.6987329692845524,0.5561562312920729,ALK,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/73,347/21728,0.6918596041024438,0.7004784666677064,0.5575455592456959,PPARGC1A,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1/73,350/21728,0.6950051885527183,0.7032650125253312,0.5597635093219403,ALK,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1/73,354/21728,0.6991500825006749,0.7070590200855241,0.5627833481429582,RAB5A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/73,366/21728,0.7112542856280681,0.7188935345975047,0.5722030253007337,GADD45A,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,1/73,368/21728,0.7132244113987245,0.7204775410061692,0.5734638145769108,DUSP6,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,1/73,369/21728,0.7142044965095808,0.721060214432033,0.573927593260396,DPY19L1,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/73,384/21728,0.7285154010491737,0.7350934182144033,0.5850973162756818,POSTN,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1/73,398/21728,0.7412334263751362,0.7475044367505604,0.5949758615841032,HRH1,1
REACTOME_M_PHASE,REACTOME_M_PHASE,1/73,415/21728,0.7558888304144378,0.7618541312181594,0.6063974952354595,TNPO1,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/73,416/21728,0.756724945244811,0.7622671561113927,0.606726242236314,TMEM158,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/73,419/21728,0.759216379074819,0.7643462194739732,0.6083810718996889,TYRO3,1
MOOTHA_PGC,MOOTHA_PGC,1/73,421/21728,0.7608633364665587,0.765573238943279,0.6093577175622944,DUSP6,1
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,1/73,432/21728,0.7697249480812358,0.7740541097689818,0.6161080633507967,ACSL3,1
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,1/73,437/21728,0.7736451173372322,0.7775590049460208,0.6188977832844815,GRB10,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/73,449/21728,0.7827869793783453,0.7863051231058884,0.6258592525839874,SPRED2,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/73,452/21728,0.7850149442959884,0.7881003483443163,0.6272881614044009,PPARGC1A,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/73,454/21728,0.7864877167137874,0.788693234707937,0.6277600690716654,VAV3,1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1/73,454/21728,0.7864877167137874,0.788693234707937,0.6277600690716654,IDH3B,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/73,458/21728,0.7894034716612841,0.7911734346022286,0.6297341831992306,GLG1,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/73,459/21728,0.7901262524120471,0.7914541956934119,0.6299576548790139,IL1RAP,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/73,467/21728,0.7958210976781721,0.796712274719245,0.6341428208056159,BICD1,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,1/73,474/21728,0.8006788776583149,0.8011269352283531,0.6376566680965109,TRIO,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,1/73,483/21728,0.8067574125947656,0.8067574125947656,0.6421382443354074,GADD45A,1
